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ACSSuT Ampicillin, chloramphenicol, streptomycin, sulfonamides and tetracyclin 
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aw Water activity 
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Salmonella are zoonotic pathogens that cause food-borne illness and that are widely 
disseminated in nature. An estimated number of 93.8 million human cases of gastroenteritis 
caused by Salmonella occur annually throughout the world. The epidemiology of Salmonella 
is characterized by a temporal dominance of certain clones. These epidemically successful 
clones are often resistant to antibiotics and associated with severe human illness. They pose a 
major threat to public health and lead to heavy economic losses. So far, little is known about 
the environmental and bacterial factors leading to the emergence of successful clones. 
However, resistance to multiple antimicrobial drugs and quinolones seems to contribute to the 
epidemic success of Salmonella as it is associated with an increased severity of illness and 
epidemicity. In order to predict and prevent future outbreaks and epidemics, research should 
focus on the evolutionary mechanisms of emerging success clones.  
The ability to spread in different food production sectors and to cause human disease seems 
critical for a clone to become successful. The aim of this PhD study was to identify common 
phenotypic and genetic traits of success clones that may have an epidemic importance with 
respect to the survival in the food chain and to human infection. Non-typhoid Salmonella 
isolates from food, production animals and humans were carefully selected and characterized 
as successful or non successful based on epidemiological data. In addition, the isolates were 
categorized based on their antibiotic resistance pattern into quinolone resistant (Q; at least low 
level resistance to one fluoroquinolone), multidrug resistant (MR; resistant to four or more 
antibiotic agents), resistant (R; resistant to less than four antibiotic agents) and sensitive (S; 
fully susceptible to the tested antibiotics). 
The ability to survive and grow after physical stress experienced in the food chain is likely to 
contribute to a successful spread of Salmonella. Thus, the response of Salmonella isolates in 
exponential and stationary growth state to freezing in minced meat and to drying at two 
combinations of temperature and humidity was investigated. The results of this study are 
presented in Manuscript I. Stationary phase cells survived freezing for up to one year 
without major decline and initiated growth with a short lag time of 1.7 hours on average. 
Exponential phase cells showed reduced survival and a tendency to exhibit shorter lag times. 
Dehydration at 82 % relative humidity (RH) and 10 ˚C was less harmful for Salmonella than 
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49 % RH and 25 °C. Dehydration, in contrast to freezing, was differently tolerated by the 
Salmonella isolates but neither the tolerance to freezing nor to dehydration appears to 
contribute to the epidemic success of Salmonella. 
MR and Q Salmonella seem to have a virulence or fitness advantage apart from the effect 
posed by the antibiotic resistance phenotype. Manuscript II describes a study aiming to 
identify genes and genetic structures in Q and MR isolates that might confer fitness or 
virulence attributes by the use of array-based comparative genomic hybridizations and PCR 
screenings. The largest fraction of the genes dominating in Q and MR Salmonella were single 
genes and gene clusters belonging to prophages, among these the virulence genes sopE 
(STY4609) and gipA (STM2599) and the genes recT (SG1183), sugR (STM3753) and trhH 
(AF261825_S012). The latter three genes were knocked out and the mutants were used in 
functional analyses. The mutants were not significantly different from the wildtype but RecT 
knockout mutants seemed to be more susceptible to the early defense of macrophages and 
exhibited increased spontaneous mutation rates. The largest group of genes dominating in 
sensitive isolates were related to metabolism indicating that many of these genes are typically 
absent or diverged in Q and MR Salmonella. The acquisition and maintenance of 
bacteriophages conferring fitness and virulence attributes may be part of the evolution of 
successful MR and Q Salmonella. 
The bacterial and host factors leading to an increased severity of illness caused by quinolone 
resistant Salmonella were investigated as they are largely unknown. Quinolone resistance is 
mostly caused by point mutations and can develop in Salmonella during infection. As 
described in Manuscript III, the spontaneous mutations rates and virulence potential of 
ciprofloxacin (CIP) resistant Salmonella in presence and absence of CIP were assessed using 
cell cultures. The rate at which CIP sensitive isolates can experience a reduction in their CIP 
susceptibility after macrophage infection and in presence and absence of CIP was 
investigated. Strain dependent differences in the mutation rate, the ability to invade intestinal 
epithelial cells and to replicate within macrophages were found, but there was no correlation 
between virulence, mutation rate and resistance pattern. The presence of clinically relevant 
CIP concentrations decreased but failed to eliminate the number of CIP resistant 
intraphagocytic Salmonella. During macrophage infection, Salmonella adapted to higher CIP 
concentrations (to at least 2 – 8 fold the initial MIC). When CIP was added to the extracellular 
medium, the frequency of intraphagocytic bacteria exhibiting reduced CIP susceptibilities 
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increased markedly. Thus virulent Salmonella strains that are likely to persist in macrophages 
for prolonged times might become resistant to quinolones and the administration of 
quinolones may increase the rate of resistant mutants.  
In conclusion, the emergence of successful clones is likely to be the result of a combination of 
factors including the acquisition and maintenance of bacteriophages encoding genes that 
increase the fitness or virulence of their bacterial host. Marker genes related to bacteriophages 
might be useful in the future for the early detection of these clones. Macrophages might play a 
role in the evolution of quinolone resistance in invasive Salmonella strains. Both in absence of 
antimicrobial drugs and when quinolones are administered, intraphagocytic Salmonella may 
become quinolone resistant and simultaneously may acquire other advantageous mutations. 
This highlights the importance of an antibiotic therapy that is effective in eliminating 





Salmonella er zoonotiske patogener, der kan forårsage fødevarebårne sygdomme, og som er 
meget udbredte i naturen. Det anslåes, at der årligt er 93,8 millioner humane tilfælde af  
gastroenteritis (mave-tarm-katar) på verdensplan. Salmonellaepidemiologi er karakteriseret 
ved en temporal (tidsmæssig) dominans af bestemte kloner. Disse epidemiologisk succesfulde 
kloner er ofte resistente over for antibiotika og er associeret med alvorlig sygdom hos 
mennesker. De udgør en stor trussel mod folkesundhed og kan føre til massive økonomiske 
tab. Indtil videre vides meget lidt om de miljømæssige og bakterielle faktorer,  der fører til 
fremkomsten af succesfulde kloner. Kloner der er resistente overfor adskillige antimikrobielle 
stoffer eller er  og resistente overfor quinoloner menes at bidragei særlig grad til Salmonellas 
epidemiologiske succes, idet disse kloner oftere er associeret med alvorlig sygdom og evne til 
at spredes. For at kunne forudsige og forebygge fremtidige udbrud og epidemier bør 
forskningen fokusere på de evolutionære mekanismer, der ligger bag fremkomsten af nye 
succeskloner. 
Evnen til at sprede sig i forskellige fødevareproduktionssektorer og  til at forårsage sygdom 
hos mennesker ser ud til at have afgørende betydning  for at kloner kan blive succefulde. 
Formålet med dette Ph.d-studium var at idetificere fælles fænotypiske og genetiske 
karaktertræk hos succeskloner, der kunne være af epidemisk betydning  i forhold til 
overlevelse i fødevareproduktionskæden og til infektion hos mennesker. Non-typhoidal 
Salmonella - isolater fra fødevarer, produktionsdyr og mennesker blev omhyggeligt udvalgt 
og karakteriseret som succesfulde eller ikke-succesfulde på baggrund af epidemiologiske data. 
Derudover blev isolaterne kategoriseret efter antibiotikaresistensmønster; quinoloneresistens 
(Q;  inklusiv lav resistens mod en fluoroquinolone), multiresistens (MR; resistens mod fire 
eller flere antimikrobielle stoffer), reistens (R; resistens mod færre end fire antimikrobielle 
stoffer) og følsom (S; følsom overfor alle testede antimikrobielle stoffer). 
Evnen til at overleve og vokse efter fysisk stress i fødevareproduktionskæden bidrager 
sandsynligvis til en succesfuld spredning af Salmonella. Derfor blev det undersøgt, hvordan 
Salmonella-isolater i eksponentiel og stationær vækst responderer på frysning i hakket kød og 
på udtørring ved flere kombinationer af temparatur og fugtighed. Resultaterne af dette forsøg 
er præsenteret i Manuskript I. Celler i stationærfase overlevede frysning i op til et år uden 
større reduktion i antallet af levedygtige cellerog de initierede vækst med en kort latenstid på 
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1,7 time i gennemsnit. Celler i eksponentiel fase viste reduceret overlevelse og en tendens til 
kortere latenstid . Dehydrering ved  82% relativ fugtighed (RH) og 10 ˚C var mindre skadelig 
for Salmonella end ved 49% RH og 25 ˚C. Dehydrering blevr i modsætning til frysning 
tolereret forskelligt af Salmonella-isolater, men hverken tolerance overfor frysning eller 
dehydrering  ser ud til at bidrage til Salmonellas epidemiske succes. 
MR og Q  Salmonella menes at have en virulens- eller fitness-fordel ud over effekten af 
antibiotikaresistens-fænotypen. Manuskript II beskriver et studie, der har til formål  at 
identificere gener og genetiske strukturer i Q og MR isolater, der kan give fitness- eller 
virulensegenskaber ved brug af array-baseret komparativ genomisk hybridisering og PCR 
screeninger. Den største fraktion af generne, der dominerede i Q og MR Salmonella var 
enkelte gener og genklynger tilhørende profager, heriblandt virulensgenerne sopE (STY4609) 
og gipA (STM2599) samt generne recT (SG1183), sugR (STM3753) og trhH 
(AF261825_S012). De tre sidstnævnte gener blev inaktiverede og mutanterne blev anvendt i 
funktions analyser. Mutanterne var ikke betydeligt forskellige fra vildtypen, men RecT 
mutanten så ud til at være mere følsom overfor det tidlige forsvar af makrofager og RecT så 
ud til også at spille en mindre rolle i hæmning af spontane mutationer. Den største gruppe af 
gener, der dominerede i sensitive isolater, var relateret til metabolisme, hvilket indikerer at 
mange af disse gener typisk er manglende  eller divergeret  i Q og MR Salmonella. 
Optagelsee og integrering af bacteriofager, der giver fitness- og virulens-egenskaber kan være 
en del af evolutionen af succesfulde MR og Q Salmonella. 
De værtsfaktorer og bakterielle faktorer, der fører til mere alvorlig sygdom og som forårsages 
af Q Salmonella, er for en stor del ukendte og blev derfor undersøgt. Quinoloneresistens 
skyldes hovedsaglig punktmutationer, som kan udvikles i Salmonella under infektion. Som 
beskrevet i Manuskript III blev den spontane mutationsrate og virulenspotentialet af 
cipofloxacin-resistent  Salmonella med og uden tilstedeværelsen af cipofloxacin  (CIP) målt 
ved brug af cellekulturer. Det blev også undersøgt, om CIP-følsomme isolater kan opleve en 
reduktion i følsomhed til CIP  under makrofag-infektion og efterfølgende udsættelse for CIP. 
Stammeafhængige forskelle i mutationsrate samt evnen til at invadere tarm-epitelceller og til 
at replikere i makrofager blev påvist, men der var ingen korrelation mellem virulens, 
mutationsrate og resistensmønster. Ved klinisk relevante CIP-koncentrationer faldt antalet af 
CIP-reistente intrafagocytotiske Salmonella, uden at de blev helt elimineret. Ved 
makrofaginfektion tilpassede Salmonella sig højere CIP-koncentrationer (mindst 2-8 gange 
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den oprindelige MIC). Når CIP blev tilsat til det ekstracellulære medium,  steg frekvensen 
markant af intrafagocytisk bakterier, der udviste reduceret CIP-følsomhed. Virulente 
Salmonella-stammer, der med høj sandsynlighed eksisterer i makrofager i længere tidsrum, 
kan således blive resistente overfor quinoloner uden tilstedeværelse af quinoloner, men  især 
når værten behandes med disse antibiotika. 
Det blev konkluderet, at fremkomsten af succefulde kloner formentlig skyldes en kombination 
af faktorer, herunder optagelse og integrering af bateriofag-kodende gener, som øger deres 
bakterieværts fitness og virulens. Markørgener for bakterofager kan muligvis anvendes i 
fremtiden til tidlig dektion af disse kloner. Makrofager spiller muligvis en rolle i evolutionen 
af quinoloneresistens i invasive Salmonella-stammer. Idet intrafagocytiske Salmonella 
udvikler reduceret følsomhed overfor quinoloner. Dette øges yderligere ved tilstedeværelse af 
fluoroquinolon og muligvis kan intrafagocystiske Salmonella blive quinoloneresistente og 
samtidig tilegne sig andre fordelagtige mutationer. Dette understregervigtigheden af 








Salmonella can cause zoonotic diseases and are widely disseminated in nature (4). It is a 
pathogen of global importance as it is one of the major causes of food-borne illness 
worldwide (150). This thesis has focused on non-typhoid Salmonella enterica ssp. enterica 
(NTS) that normally cause a localized self-limiting gastroenteritis in humans which does not 
require antibiotic therapy. However, a systemic infection can occur depending on the host 
immune status, the infectious dose and the pathogenic potential of the individual Salmonella 
strain. In these cases, antimicrobial therapy is necessary (56).  
The population structure of Salmonella is clonal and the epidemiology of NTS is 
characterized by the temporal dominance of certain successful clones (137). Their occurrence 
and spread is usually followed by a decline and by the replacement with another clone (123). 
These epidemically successful clones are often resistant to antibiotics and associated with 
severe human illness (245). The pentaresistant (ACSSuT) S. Typhimurium DT104 clone is a 
prominent example of a success clone because of its global dissemination in the 1990s. 
Research should primarily focus on these clones because they pose an important public health 
threat and lead to heavy economic losses.  
So far, little is known about the environmental and bacterial factors that lead to the emergence 
of successful Salmonella clones. These bacteria might be equipped with an increased 
virulence potential and/or might be fitter in surviving in the environment. Transmission of 
Salmonella from animals or the environment to humans usually occurs through the food 
production chain in form of contaminated foods. Not only the bacterial factors, also the food 
source plays an important role in the occurrence of outbreaks as some foods are more often 
associated with human disease. Denmark has established a comprehensive Salmonella 
surveillance program and monitors the prevalence of Salmonella in food animals, food 
products and humans. Some Salmonella subtypes seem to appear more often in food animals 
and food products and others in humans. Factors that cause a decrease or increase of these 
subtypes during this route of transmission are not well known. An understanding of these 
factors might help to elucidate mechanisms leading to the emergence of epidemically 






A success clone may be identified as a leading pathogen after it has been discovered 
repeatedly over time by the surveillance systems (110). Similar to early warning systems, it 
will be a future challenge to predict and prevent the emergence of success clones before their 
wide dissemination. Three steps are important in this respect: First to recognize a clonal 
outbreak or epidemic in a very early stage, second to assess the potential danger of the clone 
in terms of spread and pathogenicity and third to implement effective intervention strategies. 
Before this can be realized, we require a lot of knowledge about genetic and phenotypic 
characteristics of successful Salmonella clones and about factors that influence their 
evolution. For instance, the identification of critical points in the food chain or during 
infection that promote the evolution of success clones, could help to guide food safety 




Salmonella isolates from recent years and various sources (animal, food and human) were 
collected with a focus on isolates from pigs, pork and humans and with a special emphasis on 
the serovar S. Typhimurium. S. Typhimurium is one of most common serovars in humans and 
in the pork production chain and pork contributes significantly to the public health burden of 
Salmonella. Each isolate was characterized as successful or non-successful. In this thesis, 
either one of two criteria was used to define bacterial success:  
1. q-factor: This factor illustrates the relative ability of Salmonella subtypes to survive 
the food production chain and to cause human disease. It has been calculated by Hald 
et al. (104) using a mathematical model based on data from the Danish Salmonella 
Surveillance program. It varies among different Salmonella serovars and seems to 
increase in antimicrobial resistant strains. This factor has been used in this thesis to 
rank Salmonella isolates according to their epidemic success.   
2. Antimicrobial resistance pattern: Multidrug and quinolone resistant Salmonella are 
frequently isolated from human outbreaks or epidemics. Moreover, they are associated 
with an increased severity of illness in humans. Thus, the drug resistance pattern of 
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Salmonella can be used as an indicator for bacterial success. In this study, Salmonella 
isolates were therefore categorized based on their resistance pattern into quinolone 
resistant (Q; at least low level resistance to fluoroquinolones), multidrug resistant 
(MR; resistant to four or more antimicrobial agents), resistant (R; resistant to less than 
four antimicrobial agents) and sensitive (S; fully susceptible to the tested antimicrobial 
agents). 
The categorized isolates were subsequently used in phenotypic and genetic screenings 




The overall objective of this study was to determine common genetic and phenotypic features 
of Salmonella isolates that were characterized as successful and non-successful based on the 
above mentioned criteria. These features may be of importance for clonal success and may 
help in the future to assess the potential danger of certain clones and to implement targeted 
interventions programs. This was achieved by accomplishing different studies with focus on 
the following objectives: 
1. To analyze the tolerance of successful versus non-successful Salmonella subtypes to 
typical stress conditions that they are likely to experience in the food chain.  
2. To identify specific genes or genetic patterns that are characteristic for multidrug and 
quinolone resistant Salmonella. 
3. To determine the virulence potential and mutation frequencies of quinolone resistant 
Salmonella as well as the rate of occurrence of reduced quinolone susceptibilities 






1. Taxonomy and typing of Salmonella 
 
The genus Salmonella belongs to the family of Enterobacteriaceae. Salmonella are gram-
negative, facultative anaerobe bacteria that diverged from E. coli ca. 100 – 160 million years 
ago and acquired the ability to invade host cells (60,170). Based on DNA relatedness, 
Salmonella is today divided into the two species S. enterica and S. bongori. S. enterica 
comprises over 2500 known serovars and each year new serovars are discovered. S. enterica, 
that has diverged from S. bongori ca. 71 – 100 million years ago, is further divided into six 
subspecies, shown in Figure 1. The majority of the bacteria causing disease in humans and 
warm blooded animals fall into subspecies enterica (I).  
The serovars are classified by the Kauffmann-White scheme (186) on the basis of surface 
agglutination reactions of their O-, H- and Vi-antigens (Vi-antigens are only found in 
S. Typhi, S. Paratyphi and S. Dublin). S. Typhimurium and S. Enteritidis may be subdivided 
into phagetypes based on their lysis pattern after infection with a defined panel of 
bacteriophages (173). This is still the primary method for subtyping of Salmonella and often 
used in combination with antimicrobial susceptibility testing. However, this typing method 
has some limitations. Phagetypes are not always very stable and have been shown to change 
for example upon introduction of plasmids (39,139). Moreover, pure cultures from some 
serovars have shown variable expressions of minor O-antigens (114). Thus, apparently 
unrelated Salmonella can have a close phylogenetic relationship. Most of the human 
infections are caused by only view phagetypes of the two serovars S. Enteritidis and S. 
Typhimurium. To distinguish variants with small differences in these phagetypes, a high 
discriminatory power is needed which is provided by many molecular typing methods. The 
most frequently used methods are pulse field gel electrophoresis (PFGE), multi locus 
sequence typing (MLST) and multi locus variable number tandem repeat analysis (MLVA). It 
is suggested to use a combination of conventional and appropriate molecular typing methods 
to identify sources of human illness and to monitor the spread of successful clones in national 
or international outbreaks and epidemics (82). 
For simplicity, the Salmonella strains mentioned in this thesis are abbreviated by S. followed 
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Figure 1:  Taxonomic scheme of Salmonella serovars and phagetypes with relevance for this thesis (4). 
 
2. Epidemiology of Salmonella  
 
2.1. Incidence of human salmonellosis 
An expected number of 93.8 million human cases of gastroenteritis caused by Salmonella 
occur annually throughout the world of which 80.3 million cases are estimated to be 
foodborne and of which 155000 infections result in death (150). Thus, human salmonellosis is 
a global public health problem and is of economic significance in many countries.  
Important global epidemiological facts of human salmonellosis are listed below: 
The age group that is most affected by salmonellosis are small children of 0 – 4 years 
(112.4 per 100,000 population in the EU in 2009) (74).  
Most cases of enteric fever, caused by S. Typhi and S. Paratyphi, are associated with poor 
hygienic conditions and occur mainly in developing countries (177). In contrast, non-
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typhoid Salmonella generally cause gastroenteritis and are transmitted through 
contaminated food. They are the leading cause of human salmonellosis in developed 
countries.  
In the majority of countries, S. Enteritidis and S. Typhimurium are the two most prevalent 
serotypes in humans (115). The ten most prevalent serovars in the EU from 2008, when 
this project was launched, are listed in Table 1. 
The world wide epidemiology of Salmonella is characterized by a constantly changing 
picture. Some Salmonella clones appear in a population, increase and persist for a certain 
time and are subsequently replaced by new clones (123).  
In Denmark, human Salmonella infections followed a steadily decreasing trend during the 
past 14 years (17). In 1997, 95 salmonellosis cases per 100,000 inhabitants were reported 
whereas the incidence of human salmonellosis in 2010 was 28.7 cases per 100,000 inhabitants 
(17,217). This reduction was achieved through national control programs (254).  
Nevertheless, Denmark experienced a very high number of laboratory confirmed cases in 
2008 (3656 cases) and 2009 (2129 cases) (105) due to several large outbreaks caused by S. 
Typhimurium. Hence, S. Typhimurium is the most common serovar isolated from human 













Table 1: The ten most prevalent Salmonella serovars and S. 
Typhimurium phagetypes from confirmed human salmonellosis 
cases in Europe in 2009 according to the EFSA Journal, 2010 (73). 
serovar phagetype N % N % 
S. Entertidis 70091 58












S. Infantis 1317 1.1
S.Virchow 860 0.7
S. Newport 787 0.7
S. Agona 636 0.5
S. Derby 624 0.5
S. Stanley 529 0.4
S. Bovismorbificans 501 0.4
S. Kentuckey 497 0.4
Other 18495 15.3
Total 120760 100 5344 100  
 
2.2. Sources of human salmonellosis 
The routes for transmission of Salmonella to humans can be the environment, the contact with 
animals or the person-to-person contact but in industrialized countries, Salmonella are mostly 
transmitted through contaminated food (4). The main reservoir for Salmonella is the intestinal 
tract of a wide range of food animals and therefore salmonellosis can derive from various 
food sources, including plant and animal products. In Denmark, the human salmonellosis 
cases have peaked three times during the past 30 years. Each peak was attributed to a main 
food source: in the late 1980s boilers, in the mid 1990s pork and in the late 1990s eggs. Each 
time a new intervention program was successfully implemented (241).  
In Denmark, the largest part of the human salmonellosis cases (46.3 - 47.4%) is however 
related to travelling (17). Human travel and worldwide trade are considered to be very 
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important for the dissemination of Salmonella and the introduction of new clones into 
importing countries (4,56,107). This highlights the need of national and international control 
programs and collaborations across countries in preventing the global spread of epidemically 
successful clones that emerged in one country.  
 
3. Transmission of Salmonella in the food chain 
 
Salmonella are mostly transmitted through contaminated food products of animal origin such 
as fresh meat and eggs (241). Transmission often occurs when the bacteria are introduced into 
the food preparation areas and when they are allowed to replicate in the food (74). Salmonella 
in the food can directly originate from the farm reservoirs. However, Salmonella can enter at 
practically any stage of the food chain through contamination from the environment, other 
foods, animals or humans. This chapter will exclusively focus on the pork production chain as 
this is the food sector most relevant for this thesis.  
3.1. Risk factors in the pork production chain for Salmonella contaminated food 
Pork contributes significantly to the public health burden of Salmonella (232). In Europe, up 
to 25 % of the human Salmonellosis cases are ascribed to the consumption of pork (68). The 
implementation of a nationwide control program in Denmark has resulted in a substantial 
decrease in the occurrence of human salmonellosis cases attributed to pork products (241). 
Nevertheless, pork is still an important source of human salmonellosis in Denmark. The 
estimated number of human cases attributed to Danish pork has increased from 2008 to 2010 
from 8.8 % to 15.1 % (17). In 2010 Danish pork accounted for the most common food source 
for human Salmonella infections followed by imported pork which was estimated to 
contribute with 5.4% to the reported cases (17). EU-wide, the number of positive Salmonella 
samples in the pig slaughter houses ranged in 2009 from 0 – 13.7 %. At processing and 
cutting plants, Salmonella was found in up to 5.5 % of the pig meat samples and at retail it 
was detected in up to 3.5 % of the samples (74). S. Derby and S. Typhimurium are the most 
frequently isolated serovars from pig herds (breeding and production holdings) (Table 2). S. 
Derby was detected in 28.5 % and S. Typhimurium in 20.1 % of Salmonella positive 
production holdings in the EU (74). Among the S. Typhimurium phagetypes, DT120, DT193, 
DT12 and DT104 were most common in pigs and pork in Denmark in 2010 (17).  
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In pigs, the infection with Salmonella can be asymptomatic and therefore easily be spread 
from one animal in a herd to another via feces. A carrier pig can shed up to 10
6 
Salmonella 
cells per gram of feces for prolonged times (168,171). As these animals are not recognized to 
carry Salmonella, no therapeutic treatment will be applied to eliminate the pathogen. 
However, other vectors than pig to pig transmission are observed on farm level. These sources 
include rodents, insects, birds, humans and contaminated feed. Salmonella are ubiquitous in 
the environment. They survive desiccation remarkably well and can persist in a farm once 
they have been introduced (55).  
The infected pig constitutes the main reservoir for carcass contamination in slaughterhouses 
and a large part of the carcasses harbor Salmonella on the skin or in the rectum (232). 
However, the pig slaughter line is an open process with many possibilities for contamination. 
Around 30 % of all Salmonella on pig carcasses result from cross contamination during the 
slaughter line (232). An overview of a typical Danish slaughterline and the most important 
hazards of bacterial contamination are presented in Figure 2. An important source for 
contamination are the intestines as Salmonella can be found in the entire digestive tract of a 
pig (163). The time from killing until the pigs are cooled takes less than 1 h (30) during which 
the body temperature of the pig remains 37 °C, the optimal growth temperature for 
Salmonella. During the slaughterline, the pig associated bacterial numbers are reduced during 
scalding, singeing and chilling (232). However, the carcass can be recolonized by 
contaminations from tools and machines and internal organs of the pig. The equipment used 
for slaughtering includes big complex machines that are very difficult to clean and to sterilize 
and that provide niches for Salmonella to persist. 
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Figure 2:  The slaughter process at a typical Danish pig slaughterhouse. Dark grey represents the black 
slaughterline and light grey the clean slaughterline. Hazards for contamination with Salmonella are displayed in 
the center of the diagram (in red). The temperature of the pig carcasses until chilling is 37 °C and the 
temperature of the slaughter area depends largely on the outside temperature and can vary from 10 - 25 °C. The 
temperature of the processing area after chilling is approx. 10 °C. (www.danishcrown.com, (30), personal 
communications) 
 
The endpoint of the food chain is the kitchen of the consumers, restaurants or canteens. The 
environmental conditions that Salmonella has to face are very similar to those in the slaughter 
line. The main risk factors for domestic outbreaks have been associated to undercooking, 
improper storage and cross-contamination (123). The latter factor describes the situations 
where the handling of contaminated food in the kitchen, such as raw meat, results in the 
spread of the bacteria to the immediate environment followed by the contamination of ready 
to eat foods. Another risk factor might be that consumers freeze their food for long-term 
storage after which they thaw the food at room temperature for prolonged times before use.  
Overall, Salmonella transmission in the pork production is a complex multifactorial problem 
due to the ubiquitous nature of the pathogen. Full eradication of Salmonella might therefore 
be impossible but the monitoring and control at critical points in the pork production chain 
seems essential to reduce the spread of Salmonella and guaranty pork safety.  
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Table 2: Distribution of the ten most common Salmonella serovars in pig meat 
and pig herds in the EU in 2008 according to the EFSA Journal, 2010 (73). 
Serovar N % Serovar N % 
S. Typhimurium 469 33.1 S. Typhimurium 1544 31.5
S. Derby 280 19.8 S. Derby 646 13.2
S. Agona 55 3.9 S. London 177 3.6
S. Infantis 49 3.5 S. 1,4,5,12:i:- 154 3.1
S. London 48 3.4 S. Livingstone 127 2.6
S. Bredeney 46 3.2 S. Cholerasuis 119 2.4
S. Rissen 37 2.6 S. Infantis 118 2.4
S. Enteritidis 21 1.5 S. Entertidis 112 2.3
S. Livingstone 20 1.4 S. Rissen 109 2.2
S. Brandenburg 9 0.6 S. Anatum 101 2.1
Other 383 27 Others 1690 34.5
Total 1417 100 Total 4897 100
Pig meat Pig herds
 
 
4. Stress tolerance of Salmonella 
 
4.1. Definition of bacterial stress 
Microbial stress can be defined as sudden environmental changes that alter the behavior of the 
microorganism and reduce growth (100,198). However, usually stress is referred to 
environmental conditions that cause injury to the cell (242) which results in some loss of 
function (91). Sublethal injury damages but does not kill the microorganism (124) as it is able 
to respond to the stress and to repair the damage. Lethal injury eliminates the bacteria but in a 
bacterial population, a fraction of the bacteria cells may survive depending on the degree of 
injury and the time of exposure to the stress. Metabolic injury is related to damages of various 
components of the cells and is frequently distinguished from structural injury which refers 
more to damages of the cell wall or membranes. Both injuries are characterized by the failure 
of the bacteria to form colonies on selective media where uninjured cells would normally 
grow (242). Bacterial stresses can be generally classified into three categories: physical, 
chemical and nutritional (242). 
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4.2. Salmonella encounter various stress conditions in the food chain and during 
infection 
While Salmonella passes the food chain and during the course of infection, it is exposed to 
numerous stress conditions (Table 3). As many foodborne pathogens, Salmonella can sense 
and respond effectively to divers stress signals inside and outside the host.  
During food production, the food-associated microbes are exposed to food preservation 
techniques such as freezing, chilling, heating, smoking and curing. Salmonella might also 
survive on food processing surfaces where it experiences desiccation, nutrient limitation and 
where it gets in contact with disinfectants. Following, ingestion, an enteric pathogen, such as 
Salmonella, must cope with the low pH in the stomach, ranging from 2.5 – 4.5, largely 
depending on the alimentation (29). When Salmonella enters the gut, it is exposed to various 
stresses which are summarized in Table 3. Upon invasion, Salmonella is taken up by 
phagocytes where they encounters a new series of stressors. Unfortunately, Salmonella is 
known for tolerating a remarkable broad range of stress conditions and to also survive rapidly 
























high oxmotic pressure (curing, sugaring)
antimicrobial compounds (e.g. spices, nitrite, decontamination 
agents)
low or high pH
competitive exclusion by protective cultures
reduction of oxygen
radiation (e.g. UV)
limited nutrients and water
disinfectants (e.g. chlorine, quarternary ammonium compounds, 
hydrogen peroxide)
drying
Infection stomach low pH
gut bile acids
antimicrobial peptides
















4.3. Cross-protection and virulence of stress adapted cells 
Studies have shown that the exposure to sublethal stress can confer protection to the 
subsequent exposure to the same stress or other stress conditions (23). Dehydrated Salmonella 
cells can for example acquire high tolerance to heat, ethanol, high salt concentrations and UV 
irradiation (101). This is due to the production of stress proteins of the RpoS mediated general 
stress response system that maintain cell viability and thereby confer protection to different 
stresses. Thus, certain stress conditions have the potential to increase virulence because many 
of the host defense mechanisms show similarities to conditions that bacteria experience 
during food processing. For example acid or heat tolerant S. Enteritidis were observed to be 
more virulent in mice (122). Certain stress conditions that resemble host defense mechanisms 
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can also serve as signals for the expression of virulence genes, for example of the spv genes 
located on the Salmonella virulence plasmid (242). The general stress sigma factor RpoS is 
not only important for the regulation of stress proteins but is also involved in the regulation of 
the spv virulence genes (69). The stress conditions that enhance virulence in Salmonella 
include glucose starvation, low pH, elevated temperature and iron limitation (242). 
Preexposure to acids is known to induce resistance to gastric acid and thereby leads to a 
decrease in the infectious dose (251).  
4.4. The role of the growth state during stress exposure 
Lag times are good indicators for the severity of injury as they represent the time that the 
bacteria need to repair their damages and to prepare for growth. The lag time can vary 
markedly in length depending on the injury. Also on single cell level, considerable differences 
can occur (219) indicating a substantial heterogeneity of the degree of damage within a 
bacterial population. This variability might be explained by the growth states of the single 
cells at the time of stress exposure. Rapidly growing exponential cells are morphologically 
and physiologically distinct from cells in stationary phase. Cells in stationary phase are more 
robust whereas cells in exponential growth phase are more susceptible to stresses. For 
instance, E. coli that enters stationary phase synthesizes trehalose, an osmolyte that protects 
molecules and membranes from osmotic stress (189). Thus, an E. coli cell in stationary phase 
does not need to carry out as many physiological changes as exponential phase cells when 
they are exposed to stress. Exponential phase cells are presumably rare in the environment but 
in the food chain a significant amount of the single cells might grow exponentially when the 
temperature is adequate and nutrients available.  
Under severe stress conditions, it can occur that bacteria are not able to grow on routine 
laboratory media but are still metabolically active. These bacteria are in a viable but non-
culturable state and might remain pathogenic (242). In surveillance of food, this can lead to an 
underestimation of potentially harmful bacteria if molecular detection methods are not 
available. Furthermore, many stress conditions have shown to inhibit cell division leading to 
the formation of multinucleate filaments. In this case, the enumeration of CFU by direct 
plating would result in an underestimation of the cell concentration. These filaments can very 
rapidly divide and multiply when the bacteria enter favorable conditions and thereby increase 
the cell number in a short time (123).  
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4.5. The general stress response 
Salmonella has complex regulatory systems to sense and respond to environmental conditions 
(123). Stress signals influence gene expression through a variety of mechanisms. Sigma 
factors play an important role in this process as they change the transcription specificity of the 
RNA polymerases. The general stress response in Salmonella that is induced under several 
different stress conditions (starvation, high osmolarity, non-optimal temperature or acidic pH) 
is regulated by RpoS, the alternative sigma factor (2). It activates up to 500 genes (116) 
indicating numerous alterations of cellular physiology and morphology. The general stress 
response allows to rapidly adapt to changing environmental conditions but also confers long-
term protection to stress (208). 
4.6. Impact of freezing and thawing on bacterial cells 
On one hand, freezing injury is the consequence of dehydration of bacterial cells because of 
an increase in the extracellular solute concentration in the unfrozen fraction and the decrease 
of available water. On the other hand, freezing injury can be the result of a physical damage 
of the cells by intracellular or extracellular ice crystals (242). Freezing is generally recognized 
as an ineffective food preservation technique as many food components, such as peptides, 
proteins and glycerol act as cryoprotectants (149). Also fat has been suggested to contribute to 
the protection of bacterial cells by insulation (66). Moreover, the meet matrix might play an 
important role during freezing by binding free water and thereby reducing the ice formation 
(59). The cooling rate is an important factor during freezing as it highly influences the 
bacterial injury. Slow freezing results in the formation of large extracellular ice crystals 
whereas rapid freezing (between approx. 4 °C and 53 °C per min) leads to small extra- and 
intracellular ice crystal formation which is less detrimental for the bacteria (58,148,255). All 
bacteria cells need to maintain their cell turgor by an intracellular osmotic pressure greater 
than of the surrounding medium. During slow freezing, the extracellular medium freezes 
faster than the cell content, the osmotic pressure of the surrounding medium increases and the 
cytoplasmatic water flows out of the cell (148). This results in shrinkage of the cells and 
protein denaturation (89). The thawing rate has also an effect on the bacterial cell. Slow 
thawing allows small intracellular ice crystals to grow and coalesce before melting, which 
causes more damages than a fast thawing rate where the ice simply melts (180). Hence, quick 
freezing and thawing that are usually chosen to maintain product quality lead to less 
inactivation of microbes in the food. Salmonella is known for its tolerance to freezing stress. 
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It has been demonstrated to be quite stable in various foods frozen and stored between -18 and 
-22 °C (19). Repeated freezing and thawing and lowering the pH during freezing are however 
more detrimental for Salmonella (19). 
4.7. Impact of drying on bacterial cells 
The availability of water in foods is often expressed as the water activity (aw). An aw of 1 
corresponds to pure water and an aw of 0 means that no water is present (58). The optimal 
growth range for microorganisms is narrow (between an aw of 0.995 and 0.980) (148). The 
minimal aw value for Salmonella required for growth is approx. 0.95 (148). Decreasing the 
water activity is one of the most widely used food preservation methods. It reduces the 
amount of the available water to the bacteria and leads to a loss of water and a decrease in the 
cytoplasmatic volume similar to the effect observed during freezing described above (22). 
This will lead to an increase in viscosity, an increase in the intracellular concentration of salt 
and macromolecules, protein denaturation, DNA denaturation as well as to oxidative stress 
(213). Salmonella is known for being able to persist for long times in the environment leading 
to a risk of cross-contamination (88). It has to be distinguished between the increase of the 
solute concentration in the extracellular medium and desiccation (air-drying), the decrease of 
the extracellular water for example by evaporation. Under the first mentioned conditions, the 
bacteria can regain access to water by osmoregulation. To allow the water to cross the cellular 
membrane, the bacteria raise their intracellular solute concentration using compatible solutes, 
molecules that do not harm the cytoplasmatic enzymes and allow the functionality of the cell 
even at high concentrations (103). These solutes are either produced within the cell or are 
actively transported into the cell if present in the extracellular medium. A range of amino 
acids and related compounds serve as compatible solutes (148). In Salmonella glycine 
betaine, trehalose or proline are accumulated (148).  
 
5. Pathogenesis of non-typhoid Salmonella in humans  
 
5.1. A short introduction to salmonellosis 
Salmonella serovars that cause disease in humans can be divided into typhoid and non-
typhoid according to their disease pattern. Typhoid Salmonella including the human specific 
serovars S. Typhi and S. Paratyphi cause enteric fever, a systemic disease. The most common 
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disease outcome of non-typhoid Salmonella (NTS), such as S. Typhimurium and S. Enteritidis 
is a self-limiting gastroenteritis, a localized infection of the terminal ileum and colon that does 
not require antibiotic therapy. Depending on the host immune status, the bacterial strain and 
the infectious dose, a systemic infection can occur. In humans, this can manifest as septicemia 
or focal infection (4). A frequent model for studying salmonellosis is the oral infection of 
mice with S. Typhimurium which establishes a systemic infection in this animal model 
(Figure 3). This is different from the usual pathogeneses in humans and it is important to be 
aware of the limitations of this model. However, it has provided the opportunity to identify 
important Salmonella virulence factors and to study the course of a systemic Salmonella 
infection (202). This chapter will summarize the stages of salmonellosis in humans even 
though much of the current knowledge is based on animal models. In general, it is 
characteristic for NTS that they are able to colonize the gut, to cross the intestinal epithelial 
cells and to invade and survive in macrophages leading to inflammation of the intestines and 
to gastroenteritis. To establish a disease, Salmonella uses numerous virulence factors. This 
chapter will focus on some important and for this thesis relevant virulence factors.  
5.2. The route of infection during Salmonella gastroenteritis 
5.2.1. Infectious dose, passage through the stomach and colonization of the gut  
In foodborne infections, the infectious dose of a pathogen depends on three factors: 1.) on 
host resistance, which is impaired in young, elderly and immunocompromised; 2.) on the food 
composition and matrix, with fat for example lowering the infectious dose (81), and 3.) on 
virulence and physiological state of the ingested bacterium (123). The infectious dose for 
salmonellosis is therefore variable. It is thought to be typically between 10
6
 – 108 CFU for 
humans but can be significantly lower for example in outbreaks (123). After ingestion, 
Salmonella passes the stomach where it is exposed to an acidic pH (81). The surviving 
bacteria cells enter the intestines where Salmonella is able to colonize multiple sites of the 
small intestines, the colon and the cecum. The ileum is however the most frequently invaded 
site of Salmonella in humans (199).  
5.2.2. Adhesion and invasion of intestinal epithelial cells 
The epithelium of the intestines is covered and protected by a mucus layer. Thus, it has been 
suggested that Salmonella invades preferably the mucus-free M-cells situated in the Peyer’s 
Patches and dendritic cells (DCs) that lie within the epithelium. The first cellular contact 
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presumably mediated by frimbriae (301) is followed by the invasion of the epithelial cells. 
This process is conferred by the type III secretion system (T3SS) 1, a protein complex that is 
associated with at least 20 structural and regulatory proteins (81). T3SS1 has a needle like 
structure and injects protein effectors into the epithelial cell. The translocated proteins cause 
cytoskeletal rearrangements in the host cell which leads to membrane ruffling and bacterial 
internalization through macropinocytosis (83,244). The internalized bacteria cells reside in a 
membrane bound vacuole (SCV) in which they cross the epithelia layer (200). Knodler et al. 
suggested that a subpopulation of Salmonella replicates within the cytosol of epithelial cells. 
These cells are thought to be extruded from the monolayer into the intestinal lumen (131). 
This host defense mechanism might serve as a reservoir of dissemination for Salmonella. The 
extruded cells can infect new host cells or can be excreted and eventually infect new hosts. 
Upon translocation to the lamina propria, bacterial flagellin functions as the major 
proinflammatory determinant (252). It is recognized by Toll-like receptor (TLR) 5 located on 
the basolateral side of epithelial cells and on other host cells (90). After translocation, 
Salmonella it thought to either invades macrophages or once again enter epithelial cells from 
the basolateral side (109).  
5.2.3. Interaction of Salmonella with macrophages  
Within the lamina propria, Salmonella is immediately taken up by mononuclear phagocytic 
cells (macrophages or DCs) associated with Peyer’s Patches (200). Macrophages recognize 
pathogen associated molecular patterns (PAMPs) of Salmonella, such as flagellin, leading to 
an uptake of the bacteria (167). The contact of Salmonella with macrophages and other 
immune cells triggers the production of pro-inflammatory cytokines and chemokines (216). 
However, effector proteins of T3SS-1 early in infection have also been suggested to be 
directly implicated in eliciting the inflammatory response (211).  
Inside the macrophage, Salmonella is located within the phagosome. During the first 2-3 h, 
before replication begins, Salmonella modifies the phagosomal maturation and creates as 
unique niche, the Salmonella containing vacuole (SCV) (99). It has been suggested that 
Salmonella arrests the degradative pathway of the phagosome by inhibiting its fusion with the 
lysosome (41). But contradictory studies exist that propose the survival of Salmonella despite 
the fusion of these two compartments (109,250).  
Within the phagocytes, Salmonella faces a number of challenges, such as the procurement of 
nutrients, the defense against antimicrobial peptides, the protection against oxidative stress 
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and acidification. Upon phagocyte activation that occurs during uptake of Salmonella, the 
phagocyte NADPH oxidase reduces molecular oxygen to cytotoxic superoxide (234). This 
constitutes the initial bactericidal phase (called the oxidative burst) and it is followed by a 
prolonged bacteriostatic phase in the presence of nitric oxide which is synthesized by the 
nitric oxide synthases (NOS) (234). Microarray studies have shown that Salmonella regulates 
up to 919 genes differently when it senses the specific intravacuolar environment in 
macrophages (72). It is thought that genes needed for the early stages of infection, such as 
T3SS-1 and flagellin are repressed (109). The genes that are upregulated include a second 
Salmonella secretion system, the T3SS-2. It translocates effector protein across the vacuolar 
membrane into the cytsol. Among others, T3SS-2 is involved in maintaining and positioning 
of the SCV, in the defense against killing by the NOS and NADPH oxidase and in the delay 
of the apoptotic cell death (125,239).  
During the course of infection, Salmonella can remain within the SCV of macrophages for 
several hours to several days (109). It may be spread systemically but Salmonella can also 
cause macrophage apoptosis allowing it to disseminate to new macrophages and to infect the 
epithelial cells from the basolateral side. Macrophage lysis results in the release of 
proinflammatory cytokines and inflammation (199). If this process is beneficial for 
Salmonella is still controversially discussed (230). It allows Salmonella to colonize the gut 
associated tissue but also helps the host in clearing the infection. 
5.2.4. Neutrophil recruitment, antimicrobial products and diarrhea 
Within 12 to 72 h after infection, the patient experiences diarrhea, nausea, vomiting and 
intestinal cramping. CXC chemokine production, in the lamina propria results in the attraction 
of polymorphnuclear neutrophils (PMN) to the side of infection. The resulting neutrophil 
migration through the intestinal epithelium develops into a massive PMN efflux associated 
with a loss of epithelial integrity and a flow of a protein rich fluid into the intestinal lumen 
(254). This is likely to clear the infection and to prevent a systemic spread of the bacteria. 
Diarrhea is also associated with a loss of nutrients in the intestinal lumen. This affects the 
commensal microbes as well as Salmonella. However, Salmonella seems perfectly adapted to 
this environment as it efficiently uses mucus carbohydrates as an energy source (201). It has 
therefore been suggested that, Salmonella has a fitness advantage over the intestinal 
microbiota under inflammation resulting in an increased number of Salmonella in the 
intestines (218). Thus, Salmonella seems to exploit this unique environment of inflammation 
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created by the defense mechanism of the host. In relation to this, it has been hypothesized 
that, a fraction of the Salmonella population invades the intestinal barrier on a “self-
destructive mission” whereas the other fraction benefits from the inflammatory changes in the 
intestinal lumen (191).  
Another important part of the innate immune response to Salmonella is the release of 
antimicrobial proteins and peptides from epithelial cells into the lumen of the inflamed 
intestines. In order to be able to colonize the intestines during infection, Salmonella possesses 
virulence mechanisms protecting it from the antimicrobial effectors. One example is the 
iroBCDEN gene cluster that confers resistance towards lipocalin-2, an antimicrobial that 
prevents bacterial iron acquisition (191). 
5.3. Systemic infections established by non-typhoid Salmonella 
In healthy adults, salmonellosis is usually limited to the intestines where it causes an early 
inflammatory response and diarrhea as described above. Systemic infections caused by NTS 
is therefore rare in industrialized countries but it occurs frequently in Africa due to 
malnutrition, malaria and HIV (98). Not much is known about the bacterial and host 
mechanisms leading to a systemic infection of NTS. Gordon et al. suggested an intracellular 
persistence of invasive NTS and a failure of the immune system to control these bacteria (98) 
for example the lack of establishing a strong PMN influx (65). The survival within 
macrophages seems to be an essential prerequisite for dissemination to mesenteric lymph 
nodes or other parts throughout the reticuloendothelial system. From there Salmonella can 
enter the blood stream and reach different organs around the body (65,109). Reaching high 
intracellular densities would lead to a spatial and nutritional limitation of the intracellular 
bacteria and to an outgrow of the macrophages, risking the detection by the immune system. 
DCs are also likely to mediate the systemic spread of Salmonella. In DCs, Salmonella does 
not appear to replicate but remains viable (228). Genes encoded by the T3SS-2 seem to 
suppress antigen presentation by DCs which limits the immune response (239). Once 
Salmonella has reached different organs, it might multiply by replicating inside the cells and 
by inducing apoptosis (81). However, there is evidence that Salmonella rather multiplies by 
expanding to new immunological unprimed foci without undergoing massive intracellular 
growth (228). Overall, the ability to remain relatively undetected by the immune system, as 
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Figure 3: The course of an infection with S. 
Typhimurium in the mouse after oral 
administration, modified after Wray and Wray, 
2000 (86). 
 
5.4. Important virulence factors  
A broad range of genes related to stress tolerance, nutrient uptake and metabolism is 
necessary for a Salmonella infection. Many of these genes are found in other bacterial species 
than Salmonella. In addition, Salmonella has acquired an arsenal of genes encoding classical 
virulence factors that are directly linked to a successful infection within the host. Some of 
these virulence factors are limited to a number of subtypes and contribute to the differences in 
pathogenicity and virulence of Salmonella. 
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5.4.1. Salmonella pathogenicity islands 
Many virulence factors in Salmonella are encoded within large regions of the bacterial 
chromosome, within the Salmonella pathogenicity islands (SPIs). They are defined as regions 
that encode virulence genes and that are absent from the genome of E. coli K12 (77). They 
were probably taken up by horizontal gene transfer as they are composed of a distinct G+C 
content relative to the genome backbone and as they often carry remnants of transfer genes 
(1). Moreover, SPIs are often inserted adjacent to tRNA genes and insertion sequences, 
similar to mobile elements. The distribution and composition of many SPIs vary among 
Salmonella (28). In the following, SPI-1, SPI-2 and SPI-3 will be described more in detail. 
SPI-1 encodes T3SS-1 that enables Salmonella to enter many types of host cells. Its major 
role is the invasion of the intestinal epithelium as strains that harbor mutations within this 
gene island are reduced in virulence when administered orally but not when given 
systemically (77). By transporting at least 13 effector proteins into the cytosol of the host cell, 
it promotes the uptake of Salmonella cells as described above (5.2.2). Many effectors are 
located outside of SPI-1, on other pathogenicity islands or bacteriophages (28). SPI-1 is 
ubiquitous among Salmonella but absent from the closely related E. coli lineage and was 
presumably responsible for the divergence of these two genera approx. 100 - 160 million 
years ago (60,170). The acquisition of SPI-1 allowed Salmonella to cross the intestinal 
epithelium and to access a new niche. In the following, Salmonella adapted to this new 
environment by acquiring new genes, such as genes of the SPI-2 (77).  
SPI-2 is mosaic in structure and probably the result of independent horizontal transfer events 
(117). It encodes T3SS-2 that is required for survival and growth in macrophages as well as in 
epithelia cells and that is expressed 2-3 h post infection. It is induced intracellular, after 
formation of the SCV as a response to various signals, such as low osmolarity, nutrient 
depletion and acidification (81). It functions in translocating different effector proteins into 
the cytosol that interact with targets in the host cell (81,239). The region of the island 
encoding the T3SS-2 is present in all Salmonella except S. bongori (77). S. bongori carries 
another section of the island encoding a tetrathionate reductase required for anaerobic 
respiration (117). Similar as for T3SS-1, many T3SS-2 effectors are encoded outside of the 
SPI-2.  
SPI-3 appears to have a mosaic genetic structure too. It is composed of three regions with 
variant G+C content and interspersed with remnants of insertion sequences (27). The 
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transcriptional units located on SPI-3 have only little known functional relation to each other 
(103). Some parts of SPI-3 are differently distributed in some Salmonella suggesting a 
multistep process in the evolution of this island (27). The distribution of the genes rhuM, 
involved in epithelial cell invasion, and sugR, of unknown function, show the greatest 
variability as they are deleted in some Salmonella (222). The region encoding for example the 
mgtCB operon required for growth in macrophages is in contrast conserved (77). Other SPI-3 
genes have been found to harbor translational stop codons in some serovars, such as S. Typhi, 
and are considered to be pseudogenes (193).   
5.4.2. The role of prophages in virulence 
Bacteriophages invade bacteria cells and contribute to a great extend to the evolution of their 
hosts (136). After uptake of a temperate phage, the host bacterium can acquire new phage 
encoded phenotypic properties (136). P22 for example expresses the genes gtrABC that 
modify the O-antigen side chains by glycosylation, a process called O-antigen conversion 
(136). This alters host recognition of the bacterium and contributes to the bacterial evasion 
from the immune system (34). Many of the above mentioned T3SS effector proteins are 
encoded on bacteriophages located outside of the SPIs (1). For example sopE is part of the 
lysogenic bacteriophage SopEΦ and only present in a part of the Salmonella strains. It is a 
T3SS-1 effector protein and co-expressed and transferred together with all the other T3SS-1 
effectors (37). This shows that SopE has been fully integrated into the host metabolism which 
is also characteristic for other prophage gene products. Similar to other phage genes, sopE has 
been duplicated and diversified during the evolution of Salmonella. Other known phage 
virulence factors of Salmonella are presented in Table 4. However, these genes might only 
represent a small fraction of all existing phage genes that enhance fitness or virulence of 
Salmonella.  
Paradoxal, the phage could also contribute to fitness of the host bacterial population when it is 
released from individual bacterial cells. Bacteria infected with a certain phage cannot be 
reinfected with the same kind of phage (136). If some bacterial cells in a population lyse, the 
released phage can act as a weapon against competitive bacteria. It attacks competitors 
whereas the bacteria of the host population that still carry the phage are immune (179).  
A considerable part of the Salmonella genome is composed of cryptic phages that do not have 
the ability to enter the lytic cycle. During evolution, these phages became slaves of their 
bacterial hosts. Even thought the detailed mechanisms are not clear, it has been reported for E. 
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coli that these phages contribute drastically to the fitness of the host bacterium. A deletion of 
these phages reduces for example the resistance to sublethal concentrations of antibiotics, to 
osmotic and oxidative stress as well as to acidic pH (238).     
 
Table 4: The most important bacteriophages or phage remnants of 
non-typhoid Salmonella, grouped after their phylogenetic relatedness 
and their encoded virulence genes (37,136). 
Phage group Salmonella phages Virulence genes
P27 like phages ST64B
P2 like phages Fels-2
SopEφ sopE
PSP3
lambdoid phages Gifsy-1 gipA, gogAB
Gifsy-2 gtgAE, sodC1, sseI
Gifsy-3 sspH1, pagJ
Fels-1 sodCIII, nanH









phage remnants sopE2, sspH2  
*lytic phage 
 
5.4.3. The spv genes 
The spv (Salmonella plasmid virulence) locus is conserved and is located on large plasmids 
(50 – 100 kb). However, also chromosomally encoded spv genes have been detected (77). 
Strains from many serovars lack the spv genes but S. Typhimurium and S. Enteritidis are 
known harbor virulence plasmids carrying spv (81). The spv genes are thought to facilitate 
intracellular replication in macrophages and systemic spread (204). In human macrophages, 
they appear to induce cytotoxicity (146). The locus consists of five genes, namely spvABCD 
and the positive regulator gene spvR (102). Their expression is among others regulated by 
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RpoS, and notably the growth state. It has been observed that more blood isolates harbor spv 
genes than isolates from stool but spv is absent from S. Typhi, indicating that NTS bacteremia 
is fundamentally different from typhoid fever (76).  
5.5. The use of cell cultures to study Salmonella virulence 
Human and animal immortalized cell lines have often been used to study virulence in 
Salmonella. But some limitations have to be considered when using cell cultures. In vitro, 
Salmonella is replicating inside the SCV within epithelial cells resulting in a large amount of 
bacteria after 6 hours post infection (78). This is different from what is observed in vivo where 
the bacteria rapidly cross the epithelium. Macrophages contain in vivo approx. 1 – 10 bacteria 
cells, whereas the cultured macrophages are fast outgrown by a larger number of Salmonella 
cells (228). These examples reflect that many factors of the host defense are absent in cell 
cultures.   
Furthermore, the experimental setup might greatly influence the results. When cell lines are 
used, a gentamicin protection assay is usually applied. This method takes advantage of the 
inability of gentamicin to penetrate eukaryotic cells (206). Extracellular bacteria can thus be 
eliminated whereas intracellular bacteria are spared. However, this experimental procedure is 
not standardized. Varying parameters in cell culture models are the multiplicity of infection, 
using opsonized versus non-opsonized bacteria, pre-treatment of macrophages with IFN-γ 
versus no pre-treatment and the growth state of the bacteria before infection (228). The origin 
of the cell culture, for example mouse or human can also complicate the interpretation of 
results (228).  
 
6. Antibiotic resistance in Salmonella 
 
Antibiotics inhibit essential physiological or metabolic functions in susceptible bacteria cells 
(144). There are numerous different antibiotics available that are, based on their mode of 
action, divided into antimicrobial classes. Antibiotics are widely used in human and 
veterinary medicine. Hence, bacteria are frequently exposed to the selective pressure of 
antibiotics leading to the development of resistance mechanisms. Antibiotic resistances can be 
roughly divided into three categories depending on the mechanism: 1.) the destruction or 
modification of the antibiotic, 2.) the decreased influx or increased efflux of the antibiotic and 
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3.) the alteration of the cellular target of the antibiotic (144). Bacteria can be naturally 
resistant to certain antibiotics but this thesis focuses on antibiotic resistances that are acquired 
through genetic changes of the bacterium. These changes include the acquisition of new genes 
by horizontal gene transfer or the mutation of existing genes. 
The resistance of bacteria is usually determined in the laboratory by measuring the minimal 
inhibitory concentration (MIC) of a drug by broth/agar dilution methods or by recording 
inhibition zone diameters from diffusion assays (7).  Breakpoints for the characterization of 
isolates as susceptible, resistant or intermediate are usually established based on population 
MIC distributions or on clinical efficacy data (7).  
Since the 1990, Salmonella resistant to a variety of antibiotics, including agents that are used 
for treatment of humans have emerged (81). Adults with respective symptoms (such as blood 
in stool and high fever) are today usually treated with fluoroquinolones, such as ciprofloxacin, 
whereas for children β-lactam antibiotics may often be prescribed (personal communications). 
Usually most salmonellosis cases are not treated with antibiotics but during some outbreaks 
up to 40 % of the cases may receive antimicrobial therapy (personal communications). The 
increasing prevalence of particularly multidrug and quinolone resistant Salmonella limits the 
possibilities to treat severe salmonellosis cases and is a major public health problem. 
6.1. Transmission of antibiotic resistance  
The main mechanisms for transmission of resistance in Salmonella are horizontal gene 
transfer and clonal spread of resistant strains (42,160). Resistance genes can be transferred 
between different Salmonella serovars or can originate from other bacterial species (7). 
Plasmids and class one integrons are the main mobile elements responsible for the transfer of 
resistance genes in Salmonella (7). These elements often carry multiple antibiotic resistance 
genes. Not much is known about the role of bacteriophages in the transfer of resistance genes 
but there is evidence that phages contribute to the transmission of resistance determinants in 
Salmonella (36,51). 
The spread of resistant Salmonella and other resistant food borne pathogens is largely the 
result of the antimicrobial use in food animals but also the use of antimicrobials in human 
medicine is a cause for transmission of resistances (11,12,156,227). During the past centuries, 
livestock production has developed from small to extremely large herds. The enhanced 
numbers of the animals in the herds has increased the usage of antibiotics for both, therapeutic 
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and non-therapeutic reasons (171). This had implications for the emergence and spread of 
multidrug resistant pathogens and has raised public health concern. However, transmission of 
resistant Salmonella has also been suggested to occur independent on antibiotics present 
(228). Exposure to disinfectants and food preservatives might as well select for resistant 
Salmonella. The reason for this might be resistance mechanism that protect against a broad 
spectrum of toxic agents, such as increased expression of efflux pumps (7). 
6.2. Multidrug resistance 
In this study, multidrug resistance (MR) refers to strains that are resistant to four or more 
antibiotic agents as this definition has been used in previous publications (104,178). However, 
today NARMS and DANMAP define MR as resistant to at least three antimicrobial classes 
(18,45).  
6.2.1. The Salmonella genomic island 1 
Multidrug resistance in many Salmonella is often chromosomally encoded and due to the 
acquisition of the Salmonella genomic island 1 (SGI-1) and variants of it. In contrast to 
plasmid encoded antibiotic resistances, SGI-1 is stable also in the absence of the selective 
pressure (118). SGI-1 was first found in S. Typhimurium DT104 which probably acquired 
SGI-1 in the early 1980s. In the 1990s, this multidrug resistant S. Typhimurium DT104 clone 
was the most prevalent clone in many countries of the world and was reported to be more 
virulent in humans as an unusual high percentage of patients were hospitalized in the UK and 
in the US, this strain was more often isolated from blood than non-ACSSuT stains (165,226). 
It has been suggested that SGI-1 was responsible for the successful spread of this clone and 
more recent also of S. Paratyphi in Canada (118,166).  
SGI-1 carries a set of resistance genes that are all located within the boundaries of a complex 
class 1 integron (142). In S. Typhimurium DT104, it confers resistance to ampicillin, 
chloramphenicol, streptomycin, sulfonamides and tetracycline (ACSSuT). The genes that 
encode this resistance phenotype are aadA2, floR, blapse-1, sul1 and tet(G) (31,33). In variants 
of SGI-1, some resistance genes have been gained, deleted or replaced (141). This indicates 
that SGI-1 is a highly dynamic genetic element that allows variation in otherwise genetically 
uniform bacterial clones (42) and that contributes to a rather quick evolution (43). Besides the 
resistance genes, other genes associated with DNA transfer and many genes with unknown 
function have been found on SGI-1. 
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SGI-1 is an integrative mobilizable element that can be transferred via conjugation with a 
helper plasmid (61). Isolates of the same serovar from different parts of the world harboring 
SGI-1 seem to belong to one clone, indicating that the transfer of the island is rather rare 
(106). An SGI-1 variant is also present in Proteus mirabilis and parts of the SGI-1 nucleotide 
sequence are found in Shewanella indicating a participation of these bacteria in the evolution 
of this gene island (210).  
6.3. Quinolones resistance 
6.3.1. A short introduction to quinolones and their use  
For many years, chloramphenicol, ampicillin and trimethoprim/sulphamethoxazole were the 
drugs of choice for treatment of severe salmonellosis (176). Due to the increased occurrence 
of multiple resistant Salmonella, fluoroquinolones have frequently been an effective 
alternative when antimicrobial therapy was required. The first generation of quinolones 
begins with the introduction of nalidixic acid which is characterized by a limited activity 
against gram negative bacteria. In the following, structural changes have resulted in more 
potent antibiotics with broader activity spectra (248). Today, the broad spectrum 
fluoroquinolone ciprofloxacin is the most used quinolone (18). Unfortunately, treatment 
failures have been described in patients infected with strains exhibiting low level resistance 
(MIC 0.12 - 1 µg/ml; according to Eucast breakpoints) (214).  
Quinolones have also been used in the veterinary medicine and it has been suggested that 
quinolone resistance can be transferred from food animals to humans (11). However, it can 
also emerge in susceptible strains within a patient during the course of treatment (157,181). 
6.3.2. Mechanisms of action 
Quinolones target the complex of DNA and type II topoisomerase (DNA gyrase or 
topoisomerase IV) during DNA replication (95). These type II topoisomerase enzymes are 
heterotetramers of two A subunits where the active site of the enzyme is localized and two B 
subunits: GyrA and GyrB in the DNA gyrase and ParC and ParE in the topoisomerase V. 
DNA gyrase induces negative coils into the DNA superhelix which is important for 
replication and topoisomerase V allows the two chromosomes to be separated at the end of the 
replication (3,237). The interaction of quinolones with these enzymes leads to a replication 
stop and induces the bacterial SOS response, an error prone DNA repair mechanism (248). 
Furthermore, it is thought to result in lethal DNA double strand breaks (126). 
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6.3.3. Mechanisms of resistance 
6.3.3.1. Point mutations  
The acquisition of point mutations in the target genes of DNA gyrase and topoisomerase 
results in a decreased affinity to the quinolone and is the main mechanism responsible for 
quinolone resistance in Salmonella. Mutations within the genes of these enzymes usually 
cluster within the quinolone resistance determining region (QRDR) (120). Most of the 
mutations appear in the QRDR of the subunit gyrA as it harbors the active site of the DNA 
gyrase (120). A single point mutation within this region can mediate full resistance to 
nalidixic acid and low level resitance to fluorquinolones (182). Mutations in gyrB also occur 
but mutations in parE and parC are rare.  
6.3.3.2. Downregulation of outer membrane porins  
The entry of quinolones into the bacterial cells occurs through outer membrane porins as these 
antibiotics are hydrophilic molecules. Alterations in the expression of these protein, such as 
OmpF can lead to low level resistance to fluorquinolones even though gyrA is not mutated 
(183). 
6.3.3.3. Efflux pumps 
A decrease in the intracellular accumulation of the antibiotic can be achieved by an increased 
efflux of the drug.  This is mediated by antibiotic efflux pumps that mainly utilize the proton 
motive force to export the antibiotic actively out of the cell (185). Bacteria that express these 
efflux pumps usually show cross-resistance to a number of different antibiotics (185). In 
Enterobacteriaceae, the main efflux system for quinolones is encoded by acrA, acrB and tolC. 
This system is under the control of AcrR (a repressor), MarR (a positive regulator) and SoxS 
(a positive regulator; in presence of oxidative stress it is turned on by SoxR). Some strains can 
become resistant because they acquire point mutations in the genes encoding AcrR, MarR and 
SoxR resulting in an overexpression of the efflux pump (135,185,243). This efflux system 
seems to play a major role in fluoroquinolone resistance as the resistance level is highly 
reduced when it is inactivated even though multiple point mutations within the target genes of 
the type II topoisomerase enzymes are present (21).  
6.3.3.4. Plasmid-mediated quinolone resistance 
Even though it is still rare in Europe, plasmid mediated resistance to fluoroquinolones is 
increasingly found in Salmonella (178). The plasmid genes that confer resistance are qnr, 
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qepA, oqxAB and aac(6’)-Ib-cr. The qnr genes are proteins that protect the DNA gyrase 
enzyme from the inhibition by quinolones. The genes qepA and oqxAB mediate efflux and 
aac(6’)-Ib-cr is an altered aminoglycoside acetyltransferase an is capable of modifying certain 
fluoroquinolones, such as ciprofloxacin (220). Plasmid mediated quinolone resistance has 
only been reported to confer low level resistance. However it decreases the mutant prevention 
concentration and enhances the occurrence of chromosomal mutations (220). 
 
7. The importance of gene transfer and mutation rates for virulence and 
resistance 
 
Two main molecular mechanisms are responsible for the genetic differences among 
Salmonella strains: point mutations leading to the inactivation or modification of existing 
genes and lateral gene transfer leading to the acquisition of new genes mediated by 
bacteriophages, plasmids and transposons (84). This chapter describes briefly the genetic 
elements that drive diversity in Salmonella and mentions how mutation rates influence the 
evolution. 
7.1. Prophages 
Bactriophages exist in large quantities in the environment. An estimated amount of phage 
particles of 10
7
 per g feces can be found within the mammalian gut comprising approximately 
160 – 1200 viral genotypes (36,46). Approximately two thirds of the Gammaproteobacteria 
harbor intact bacteriophages or phage remnants (36). Presumably, all Salmonella carry a set of 
prophages which are thought to contribute significantly to the diversity of Salmonella (1). 
Salmonella phages can be divided into at least five groups which are presented in Table 4. 
Phage specificity is mediated by the ability of the phages to adhere to the host surface and by 
bacterial defense mechanisms, accomplished through nucleases and methylases (136). The 
phagetyping system that is used to subtype different Salmonella serovars is built on the 
diversity of phage specificities (Chapter 1). After attachment of the phage to the cell, the only 
component that enters the bacterium is the nucleic acid of the phage. Most Salmonella phages 
have linear double stranded DNA. The genomes of phages are typically composed of different 




Bacteriophages can undergo two lifecycles: a lytic and a lysogenic cycle (Figure 4). During 
the lytic cycle, the phages use the replication and translation machinery of the host bacterium 
to produce a big number of progeny. Multiplication is followed by the phage induced lysis of 
the bacteria cell (136). More than 100 new phage particles can be produced within 30 min 
after infection of a single host (36). During the lysogenic cycle the phages integrate into the 
bacterial chromosome by recombination. In the case of lambdoid phages, the DNA 
circularizes and recombines with the host DNA via site specific recombination mediated by a 
phage encoded integrase enzyme. In the following, the phage replicates together with the host 
bacterium. The expression of phage proteins leading to the excision of the phage and lysis of 
the host are repressed. These temperate bacteriophages can enter the lytic cycle which is 
elicited by environmental stress. Induction can for example occur when the host bacterium 
experiences DNA damage, such as during exposure to quinolones (36,154). While functional 
phages are integrated in the bacterial chromosome, they are named prophages (136). The 
genomes of all temperate prophages are mosaic in nature and variants of one kind of phage 
exist, indicating that recombination between phages occurs frequently.  
 
 
Figure 4: The lifecycles of bacteriophages (http://www.csm.bio.dtu.dk). The left side shows the lytic cycle and 




Phages can pack host DNA and transduce it to other bacteria (136). This can happen in two 
ways. General transducing phages can transfer virtually any gene of the host chromosome. 
The bacterial genome is degraded and parts of the host genome can accidentally be packed 
into the progeny heads of the phages. These particles are defective in their function as a virus. 
However, they can deliver the donor bacterial DNA into a recipient cell, where it is either 
degraded or recombined with the host DNA. The requirements for this type of transduction 
are that the packaging machinery of the phage is not too precise and that the host genome is 
not fully degraded. Both temperate and lytic phages can mediate generalized transduction 
(36). Specialized transducing phages can only transfer bacterial DNA adjacent to the phage 
integration site. This mechanism occurs only in temperate phages when the excision of the 
phage DNA upon induction is imprecise. The progeny phage might be functional or defective 
depending on the phage genes that have been replaced. The piece of host bacterial DNA can 
be subsequently transferred to a recipient and integrated into the chromosome along with the 
phage DNA (36). Both mechanisms can result in a change of the recipient’s phenotype when 
the transduced DNA is expressed. A fully functional bacteriophage can also carry genes that 
are not required for phage replication and transfer. These genes also change the phenotype of 
the host bacterium, usually to its advantage and thus are also beneficial for the phage (37). 
This process is called lysogenic conversion (36). In principle, lysogenic conversion always 
occurs upon acquisition of a temperate bacteriophage because it generally confers immunity 
to the host bacterium to further infection by the same or similar bacteriophages (36). 
Lysogenic conversion is a key mechanism in the movement of virulence genes between 
bacterial strains. As described in Chapter 5 and 6, prophage elements (temperate phages and 
phage remnants) are important for Salmonella diversity particular with regard to the 
acquisition of virulence determinants.    
7.2. Transposons 
Transposons are gene elements that can change their relative position within the genome of a 
single bacterial cell. They can also jump on plasmids and thus be transferred to other cells. 
Transposons can be flanked by insertion sequences that encode the transposase enzymes (insA 
and insB). They can also be flanked by inverted repeats and express another kind of 




Transposons can carry integrons that accumulate and express gene cassettes. They encode the 
integrase Int1 which is similar to the phage integrases. In addition, they contain a promoter 
and an attI recombination site. Integrons capture and express gene cassettes that contain an 
attC site (79). They are themselves not mobile but in Salmonella, they have been found to lie 
on transposons, genomic islands or plasmids (7). Only class 1 and 2 integrons have been 
described in Salmonella (80). They are associated with multidrug resistance (79) because they 
can carry complex arrays of several resistance genes (162).   
7.3. Plasmids 
Plasmids are mobile elements that can replicate autonomously without integration into the 
host genome. They are transferred by conjugation to new hosts which can occur even across 
species boundaries (212). But not all bacteria have equal abilities to be efficient donor or 
recipient cells. Due to successive transfer events, plasmids have a mosaic genome structure.  
Salmonella harbor different virulence and resistance plasmids. Most of the virulence factors 
of Salmonella are encoded chromosomally but certain serovars harbor serovar-specific 
virulence plasmids including Typhimurium, Enteritidis, Choleraesuis, Dublin and Gallinarum 
(195). They all share the conserved spv region mentioned in Chapter 5. The plasmids of S. 
Typhimurium (pSLT) and S. Enteritidis (pSEV) carry an additional virulence gene cluster, the 
pef (plasmid encoded fimbriae) operon contributing to adhesion to host intestinal cells (196). 
Virulence plasmids of Salmonella are large low copy number plasmids. Only the pSLT is self 
transmissible whereas the transfer region of the other virulence plasmids is absent or 
incomplete. Putative integrase and resolvase genes, insertion sequences and putative DNA 
repair genes can also be found on the Salmonella virulence plasmids (195). Resistance 
derivatives of these virulence plasmids have been identified in S. Enteritidis, S. Typhimurium 
and S. Cholerasuis (pSCV). And resistance plasmids carrying virulence determinant have 
been found in S. Enteritidis, S. Typhimurium and its monophasic variant S. 4,5,12:i:- (195).  
7.4. Elevated mutation rates and mutator bacteria 
The role of point mutations is well known for the development of antibiotic resistance 
mediated by alteration of target or transporter genes (48). Point mutations are less frequent in 
the evolution of virulence genes (153). However, it might be an important mechanism in the 
inactivation of antivirulence genes. During adaptation of a pathogen to its host, certain genes 
may become dispensable or even create a disadvantage. These genes are termed antivirulence 
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genes (155). In S. Typhi for example, several genes are inactivated by point mutations as they 
are not required in the specific human environment to which the bacterium has adapted.  
Bacteria with elevated mutation frequencies are usually termed mutator or hypermutator 
strains (if the mutation rate is at a very high level) (161). A mutator phenotype can be 
regulated (transient) or permanently expressed (48). It has been suggest that mutator bacteria 
that exhibit constitutively high mutation rates and that usually account for a small part of a 
bacterial population are an important driver of the evolution in pathogenic bacteria like 
Salmonella (253). Hypermutator populations can have an increased mutation rate of around 
10000 fold and are usually defective in their methyl-directed mismatch repair system or 
proof-reading function (153). These strains have the potential to develop rapidly resistance 
and virulence attributes but are considered to be less fit than the wildtype strains in the 
absence of the selective pressure. It has been shown that E. coli expressing increased mutation 
rates have an advantage in vivo as long as adaption is achieved. Thereafter, their fitness 
decreases compared to the wildtype because the hypermutator phenotype also results in the 
accumulation of deleterious mutations (92). Mutators probably survive in natural population 
because they are continuously enriched when bacteria encounter unfavorable conditions (71).  
Transient mutators express only temporarily increased mutation rates. Certain environmental 
conditions can for example induce enhanced mutation rates. These conditions include the 
exposure to reactive oxygen species (ROS), to quinolone antibiotics or ionizing radiation and 
can be encountered in the food chain and/or during infection. They have the potential to 
induce DNA strand breaks, deamination, depurination and alteration of bases leading to a 
transversion event of the base pair (51). Quinolones elicit a replication arrest resulting in the 
exposure of single stranded DNA and DNA double strand breaks. Bacteria have developed 
different strategies to repair DNA. One of them is the SOS response which creates a transient 
mutator phenotype. During the SOS response, an error-prone DNA polymerase with a lower 
specificity that introduces mutations is used for replication of DNA (231).  
Resistance to rifampicin is the result of at least 69 different point mutations in the rpoB gene 
and is frequently used to measure the mutation rates of bacteria (87). With this method, the 
number of mutants in a population can be estimated (not the number of single mutational 
events) (152). The spontaneous mutation rates in bacteria are generally around 10
-10
 – 10-9 per 
base pair per cell per generation (48). However, some genes are more subjected to mutations 
than others, depending for example on the size of the gene and number of duplications. 
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During growth under selective pressure, the mutation rates can be much higher and the 
genetic adaptation can thus be rapid (190). Also when bacteria do not grow or when they 
grow very slowly, for example during the course of infection, they can experience elevated 
mutation frequencies (152). This is because many stress conditions such as starvation have an 
enhancing effect on mutation frequencies (52). These findings suggest that mutation rates 
determined under standard laboratory conditions differ from those that occur in the natural 
environment.  
 
8. Genetic and phenotypic diversity in Salmonella 
 
8.1. The clonal nature of Salmonella 
A clone is usually defined based on its similarity to different isolates determined with a 
certain typing method but only a few molecular methods are discriminatory enough. For 
instance MLVA typing is used to distinguish between different Salmonella clones (personal 
communications). The utility of this concept is the identification of strains that have a 
common ancestor and thus similar biological properties (26) and it is used to trace origins of 
infection, for example during outbreaks. The population structure of Salmonella is clonal with 
a comparatively low recombination rate between subspecies and a very high recombination 
rate within subspecies (137). New clonal Salmonella lineages can thus emerge by the 
replacement of one clone by another fitter clone or by the acquisition of phenotype-converting 
profitable genes (153). Despite their close genetic relatedness, the phenotype and 
epidemiology can vary substantially among Salmonella subtypes. In the following, this 
diversity will be described more in detail. 
8.2. Phenotypic diversity 
8.2.1. Differences of Salmonella isolates in their resistance to antibiotics 
Some Salmonella subtypes are rarely antibiotic resistant compared to other subtypes. S. 
Typhimurium DT12 appears to acquire resistance only very slowly if at all (18) whereas only 
6 % of the S. Typhimurium DT104 isolates that were collected from persons with clinical 
disease within a time period from 2003 to 2006, were fully susceptible (169). Interestingly, in 
1998 DT12 was the far most prevalent phagetype isolated from pig farms but it declined 
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markedly and became replaced by DT120, DT170 and DT104. In contrast to DT12 which 
remained almost fully susceptible to antibiotics despite the increased use of antibiotics in the 
pig industry, DT104, DT170 and DT120 were to a large part multidrug resistant (18,71). It is 
not quite clear if one should conclude that the observed emergence of resistant Salmonella is 
the result of a change in the distribution of clones (70) or if it is the result of the acquisition of 
resistance genes and if some Salmonella subtypes have a higher ability to take up new genes 
than others.  
In the US, the most common Salmonella serovars with a multidrug resistance phenotype are 
Typhimurium and Newport (45). Other clinical important serovars that are observed to be 
frequently associated with multidrug resistance are Heidelberg, Dublin, Agona, Enteritidis 
and Virchow (7). In a Danish study, Skov et al. reported that the proportion of multidrug 
resistant Salmonella for some serovars was much higher in humans than compared to the 
proportion in meat (213). These serovars were Typhimurium, Vichow and Hadar. For S. 
Saintpaul and S. Newport the opposite was the case. In this study, multidrug resistance was 
generally less a problem in S. Entertidis. In Denmark, 78 % of the human isolates attributed to 
outbreaks in 2010 were resistant to multiple antibiotics whereas 43% of the domestic sporadic 
human cases were multidrug resistant (18). This is reflected by data from the United States 
where a high number of human Salmonellosis outbreaks is caused by multidrug resistant 
strains (7). In Denmark and many other countries of the world, the most common multidrug 
resistance pattern is ACSSuT. It is conferred by the acquisition of SGI-1 as described in 
Chapter 6 and most often associated with S. Typhimurium DT104 (7,18). Other serovars than 
S. Typhimurium were SGI-1 has been identified are Agona, Albany, Cerro, Derby, 
Dusseldorf, Infantis, Kentucky, Kiambu, Meleagredis, Newport and Tallahassee 
(6,32,63,64,67,142,143). So far no SGI-1 could be found in other phagetypes of S. 
Typhimurium than DT104 (5,62,139).  
Skov et al. reported that nalidixic acid resistance was highest for S. Hadar, S. Newport, S. 
Kottbus and S. Virchow (213). In a large study from the United States, encompassing the 
years 1996 – 2007, it was shown that nalidixic acid resistance was the resistance pattern 
mostly associated with isolates from blood stream infection (54). The occurrence of high level 
fluoroquinolone resistant strains with an MIC above 2 µg/ml is still not very frequent among 
Salmonella (94). Higher MICs are more commonly observed in other pathogens, such as E. 
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coli (94). Overall, the antibiotic resistance pattern in Salmonella seems to be associated with 
the Salmonella serovar or phagetype and with the source of isolation. 
8.2.2. Virulence and host preference  
Salmonella cause disease in a wide range of animals, including warm blooded and cold-
blooded animals, and humans. Salmonella serovars show a remarkable variety of host 
preferences. Some serovars are host specific, such as S. Typhi and S. Paratyphi for humans 
(53). These serovars are not able to cause disease in animals. Some serovars are host adapted, 
such as S. Dublin to cattle (215), and S. Cholerasuis to pigs which implicates that they are 
more often found to cause disease in these animals than in others. Some serovars are 
generalists and able to infect a broad host range, such as S. Typhimurium and S. Enteritidis 
(129).  
Most human Salmonella infections are caused by one species, Salmonella enterica (127). 
Within this species, only a limited number of subtypes are responsible for the majority of 
salmonellosis cases. The disease outcome of salmonellosis can vary substantially ranging 
from mild gastroenteritis to severe extraintestinal infections with differences occurring even 
within strains of the same serovar (112,127,221). Even within the serovar S. Typhimurium, 
the disease outcome can vary tremendously. Some Salmonella serovars, such as Dublin and 
Cholerasuis are associated with severe invasive diseases (Figure 5). For other Salmonella 
subtypes, the disease outcome seems to depend on the antibiotic resistance pattern, with 
multidrug and quinolone resistant strains being more often associated with severe illness 
(Chapter 9) (38,111,113,121,140,151,229,233). By comparing surveillance data of non-
typhoid Salmonella from food, food animals and humans, epidemiologists have calculated the 
ability of different serovars to cause disease and found remarkable differences 
(104,105,184,203,246). Variations in the number of human salmonellosis cases caused by 
different Salmonella subtypes also indicate different abilities to infect humans (105,246). 
These observations indicate that the disease burden of Salmonella is not only dependent on 
host and environmental factors but also on the pathogenic potential of the particular 
Salmonella strain.  Figure 5 compares the prevalence of different Salmonella serovars in 
humans with the outcome of disease (127) as the pathogenic relevance depends mainly on 
these two properties: the degree of virulence and ability to be transmitted and thus to cause 























Figure 5: The relative distribution of 58 Salmonella serovars from humans during 1996 – 2006 and their 
proportions showing an invasive disease outcome. The table presents only those serovars with a relative 
distribution in humans above 3 % or a relative proportion with an invasive disease outcome above 10 % (dashed 
lines); The data were taken from Jones et al., 2008 (127); Invasive means isolation of Salmonella from blood, 
cerebrospinal fluid, bone or joint fluid or a sterile site not further specified. 
 
8.3. Genetic diversity 
Salmonella is genetically closely related to E. coli but have an additional large number of 
virulence genes (108). The population structure of Salmonella is clonal and the chromosomal 
backbone therefore relatively conserved. However, the genome is interspersed with regions of 
variation including genomic islands and prophages (1). Microarray studies revealed that one-
third of the S. enterica subspecies I pan-genome is variable (13). Prophage-like elements seem 
to constitute the major source of variation within Salmonella (24,256). Another genetic 
mechanism that leads to diversity among Salmonella is pseudogene formation. This is 
frequently observed in host specific serovars such as Typhi and Gallinarum. The largest 
Salmonella genome belongs to S. Typhi whereas the smallest belongs to S. Javania (103). S. 
Typhi is the serovar with the highest number of unique genes (genes that are absent in other 
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serovars of Salmonella). Among the non-typhoid Salmonella, S. Schwarzengrund, S. Tennesse 
and S. Newport carry the highest amount of unique genes whereas S. Typhimurium and S. 
Enteritidis contain the fewest number of unique genes (103).  
The differently distributed gene islands in Salmonella are SGI-1 and SPI-3 described in 
Chapter 5 and 6. Apart from that, SPIs seem to be very well conserved in Salmonella. 
Nevertheless, genetic variations are often associated with pathogenicity. Surface structures, 
such as LPS, flagellin and fimbriae (77) underlie particular selective pressure as they are the 
main targets of the host immune defense. Salmonella serotyping after Kauffmann and White 
is based on the antigenic polymorphism of these structures (186).  
8.4. Usage of DNA microarrays to study genetic diversity  
Genomic microarrays usually contain DNA probes representing all identified open reading 
frames of one or more sequenced strains (205). Array-based comparative genomic 
hybridization (aCGH) is the comparison of these fully sequenced strains to unsequenced but 
related genomes. DNA microarrays have been used to study genetic diversity in Salmonella, 
frequently in relation to pathogenesis (1,13,24,174,187,188,192). The aCGH approaches are 
also used for typing and understanding of the evolution of Salmonella (313, 315, 320). DNA 
microarray based methods allow the comparison of a relatively large number of bacterial 
strains and to identify strain specific genes (1). With the rise of genome sequencing and the 
accumulation of whole chromosomal sequence data, microarray technology is constantly 
improving (1). In future, the coding sequence of virtually every gene might be known and this 
knowledge can be exploited in the design of microarrays (1). However, some limitations have 
to be considered when microarrays are used. False positive or negative results can be obtained 
with divergent genes. They might be displayed as absent when the sequence alteration 
prevents the hybridization to the probes on the microarray slide. They might eventually be 
shown as present when the gene alteration is not part of the probe fragment of the array (gene 
probes constitute gene parts and do not cover the whole nucleotide sequence of the gene). The 
amount of genes that can be detected is restricted to the probes present on the array. It is not 
possible to identify additional genes but only absent genes with respect to the strains that were 
used for constructing the array (1). Furthermore, it is important to consider that the detected 




9. Evidence of increased fitness and virulence in multidrug and quinolone 
resistant Salmonella  
 
Antibiotic resistance and virulence determinants share some common characteristics in terms 
of evolution and ecology (153). Both can be acquired by horizontal gene transfer and in both 
cases point mutations can play a role with respect to pseudogene formation and target gene 
alteration. Antibiotic resistance and virulence are both mechanisms that help to survive 
antibacterial defense systems. As antibiotics and host defense mechanisms, aim to prevent or 
to defend bacterial infections, there is evidence for a co-selection of antibiotic resistance and 
virulence determinants in the evolution of pathogenic bacteria (153). 
9.1. Clinical and epidemiological data support the evidence of a linkage between 
virulence and resistance 
The analysis of clinical data from hospitals has revealed that multidrug and quinolone 
resistant Salmonella are associated with an increased burden of illness in humans as patients 
infected with these bacteria have a higher risk for hospitalization, mortality and bacteremia as 
well as a longer duration of hospitalization than patients infected with fully susceptible 
Salmonella (111,140,151,229,233). SENTRY reported that quinolone resistant Salmonella 
were more frequently isolated from blood than from stool (42) suggesting that these isolates 
are more likely to be transported to systemic sites of the organism. Gorden observed an 
increase in the incidence of cases with bacteremia in children associated with the occurrence 
of multidrug resistant Salmonella in a hospital in Malawi over a period of seven years (98). 
The pentaresistant (ACSSuT) S. Typhimurium DT104 clone is a concrete example of a 
multidrug resistant clone with increased virulence. It was associated with increased severity of 
clinical illness as an unusual high percentage of patients were hospitalized in the UK and in 
the US, this strains was more often isolated from blood than non-ACSSuT stains (226). 
Epidemiological data from Salmonella surveillance programs could also show a linkage of 
virulence and resistance in Salmonella. In Denmark, the surveillance data show that antibiotic 
resistant Salmonella are more frequently isolated from human outbreaks than sensitive ones 
(18). In a study of Hald et al. (244), they used a mathematical model based on prevalence data 
of Salmonella from food, food animals and humans to estimate the relative ability of 
Salmonella serovars with different antimicrobial resistance pattern to survive the food 
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production chain and to cause human disease. Except for S. Saintpaul, this ability seemed to 
increase in antimicrobial resistant strains (244). Hence, multidrug and quinolone resistant 
Salmonella seem to be more successful in infecting humans and in causing a disease outcome 
with increased severity. In Section 9.1.3, particular mechanisms that may build a linkage 
between virulence and antibiotic resistance will be discussed.  
9.1.2. The q-factor – The ability to survive the food chain and cause human infection 
Based on prevalence data of Salmonella in food, food animals and humans from the Danish 
Salmonella Surveillance Program, Hald et al (104,105) developed a mathematical model to 
quantify the contribution of animal food sources to human salmonellosis cases. These 
calculations included a food source dependent factor accounting for the relative importance of 
a food source to act as a vehicle in foodborne salmonellosis. The model also included a 
subtype dependent factor, namely q-factor, accounting for the presumed differences of 
Salmonella strains in their overall ability to survive the food production chain and to cause 
disease in humans. The q-values were estimated for serovars with different antibiotic 
resistance pattern (Q, MR, R and S) but not for different phagetypes of S. Typhimurium as it 
was assumed that q for phagetypes with the same resistance level where equal. The q-factor 
for S. Enteritidis sensitive to antibiotics was set to 1 so that all q-values were estimated 
relatively to this one and to each other. As the overall ability to survive and to cause disease 
might be high in successful clone, the q-factor was used as a parameter to rank the isolates 
after their potential epidemic success. To separate successful from non-successful Salmonella, 
the cut off value q = 1 was chosen as it was the median of all q-factors provided. It is 
important to be aware that these factors are only indicators and that they are associated with a 
relatively big statistical uncertainty. Thus, Table 5 shows only if a given q-factor was above 









Table 5: The q-factors of selected Salmonella serovars of importance for this thesis.  
Serovar
Resistance 
pattern1 Hald et al. , 2007 3
Data from Pires and Hald, 2009 
(personal communication)
Typhimurium Q > 1
MR > 1
R < 1 
S < 1 
Virchow Q > 1
S < 1 
Saintpaul MR < 1 
S > 1
Newport S > 1
Infantis < 1 
Derby < 1 
q-factor2
 
The combinations of serovars and resistance pattern estimated to have a high q-factor (>1) are indicated in bold 
and those with a low q-factor are indicated in italic (q<1); 
1
Q: resistant to quinolones; MR: resistant to four or 
more antibiotic agents; R: resistant to less than four antibiotic agents; S: susceptible to the antimicrobials tested; 
2
the q-factors range from 0.02 (S. Derby) to 3.4 (S. Typhimurium, Q; S. Saintpaul, S); 
3
Reference: (104)  
 
9.2. Mechanisms that connect resistance, fitness and virulence 
Usually, the development of drug resistance and presumably also the acquisition of new 
virulence determinants are initially associated with a fitness disadvantage in the absence of 
the antibiotic (153,253). On one hand, this can be due to point mutations in the target genes 
that may alter the function of the gene and result in a fitness loss. On the other hand, 
resistance genes acquired by gene transfer might impose additional energy costs. However, 
compensatory second site mutations that restore or even increase fitness are observed to occur 
in Salmonella and other bacteria in the absence of the antibiotic (25,253). Since compensatory 
mutations can occur in several different genes they are more likely than the reversion of the 
resistance mutation (10). The compensatory evolution does however not take place in highly 
fluoroquinolone resistant Salmonella. They are observed to have a drastically decreased 
growth capability (95) and they are not able to compensate for their mutations (94). In 
contrast, intermediate fluoroquinolone resistant isolates have no or only little disadvantages 
compared to their wildtypes. Giraud could show that in vivo selected mutants show only 
intermediate resistance compared to in vitro selected mutants which showed high resistance to 
fluoroquinolones (94). Hence, the infrequent findings of highly fluorquinolone resistant 
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Salmonella might be because these bacteria are counterselected by competitive 
microorganisms in the absence of antibiotics.   
Some stress conditions increase the rate of mutations (point mutations and horizontal gene 
transfer) (153). Point mutation rates are increased in the presence of quinolones and reactive 
oxygen species whereas horizontal gene transfer is enhanced in vivo and in the presence of 
antibiotics (153,159). These observations suggest that in presence of antibiotics and inside the 
host, the bacteria evolve more rapidly and a host treated with antibiotics may co-select for 
resistance and virulence determinants (153). But also in the environment, for instance in the 
food production chain, the bacteria might encounter antibiotics, in subinhibitory 
concentrations. They may also be exposed to other antibacterial agents such as disinfectants. 
Some of these substances have the potential to induce the rate of mutations. This can be 
detrimental for the bacteria but it can also lead to an increased adaptation of the bacterium to 
its environment. In the food chain, the bacteria may adapt to conditions that are very similar 
to host defense mechanisms (as mentioned in Chapter 4) increasing the pathogenic potential 
of the ingested strain (69,122,242,251).   
Some resistance and virulence genes are located closely because they are encoded by the 
same replicon. Fluit et al. (79) observed that Salmonella isolates that harbored the virulence 
plasmid also carried resistance islands and/or integrons encoding resistance genes. In the 
course of evolution, these elements might have merged. And indeed, today virulence and 
resistance determinants are frequently found on the same plasmids in Salmonella 
(49,85,119,194,225). It has been reported that Salmonella virulence plasmids can capture 
genes conferring resistance to antibiotics. It has been shown that this is the result of a 
cointegration of virulence with resistance plasmids or of the acquisition of insertion 
sequences, transposons and integrons carrying resistance cassettes by virulence plasmids. 
Resistance plasmids that contain virulence genes, for example the spv region are also 
observed (195). 
The correlation of resistance and virulence attributes in Salmonella could also be explained by 
defense mechanisms that are effective against both, antibiotics and the host immune system. 
And indeed, efflux pumps that are multidrug resistance determinants, such as acrAB of S. 
Typhimurium and E. coli have been reported to extrude bile salts conferring an advantage 
during the colonization of the gut (195,223). In addition, the multidrug resistance system 
SapA of S. Typhimurium has been reported to be involved in the active export of 
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antimicrobial peptides which constitute an important part of the host defense against 
Salmonella (Chapter 5) (175). 
Finally, the exposure to antibiotics might induce virulence genes leading to an increased 
virulence of resistant strains when the antibiotic is present. This has been reported for E. coli 
in the presence of quinolones. These antibiotics induce the Shiga-toxin encoding 
bacteriophage leading to an increase in virulence (128). 
Antibiotic resistance can also lead to a more severe disease outcome without being directly 
linked to virulence determinants. Treatment failure resulting from the choice of the antibiotic 
can for example result in a prolonged duration of the disease. However, salmonellosis is 
normally not immediately treated with antibiotics. Antibiotic treatment is only applied in the 
later stage of disease when complications have already arisen. This suggests that very virulent 
Salmonella strains are more likely to come in contact with an antibiotic and to develop 
resistance than those that cause only mild illness.  
 
10. Success clones of Salmonella – Some examples of epidemiological 
importance 
 
Characteristic for epidemics of Salmonella is that they are temporarily dominated by one 
clone. A period of increase is typically follows by a decline. The mechanisms of expansion 
and subsequent decline or replacement by another success clone are unknown (56). It can be 
the result of environmental and/or bacterial factors. Antibiotics are an important 
environmental factor that can select for clones that are resistant resulting in an overgrowth of 
theses clones and in a replacement of susceptible ones (153). Outbreaks or epidemics may 
also occur following the alteration of strains through mutations that enhance their fitness 
(including horizontal gene transfer). For instance, it has been suggested that the re-assortment 
of phage encoded fitness factors is largely responsible for the epidemic success of pathogenic 
clones (40). Overall, prevalent clones are often resistant to multiple antibiotics (245), may 
have additional virulence properties and an increased potential for transmission (195). But 
non-bacterial factors may also contribute to their success. Some of the recent Salmonella 
clones with epidemiological importance are presented below.  
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A well described example for a multidrug resistant successful Salmonella clone was S. 
Typhimurium DT104 with an ACSSuT (ampicillin, chloramphenicol, streptomycin, 
sulfonamide and tetracycline) resistant phenotype encoded by the SGI-1 (Chapter 6). The 
phage type DT104 is in fact quite heterogeneous representing different clones (137). This 
genetic island was probably taken up by one of these clones in the early 80s or a bit before 
and in the 90s, the multidrug resistant S. Typhimurium DT104 clone was of global importance 
because it became widely disseminated and was observed to be more virulent in humans 
(56,107,137,226). The global emergence of this DT104 clone was accompanied by a decline 
of other Typhimurium clones probably due to clonal competition as the total number of 
Typhimurium salmonellosis cases did not increase (107). Phagetypes that have been displaced 
were among others DT12 that were not resistant to antibiotics. The spread of this clone was in 
part the result of the increasing use of antibiotic but cannot fully be explained by that. The 
rapid dissemination of the multidrug resistant DT104 clone in the United Kingdom occurred 
after the pertinent antimicrobials were banned for use as growth promoters, indicating that the 
wide distribution of this clone is not primarily attributable to its resistance pattern (56). This 
suggests that other fitness or virulence attributes were associated with this clone.  
Currently, the clonal dissemination of Typhimurium-like strains with the antigenic structure 
1,4,5,12:i:- lacking the expression of phase 2 flagella is of concern (18,164). This serovar 
exhibits variable chromosomal mutations and deletions affecting the genes hin, fljB and fljA 
depending on the isolates (164). Interestingly, this serovar represents a considerable diversity 
of subtypes even within a given country (164). Also, the drug resistance pattern varies from 
pansusceptible to multidrug and quinolone resistant (164). The European isolates usually 
express a multidrug resistance phenotype whereas the American and Asian isolates appear to 
be rarely multidrug resistant (164). There is evidence in the literature that strains lacking 
phase 2 flagella are more virulent but the molecular mechanisms behind this increase in 
virulence are not clear (164). Overall, the clonal success of these S. Typhimurium isolates is 
not fully understood yet and remains to be investigated. 
Systemic infections with non-typhoid Salmonella are rare in industrialized countries. There is 
an estimated annual incidence rate of 1.02 per 100,000 population (138). But in sub-Saharan 
Africa, cases of severe non-typhoid salmonellosis are now more numerous than cases of 
enteric fever caused by S. Typhi and S. Paratyphi. The recently discovered S. Typhimurium 
subtype ST313 has been reported to be uniquely associated with invasive non-typhoid 
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Salmonella infections in Africa. This clone is frequently multidrug resistant and is thought to 
be adapted to the human host (130). A distinct prophage repertoire has been found when the 
whole genome sequence of one member of this ST313 clone was analyzed. There was also 
evidence for genome degradation, including pseudogene formation and chromosomal deletion 
























The epidemiology of Salmonella is characterized by a temporary dominance of certain non-
typhoid Salmonella clones (123). It is of importance to determine genetic and phenotypic 
characteristics of these successful clones and to identify bacterial and environmental factors 
that influence their evolution in order to predict future epidemics and outbreaks in a very early 
stage of clonal dissemination. A comprehensive knowledge about these clones will also help 
to implement effective targeted intervention strategies. The overall objective of this study was 
to identify environmental as well as genetic and phenotypic bacterial factors that determine 
diversity in Salmonella and that are important for the emergence of successful clones. This 
was achieved by characterizing Salmonella isolates categorized as successful and non-
successful using phenotypic and genetic screenings followed by more targeted small-scale 
analyses. This chapter of the thesis will discuss different aspects of the selection and 
categorization of the Salmonella isolates that constitute the basis of all experiments carried 
out (Section 14.1.). Thereafter (Section 14.2), the diversity of stress responses of Salmonella 
to conditions of the food chain and their importance for clonal success will be the subject of 
discussion (this comprises the work of Manuscript I and Manuscript II). In Section 14.3., the 
pathogenic potential of multidrug and quinolone resistant Salmonella will be discussed with 
focus on specific virulence genes and host pathogen interactions determined using eukaryotic 
cell culture models. This section includes the work presented in Manuscript II and III. The 
final Section (14.4.) of this chapter will discuss possible evolutionary mechanisms that may 
be involved in the emergence of successful multidrug and quinolone resistant Salmonella 
including the role of bacteriophages, spontaneous mutation rates and macrophages. This 
section deals with the results from Manuscript II and III.   (241) 
11.1. The ranking of relevant Salmonella isolates based on their epidemic success 
The bacterial isolates built the basis of the experimental work and their selection and 
categorization was thus an essential part of this thesis. The selection of isolates was based on 
prevalence data from the Danish Salmonella Surveillance Program encompassing the years 
2007 - 2008 (14,15). The isolates originated from different sources with focus on the pork 
chain because pork is an important source of human salmonellosis in Denmark (17). An 
important criterion for the isolate selection was their relative distribution in pigs, pig carcasses 
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after slaughter and humans providing information about their decrease or increase during the 
transmission in the food chain. This information served as an indication of their ability to 
cause disease or to survive in the food or food preparation areas. The emphasis of this study 
was laid on S. Typhimurium as it is an important serovar in the pork chain and in humans and 
as different S. Typhimurium phagetypes vary substantially in their resistance to antibiotics 
and their epidemicity (18,71).  
Using the comprehensive data of the Danish Salmonella Surveillance program, a source 
attribution model was implemented by Hald et al. (17)  that estimated the contribution of 
different animal-food sources to human salmonellosis. This model included a subtype 
dependent factor q which accounted for the relative ability of Salmonella serovars with 
different antibiotic resistance pattern to survive the food production chain and to cause human 
disease (Chapter 9.1.2) (104). This factor has been used in this thesis to rank Salmonella 
isolates after their potential epidemic success. However, this categorization had some 
limitations. The q-factors did not distinguish between S. Typhimurium phagetypes and were 
not available for all possible serovar/antibiotic resistance combinations. Moreover, the values 
for q were associated with a relatively big statistical uncertainty. Interestingly, the q-factors 
increased in antibiotic resistant Salmonella, except for S. Saintpaul. Quinolone resistance was 
associated with the highest q-factors. 
In accordance with the q-factors, antibiotic resistance in Salmonella, particularly multidrug 
and quinolone resistance, is associated with an increased human health burden with respect to 
both, an increased severity and incidence rate of illness (42,98,104,111,140,151,229,233). 
Hence, the antibiotic resistance pattern seems to be an indicator for the epidemic success and 
was used to group the isolates into quinolone resistant (Q; at least low level resistance to 
fluoroquinolones), multidrug resistant (MR; resistant to four or more antibiotic agents), 
resistant (R; resistant to less than four antibiotic agents) and sensitive (S; fully susceptible to 
the tested antibiotics). These definitions have been used in previous publications and where 
also used for the calculation of the q-factors of antibiotic resistant Salmonella (104,178). 
Today NARMS and DANMAP define multidrug resistance more correctly as resistant to at 
least three antimicrobial classes (18,45). An antimicrobial class includes those antibiotics that 
share the same mechanism of action. The classification of the isolates in this study was based 
on single antibiotic agents which might be a limitation of the study but in this manner the 
categorizations based on the resistance pattern and on the q-factors were comparable. When 
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q-factors of antibiotic resistant Salmonella are calculated in the future the categorization 
based on antimicrobial classes may be considered. 
Overall, thanks to the availability of comprehensive epidemiological data, it was possible to 
rank a large number of field isolates after their potential epidemic importance.  
11.2. Salmonella in the food chain – Varying tolerance to dehydration and limited 
diversity with respect to the freezing 
11.2.1. Long-term freezing and thawing in minced meat is tolerated by all Salmonella 
without considerable cellular injury 
A high prevalence of Salmonella in the foods and a successful spread in different food sectors 
may result in an increased number of human cases and in outbreaks. To achieve this, the 
bacteria must be able to survive within or on the food or in food preparation areas where they 
are exposed to different stresses. As freezing is a widely used preservation technique of fresh 
meat, the tolerance of Salmonella isolates to freezing of minced meat for up to one year was 
analyzed (Manuscript I). The impact of freezing and thawing on all Salmonella strains tested 
during the whole experimental period was very low. Within the meat, the bacteria cells 
seemed to be remarkably well protected from injury as Salmonella were capable of growing 
without reduction on selective media (35,242) and as the lag times in meat juice after thawing 
were relatively short (approx. 1.7 h). Growth was measured at room temperature (25 °C) and 
demonstrated that meat thawed on the kitchen table poses a risk for human health as 
Salmonella can readily multiply in the meat juice. Also other meat types than minced meat are 
associated with high survival rates of Salmonella (59,66). This indicates that meat requires 
specific attention with respect to food safety procedures.  
The physiological state of the bacteria was shown to have an impact on the freezing tolerance. 
Cells in exponential growth phase were more susceptible to freezing but surprisingly, had 
shorter lag times after thawing. In the food chain, a fraction of the bacteria might appear in an 
exponential growth state posing a special risk if the meat is not thawed adequately. It is 
generally recommendable to thaw the meat in the fridge before transferring it to room 
temperature as slow thawing is more detrimental for the bacteria cells. Additionally, meat 
may be exposed to chilling before freezing to prevent that single bacterial cell are frozen in an 
exponential growth state.  
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As all Salmonella strains survived the freezing treatment equally well, it can be concluded 
that freezing and thawing in minced meat does neither contribute to diversity nor to clonal 
success of Salmonella. However, other stress conditions in the food chain might be better 
tolerated by successful Salmonella clones than by minor clones. A recent study could identify 
strain specific differences in survival of Salmonella on beef cuts subjected to cold storage 
(132). Interestingly, isolates that survived longer were S. Typhimurium DT104 and S. 
Enteritidis PT4 and PT8. These phagetypes belong to the most prevalent Salmonella 
phagetypes in food and humans in Denmark (16,17) and represent potential success clones. In 
contrast, S. Dublin, S. Derby and S. Infantis which are epidemically not so important showed 
shorter survival times during cold storage. The response of Salmonella to chilling requires 
further attention in order to determine if this is a treatment that favors successful clones.  
11.2.2. Dehydration affects Salmonella subtypes differently but does not contribute to 
their clonal success  
Water deprivation is experienced by microorganisms in a wide range of foods and on tools, 
machines and surfaces in food processing areas. The tolerance of different Salmonella isolates 
to drying under two different combinations of temperature and humidity simulating the 
condition in a typical Danish pig slaughterhouse and in private or public kitchens was 
investigated (Manuscript I). Due to the experimental setup of the dehydration experiment 
(bacteria resuspended in 0.9 % NaCl where subjected to air-drying), the bacteria experienced 
simultaneously an increase in osmotic pressure, nutrient limitations and temperatures below 
the optimum (10 °C or 25 °C). Interestingly, S. Infantis was most robust under these 
conditions which might explain why the relative distribution of this serovar on pig carcasses 
after slaughter is often observed to be higher than in pigs (14,15). The slaughter process 
decreases the overall number of carcass associated Salmonella due to scalding, singeing and 
chilling (232). But recontamination of the carcasses from insufficiently cleaned equipments 
and other sources accounts for approx. 30 % of all Salmonella on pig carcasses (232). S. 
Infantis could be able to persist and to recontaminate the carcasses in the slaughter line. In 
contrast, S. Derby and S. Typhimurium DT12 were impaired in surviving dehydration. They 
are both frequently isolates from pigs and pork but comparatively seldom cause human 
infection (14,15). They are eventually not able to persist in food processing areas, such as in 
kitchens which may result in fewer cross contaminations of ready-to-eat food. To conclude, 
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the tolerance to drying might play a minor role for some Salmonella to cause infection but it is 
not characteristic for success clones. 
In line with these observations are the results from the array-based comparative genomic 
hybridizations (aCGH) (Manuscript II). They show that only two genes related to stress 
tolerance and survival dominated in successful MR and Q Salmonella. These genes encode an 
acid shock protein (Asr) and a putative copper homeostasis protein (CutC). Thus, it would be 
interesting to investigate copper and acid tolerance of success clones. Nevertheless, the 
overall results point out that the tolerance to stress conditions does not seem to be a major 
characteristic of epidemically successful Salmonella clones.  
11.3. The pathogenic potential of quinolone and multidrug resistant Salmonella 
11.3.1. Genes located on mobile elements seem to be involved in virulence of quinolone 
and multidrug resistant Salmonella  
The impact of MR and Q Salmonella on human health has been the focus of several 
epidemiological studies that compared prevalence and clinical data of Salmonella with 
different antibiotic resistance patterns (20,104,111,151,229,233). These studies suggested that 
besides their selective advantage in presence of antibiotics, Q and MR Salmonella are more 
virulent and/or fitter than susceptible ones. An increased virulence potential could indirectly 
be the result of an improved ability to survive in the food chain. However, as discussed in 
Section 13.2., this evidence could not be proven experimentally. Consequently, factors that 
might determine the pathogenic potential of Q and MR isolates were studied with regard to 
virulence genes (Manuscript II) and host pathogen interactions in cell culture models 
(Manuscript III). Two genes with an experimentally proven function in virulence, gipA 
(STM2599) and sopE (STY4609) (246), and three genes that were suspected to be involved in 
virulence, sugR (STM3753), recT (SG1183) and trhH (AF261825_S012) were found to 
dominate in Q and MR Salmonella. All five genes are encoded by mobile elements, more 
precisely, by prophages (sopE, gipA and recT) and genomic islands (trhH and sugR). The 
genes sugR, recT and trhH were deleted and analyzed for their function.  
RecT seemed to have a weak contribution in surviving the early defense mechanisms of 
macrophages. As this gene shows sequence similarities to a phage encoded recombination and 
repair protein in E. coli involved in double stranded break repair (134), recT might contribute 
to the reduction of lethal DNA damages in macrophages. Other Salmonella serovars that carry 
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recT are S. Gallinarum, S. Dublin, S. Partyphi and S. Typhimurium 14028s. These serovars 
are all highly virulent in their particular hosts (75,145,197,207) which supports the hypothesis 
that recT is of importance for virulence. RecT also seemed to have a week effect in preventing 
spontaneous mutations. However, its activity seemed to be enhanced by ciprofloxacin (CIP) 
or by the CIP induced DNA damages. It might be surprising that many Q and MR strains 
harbor an additional gene that is involved in reducing mutations because resistances towards 
certain antibiotics, such as quinolones, are conferred by gene mutations. The benefit of recT 
might be that it allows the bacteria to survive conditions that induce mutations such as the 
macrophage defense and quinolone exposure. The surviving bacteria may then profit from 
beneficial mutations generated under these conditions and for instance acquire quinolone 
resistance. 
As expected, genes encoded by the Salmonella genomic island 1 (SGI-1) that is the cause of 
multidrug resistance in S. Typhimurium DT104 and in some non-Typhimurium serovars 
(6,32,63,64,67,142,143), were strongly associated with the Q and MR isolates. One of these 
genes trhH is annotated as a putative pilus assembly protein and was assumed to play a role 
either in bacterial cell or in host cell contact (31,33). But trhH did neither influence the 
adhesion to epithelial cells nor the conjugation frequencies with the ΔtrhH::kmR mutant as the 
recipient. However, this gene may play a role in other cellular contacts that have not been 
investigated. For instance, it might be involved in the adhesion to M-cells which seem to be 
important in the infection process of Salmonella (109). 
The gene sugR that was also found to dominate in Q and MR strains appeared to have a very 
weak positive effect on intraphagocytic growth. The gene sugR exhibits sequence homology 
to the ATP binding subunit ClpX of a Clp protease and might thus contribute to growth in 
macrophages because it degrades or repairs missfolded proteins during for example acid stress 
that is part of the phagocytic defense (224,240,247). The reason why the effect observed was 
only weak and not significant might be that the absence of this enzyme can be in part replaced 
by other chaperones (226).  
The use of microarrays for the identification of virulence genes in a certain group of strains 
has some limitations. Only the genes that the test strains share with the strains that have been 
used to design the array can be identified. The microarray utilized in this study was based on 
the genomes and plasmids of seven distinct Salmonella serovars including virulent and/or 
antibiotic resistant strains, for example S. Typhi CT18 and S. Typhimurium DT104 (NCTC 
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13348). It was thus expectable that a wide range of Salmonella virulence genes was present 
on the array. Furthermore, the formation of pseudogenes that contributes to Salmonella 
pathogenesis cannot be detected with the help of microarrays which is a disadvantage when 
virulence attributes are studied. Thus, it might be a good alternative to use methods such as 
whole genome sequencing or optical genetic mapping that have the potential to identify novel 
strain specific virulence genes or small sequence alterations. 
11.3.2. Diversity in epithelial cell invasion and macrophage survival does not contribute 
to the success of multidrug and quinolone resistant Salmonella  
So far, the bacterial and host factors that contribute to the increased virulence potential of Q 
and MR Salmonella are unknown. Infections with these strains are often associated with 
bacteremia (42,98,233) suggesting that they must be capable to invade and disseminate 
systemically and macrophages are very likely to be a vehicle in this respect (109). The ability 
of MR and Q Salmonella to adhere and invade intestinal epithelial cells and to survive and 
replicate in macrophages in absence and presence of CIP was investigated (Manuscript III). 
The number of bacteria capable of adhering to epithelial cells was similar for all isolates 
investigated indicating that adherence is not a criterion that determines diversity in non-
typhoid Salmonella. In contrast, considerable differences of the Salmonella strains to invade 
the intestinal epithelium were detected. These differences appeared to be strain specific and 
occurred within the serovars S. Typhimurium, S. Saintpaul and S. Derby. These results 
support other studies that have observed that the disease outcome of non-typhoid Salmonella 
in humans is divers and not only host but also strain dependent (77,112,127,249). 
Nonetheless, neither Q nor MR strains showed increased invasion of epithelial cells. The 
ability to survive and replicate in macrophages was similar for all test strains except for one 
MR S. Infantis isolate that exhibited reduced intracellular counts and a decreased cytoxic 
effect on the macrophages. This is in line with other studies that have shown that the survival 
within macrophages is strain dependent (172,235). In the time period from 2 h to 4 h post 
infection, the intracellular level of Q isolates increased slightly more compared to the other 
isolates. However, at 24 h post infection, this difference was not observed. Interestingly, in a 
study of Volf et al. (235) S. Typhimurium showed increased counts in porcine macrophages at 
4 h post infection compared to S. Derby and S. Infantis but at 24 h post infection, this 
difference disappeared. As S. Typhimurium was thought to be more virulent in pigs than S. 
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Derby and S. Infantis, this might suggests that the 4 h sample in a cell culture model of 
macrophage survival is most indicative for the actual in vivo conditions. 
The impact of CIP on survival in macrophages was analyzed using a Q S. Typhimurium 
DT104 isolate. The intracellular counts were not affected by the addition of CIP (in a 
concentration of 1 x and 20 x MIC) until 4 h post infection indicating that CIP reaches only 
subinhibitory concentrations in the Salmonella containing vacuole (SCV). After 24 h, the 
intracellular bacteria were reduced but not eliminated which was presumably the reason of 
macrophage apoptosis followed by the release and killing of the bacteria in the extracellular 
medium. If virulence was affected in Salmonella by the addition of CIP could not be 
concluded from these observations. In Staphylococcus aureus and Shiga toxin–producing 
E. coli, CIP has been shown to induce phage encoded virulence genes (96). As severe 
systemic diseases may be due to a dissemination of Salmonella within macrophages without a 
rapid induction of apoptosis (Section 5.3) (65,109), it is very important that antibiotics are 
effective against Salmonella within the SCV. Ofloxacin has been shown to be more effective 
in killing intraphagocytic Salmonella as it eliminated the intracellular bacteria in a 
concentration corresponding to 10 x MIC after 8 h post infection. (47). 
To conclude, the mouse macrophage and human epithelial cell culture models used in this 
study were applicable to study pathogenic diversity in Salmonella but they did not seem to be 
suitable to investigate the virulence potential of successful MR and Q Salmonella. Other 
factors than the ability to adhere and invade epithelial cells and survive in macrophages may 
lead to the observed increased severity of illness associated with quinolone and multidrug 
resistance. Alternatively, the cell culture models were not sensitive enough as they were 
lacking many aspects of the host immune system. Cell culture models that are more similar to 
in vivo conditions, such as mucus-secreting cell lines (97) and PMN transepithelial migration 
assays (158) are available and should eventually be prioritized for virulence studies. The 
dissemination of Salmonella within dendritic cells to systemic sites of the host may be of 
importance in the pathogenesis of severe salmonellosis (228,239) and thus the persistence of 
Q and MR bacteria within these cells would be an interesting research subject. There have 
been several attempts to investigate virulence of the pentaresistant S. Typhimrium DT104 
clone using cell cultures and mouse models (8,44) but these studies also failed to show an 
increased invasiveness of this clone. Thus, factors that are specifically related to humans and 
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that cannot be shown using mouse macrophages or mice may account for the increased 
virulence in MR and Q Salmonella.  
11.4. Evolution of quinolone and multidrug resistant Salmonella - The role of phage 
repertoire, mutation rate and macrophage infection  
11.4.1. Mobile elements, in particular prophage genes, are key elements in multidrug 
and quinolone resistant Salmonella 
The dynamics in the genetic evolution of successful MR and Q Salmonella clones are still not 
well understood. As described in Manuscript II, most of the genes that dominated in Q and 
MR isolates were related to mobile genetic elements of which the largest fraction accounted 
for single genes or gene clusters of prophages. It may seem surprising that MR and Q 
resistance is associated with phagegenes as bacteriophages are not frequently reported to carry 
and transfer antibiotic resistance genes (190). However, in vitro studies have shown that 
bacteriophages are capable of transferring resistance determinants, including SGI-1 (51,204). 
Hence, it might be that the role of bacteriophages in the dissemination of antibiotic resistance 
is underestimated (36). Alternatively, phages might be indirectly linked to antibiotic 
resistance by the following mechanisms: 1.) Resistant Salmonella may have an improved 
ability to take up temperate bacteriophages or 2.) they might be more robust towards 
environmental conditions that induce phage lysis and are thus capable of maintaining their 
phages. These environmental conditions include certain antimicrobials, such as quinolones 
(57,236). Thus, in presence of quinolones, quinolone resistant Salmonella are protected from 
phage lysis and might instead take up new phages that are released by quinolone susceptible 
bacteria that are nearby.  
The question has been ask if the take up of a single mobile element is enough to turn a minor 
clone successful (245). Of all the phage genes identified in the Q and MR Salmonella, the 
function of one particular gene (recT) was investigated. This gene was observed to have a 
weak effect on the phenotype (Section 14.3.1) which is supported by findings that individual 
prophages only slightly modify the fitness of a bacterium and confer only small advantages 
(40). Thus, the acquisition of one single phage would presumably not turn a bacterium into a 
successful clone. Instead, the quantity of converting prophages within a cell might lead to a 
fitter or more virulent phenotype. However, it is thought that the acquisition of a single 
mobile element (SGI-1) was responsible for the successful spread of S. Typhimurium DT104. 
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Along with resistance genes, this island encodes several genes with still unknown function 
that could be involved in virulence or fitness. But also the environmental conditions, the 
increased use of antibiotics, contributed to the fitness and spread of this clone.  
To conclude, the evolution of successful clones is complex and several factors have to come 
together to enable the emergence of a success clone. Future surveillance and prevention 
strategies may have to concentrate on both, successful mobile elements as well as on 
successful bacterial strains and they have to consider the contribution of given environmental 
conditions to the emergence of outbreaks and epidemics. For the early assessment of the 
epidemic potential of a clone, molecular typing methods may be complemented with 
screenings for success marker genes, for example a combinations of certain resistance, 
virulence and phage genes.  
11.4.2. The macrophage pathogen interaction might play role in the evolution of 
quinolone resistance and virulence 
Quinolone resistant Salmonella are reported to exhibit the highest mortality rates in humans 
when compared to Salmonella that are susceptible or that harbor other resistances (111). The 
factors that drive the simultaneous evolution of virulence and resistance are not well 
understood. As quinolone resistance is often mediated by target gene alteration, it was 
hypothesized that mutation rates play an important role in the evolution of Q Salmonella. The 
results shown in Manuscript III point out that the mutation frequencies under static non-
selective conditions are not elevated in CIP resistant Salmonella. This is contradicting with 
other studies that found a correlation of quinolone resistance and slightly elevated mutation 
rates (9,147). It might be a limitation of the study that the underlying resistance mechanisms 
of the isolates were unknown. However resistance to quinolones is most often caused by point 
mutations (113) and thus it is likely that the CIP resistance of most if not all the isolates was 
due to point mutations. A strength of the study is that the test group of CIP resistant isolates 
and the control group of CIP susceptible isolates were equal in size and in many aspects 
comparable (serovar, phagetype and resistance to other antibiotics than CIP). Hence, Q 
Salmonella might rather have transient elevated mutation rates, under conditions when an 
increased genetic adaptability is favorable such as during infection and in presence of 
antibiotics (93).  
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Macrophages are likely to be a vehicle of Salmonella during prolonged persistence and 
systemic spread. The macrophage defense activates the bacterial SOS response which may 
lead to increased mutation rates of intracellular bacteria that are able to survive the defense. 
The results discussed in Manuscript II show that the frequency of most CIP sensitive strains to 
acquire a reduced CIP susceptibly increases after macrophage infection. This frequency was 
substantially enhanced when CIP (in a concentration of 20 x MIC) was added suggesting that 
CIP penetrates the SCV. But overall, it seemed that the intravacuolar CIP concentration at that 
time is only subinhibitory for Salmonella. It is possible that the reduction of the CIP 
susceptibility predisposes the bacteria to become resistant to higher concentration when 
survival in macrophages is prolonged. Severe cases of salmonellosis are more likely to be 
treated with antibiotics and thus, virulent Salmonella may be more likely to come in contact 
with antibiotics. In this respect, macrophages may pose a risk for the acquisition of quinolone 
resistance. As a decrease in the CIP susceptibility occurs also in absence of the antibiotic, 
macrophages might generate resistant mutants already before antibiotic therapy is started.   
When treating salmonellosis, an antibiotic in a concentration that efficiently eliminates the 
bacteria in the SCV should be given. The administration of agents that inhibit the bacterial 
SOS response might be considered in addition to quinolones (50,133). Alternatively, 
antibiotics to which bacteria cannot become resistant by a single mutation event might be 
prioritized.  
 
12. Conclusions and recommendations 
 
1) The tolerance to drying and rehydration was observed to be serovar and phagetype 
dependent whereas Salmonella exhibited a general robustness to freezing and thawing in 
minced meat. These observations underline that meat requires specific attention with 
respect to food safety procedures. However, interventions with the aim of reducing the 
spread of epidemically successful clones should presumably target other processes than 
freezing and dehydration. 
2) Prophage acquisition seems to be of importance in the successful evolution of multidrug 
and quinolone resistant Salmonella clones. Prophage genes may be used in the future in 
combination with other methods to assess the potential epidemic importance of a clone in 
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an early stage of dissemination. However, the global spread of clones might also in the 
future be difficult to predict and prevent as they are not restricted to one country. Such a 
clone might emerge in developing countries which do not have a routine surveillance 
system. Thus, it is important to develop simple methods for the detection of these clones 
(that are easy to use and not too costly) that can be standardized and used in all national 
and international surveillance programs. In the future, whole genome sequencing may 
provide a tool that allows a fast detection of success clones but before this can be 
realized, the costs of this method must decrease and the data analyses must become more 
user-friendly. 
3) Finally, the macrophage pathogen interactions seem to be important in the evolution of 
successful quinolone resistant Salmonella. The results suggest that Salmonella that are 
able to persist for prolonged periods within macrophages have a higher chance of 
becoming resistant to fluoroquinolones, particularly when fluoroquinolones are 
administered. The increased occurrence of invasive non-typhoid Salmonella infections 
highlights the importance of an antibiotic therapy with agents that are effective against 
pathogens within the Salmonella containing vacuole and to which bacteria cannot become 
resistant by a single mutation event.  
Overall, the tolerance to drying and rehydration and the ability to invade intestinal epithelial 
cells as well as to survive in macrophages are important factors in the diversity of non-typhoid 
Salmonella but do not seem to contribute to clonal success. Success might be the result of a 
combination of factors and might include favorable environmental condition and a clonal 
group of bacteria with a selective advantage under the given conditions. The selective 
advantage might be conferred by the acquisition of prophage genes, genomic islands and 




Successful clones of Salmonella should be prioritized for whole genome sequencing (245) in 
order to be used in comparative genomic analyses. This will allow to identify genetic markers 
that could be used for an early detection of clones that have the potential to spread and to 
cause disease. Along with sequence analyses, phenotypes and gene expression profiles of 
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success clones might have to be studied in order to get a comprehensive understanding of the 
relations of resistance, virulence and epidemic success. This understanding will be useful for 
the development of targeted intervention strategies.  
In addition to the investigation of pathogen specific factors, environmental conditions along 
the food chain or within the host that have an impact on clonal success should be identified. 
This may include environments were phage transfer is enhanced or where mutation rates are 
increased. This might help to find hotspots of gene acquisition that pose a risk for the 
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The spread of epidemically successful non-typhoidal Salmonella clones has been suggested 
as the most important cause of salmonellosis in industrialized countries. Factors leading to 
the emergence of success clones are largely unknown but their ability to survive and grow 
after physical stress may contribute. Epidemiological studies developed a mathematical 
model allowing the estimation of a factor (q) accounting for the relative ability of Salmonella 
serovars with different antimicrobial resistances to survive the food chain and cause human 
disease. Using this q-factor, 26 Salmonella isolates were characterized as successful or non-
successful. We studied their survival and growth after freezing for up to 336 days in minced 
meat using stationary and exponential phase cells. We also investigated survival and growth 
after dehydration at 10 ˚C and 82 % relative humidity (RH) as well as 25 °C and 49 % RH for 
112 days. Stationary phase cells declined less than one log unit during one year of freezing 
and initiated growth with an average lag phase of 1.7 h. Exponential phase cells showed 
reduced survival, but tended to have shorter lag phases. High humidity/low temperature were 
less harmful for Salmonella than low humidity/high temperature whereas the tolerance was 
highest for Infantis and one Typhimurium U292 isolate and lowest for Derby and one 
Typhimurium DT170 isolate. This study shows that dehydration, in contrast to freezing, was 
differently tolerated by the Salmonella strains. But the tolerance to freezing and dehydration 















Salmonellosis is one of the most reported zoonosis in the EU (5) and causes foodborne 
diarrheal disease worldwide (2). Denmark, known to have successfully achieved a reduction 
in human salmonellosis through national control programs (41), had a very high number of 
laboratory confirmed cases in 2008 (3656 cases) and 2009 (2129 cases) (4) due to several 
large outbreaks caused by Salmonella Typhimurium. In order to prevent outbreaks, it is 
important to continuously develop and implement effective intervention strategies. 
A rapid spread of a limited number of epidemically successful Salmonella clones in different 
sectors of food animal production has been suggested as the most important cause of disease 
in industrialized countries (37,41). In other words, Salmonella subtypes differ in their 
importance for human health. This has been reflected in epidemiological studies, which used 
a mathematical model allowing the estimation of a subtype dependent factor (q) (22,23). This 
factor illustrates the relative ability of Salmonella serovars with different antimicrobial 
resistance pattern to survive the food production chain and to cause human disease. It varies 
among different Salmonella serovars and seems to increase in antimicrobial resistant strains 
(22,23) and can thus be used to rank Salmonella serovars according to their epidemic success.  
Circumstances leading to the emergence of success clones are largely unknown. The success 
of certain Salmonella subtypes seems to be primarily due to an increased virulence potential 
(27). Epidemiologists have demonstrated that antimicrobial resistant bacteria can cause 
infections with increased fatality rates in humans (24,29,40). But an association between 
virulence and resistance (13) or virulence and major worldwide clones (33) could not be 
proven by in vivo or in vitro studies. Therefore, other factors than virulence, such as the 
ability to survive the food chain may contribute to the epidemic success of specific clones. 
However, little is known about variations in tolerance of different clones to environmental 
stress in the food chain.  
Raw meat, especially pork, is a common source of human salmonellosis (4,41). Bacteria 
entering the fresh meat line are commonly exposed to various stress conditions such as 
freezing and dehydration. Freezing is a widely used preservation method for controlling 
bacterial growth in fresh meat. Dehydration may be experienced when bacteria attach to 
surfaces of processing equipment for prolonged periods, and a reduction of the water activity 
in food is also a long established preservation method. Drying as well as freezing prevent 
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microbial growth but do not necessarily eliminate microorganisms, which may allow the 
bacteria to regain their growth capacity and their ability to cause disease when the 
environmental conditions become favourable (15,38).  
Studies on bacterial survival during environmental stress are often carried out with stationary 
phase cells, possibly because they are more stress tolerant (3,8,14), and this will lead to more 
conservative estimates on growth and survival. The growth phase of pathogens contaminating 
the process line in the food industry, is however uncertain  as bacteria in faeces, in waste 
material of the slaughter line and in food products may appear in mixed growth phases 
depending on temperature and nutrients available. 
The aim of this study was to investigate the responses of Salmonella serovars and phagetypes 
with different antimicrobial resistance patterns to physical stress likely to occur in the fresh 
meat chain and to evaluate if the findings correlate with the level of epidemic success 
according to the ranking by the q-factor. We analyzed the response to freezing in minced 
meat using exponential and stationary phase cells and to dehydration at two different 
combinations of temperature and humidity.  
 
Materials and Methods 
 
Bacterial strains and culture conditions. We included 26 isolates of Salmonella enterica 
spp. enterica, representing different sero- and phagetypes originating from sporadic or 
outbreak cases from humans as well as from animal and food sources (Table 1). Most of the 
isolates were different phagetypes of S. Typhimurium as it is the dominant serovar in pork in 
Denmark (2). The isolates were characterized by their q-factor as successful (q≥1) or non-
successful (q<1). These factors were obtained from Hald et al. (22,23) and from the research 
group Epidemiology and Risk Modelling, Danish National Food Institute (unpublished data). 
Based on data from the Danish Salmonella Surveillance Program, they used a mathematical 
model to calculate a factor (q) accounting for the presumed differences of Salmonella strains 
in their overall ability to survive the food production chain and cause disease in humans. To 
separate successful from non-successful Salmonella, the cut off value q = 1 was chosen as it 
was the median of all q-factors provided. 
Overnight stationary phase cultures were prepared by inoculating a colony from calf blood 
agar into 20 ml Brain Heart Infusion (BHI) broth in a shaking incubator (at 37 °C, for approx. 
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18 h). To obtain inocula, the cells were collected by centrifugation (6000 g, 5 min), washed 
and resuspended in 0.9 % NaCl (w/v).  
Cell counts were determined by plating five 10 µl droplets from relevant 10-fold dilutions 
prepared in 0.9 % NaCl (w/v) on Xylose Lysine Desoxycholate (XLD) agar (Oxoid) or BHI 
agar followed by overnight incubation at 37 °C. Two technical replicates were performed and 
the experiments were repeated twice if not otherwise stated.   
Survival and growth after long-term freezing in minced meat. The optical density (OD600) 
of the inocula was adjusted to 0.5 corresponding to a cell concentration of 10
8
 CFU/ml and 
further diluted to obtain a second inoculum of 10
5
 CFU/ml. 
Minced pork was purchased in a local supermarket within one day prior to the experiment 
and stored at 5 °C. The fat content of approx. 10 % was determined as previously described 
(12). The water content of 70 % was measured by a gravimetric method (6). To obtain an 
equal distribution of the bacteria in the meat, smaller meat portions (100 g) were first mixed 




 CFU/ml of Salmonella. Then, 300 g 
of meat were added and blended giving a final Salmonella concentration of 10
3





respectively. As a negative control, meat portions inoculated with sterile 0.9 % 
NaCl (v/w) were prepared. The inoculated meat was finally divided into portions of 25 g, 
tightly packed into sterile plastic bags and frozen at -18 °C for 336 days. This time period 
was chosen as maximum storages times of 4 to 12 months in a freezer are recommended for 
minced meat (US Department of Agriculture. Freezing and Food Safety. Available at 
http://www.fsis.usda.gov/factsheets/focus_on_freezing/index.asp).  
Duplicates of the 25-g meat portions were used to determine the number of Salmonella before 
freezing (at day 0) to confirm the initial cell number and after freezing for 1, 4, 7, 14, 28, 57, 
84, 169, 259 and 336 days. For this purpose, the meat portions were allowed to thaw for 3 h 
at 5 °C, then transferred to 225 ml 0.9 % NaCl (w/v) and stomached (Colworth Stomacher 
400) for 30 s to release the bacteria into the water phase. Bacterial counts on XLD agar were 
done as described above. In order to confirm the absence of Salmonella in the uninoculated 
minced meat, two negative controls were analyzed at each sampling day.  
After approximately 180 days of freezing, 2 replicates of the 25-g samples were thawed at 
25 °C for 3 h and 2 ml of meat juice were collected. The meat juice was subsequently 
incubated at 25 °C for 8 h. To assess growth, 100 µl meat juice where used for direct colony 
counts on XLD agar after 0, 1, 2, 2.5, 3, 3.5, 4, 5, 6 and 8 h. The temperature of 25 °C and the 
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time period of 8 h were chosen to imitate the behaviour of the consumers where meat might 
be thawed at room temperature during a working day (8-11 h). 
Survival and growth of stationary and exponential phase cells after short-term freezing 
in minced meat. In a second freezing experiment, overnight stationary phase cultures of S. 
Typhimurium DT12 and U292 were prepared as described above using Luria Bertani (LB) 
broth. They were adjusted to 10
7
 CFU/ml and used as inocula for stationary phase cells. For 
the preparation of the inocula of exponential phase cells, the overnight cultures were diluted 
to 10
4
 CFU/ml and incubated at 37 °C for additional 4.5 h until the cell concentration had 
reached 10
7
 CFU/ml.  
The meat inoculation was carried out as for the long-term study with some modifications. 
First, 350 g of minced beef (fat content approximately 15 %) were blended with 13.5 ml of 
the inocula containing cells in stationary or exponential growth phase. Then, further 1000 g 
of meat were mixed into it leading to a final Salmonella concentration of 10
5
 CFU/g. The 
meat was divided into portions of 60 g and frozen at -20 °C.  
Growth curves in meat juice and the Salmonella concentration of the meat portions were 
determined before freezing (day 0) and after 1, 2, 8, 20, 34 and 49 days. For this purpose, the 
meat portions (60 g) were thawed over night at 5 °C. Then, 10 g of meat were removed, 
transferred to 30 ml 0.9 % NaCl (v/w) and stomached for 2 min. Direct colony counts on 
XLD agar were made as described above.  
The remaining 50 g of meat sample were transferred to 25 °C for 1 to 2 h to collect meat juice 
which was subsequently incubated at 25˚C for 27 h. In this experiment, 50 g of meat were 
chosen as smaller volumes were not sufficient to obtain enough meat juice. The Salmonella 
concentration was measured after 0, 2, 4, 6, 8, 10, 27 h by plating 100 µl of meat juice on 
XLD agar. 
Survival and growth after dehydration under two temperature/humidity conditions. 
Two days prior to the experiment, an air-tight chamber (Nalgene Labware) was moved to 
10 ˚C and adjusted to 82 % relative humidity (RH) by placing 300 ml of a saturated NaCl 
solution on the bottom of the chamber. By a similar procedure, a second chamber was placed 
at 25 °C and adjusted to 49 % RH using a K2CO3 (Merck) solution. The conditions of the first 
chamber are representative for a typical cutting and deboning area in a Danish pig 
slaughterhouse, where the temperature is around 10-12 °C and the humidity very high 
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(personal communications). The conditions in the second chamber are likely to happen 
during summer in private kitchens. 
The inocula were prepared as described above, adjusted to a concentration of 10
7
 CFU/ml 
and 50 l were transferred in triplicate into microtiter wells resulting in 5 x 10
5
 CFU/well. 
Sterile 0.9 % NaCl (v/w) served as negative controls. After short and gentle shaking, cell 
counts and growth of Salmonella were established (day 0), and the plates were transferred to 
the respective chambers. Cell counts and growth were determined at specific time points from 
day 1 to 112 (Table 2), by rehydrating the bacteria with BHI. This was done by adding 400 µl 
to wells that were completely dried out and 350 µl to wells that still contained liquid. 
Vigorous pipetting ensured resuspension of the cells. From two wells, 100 µl were used to 
perform direct colony counts on BHI agar. The remaining 300 µl in the wells were used to 
establish growth curves in a Bioscreen C reader (Thermo Labsystems) for up to 2 days at 
25 °C without shaking (except for a short shaking before each OD600nm measurement every 
20 min). 
Calculation of lag phases and maximum growth rates. The log transformed and averaged 
data of the growth curves were fitted to a model of Baranyi and Roberts (9) using the web 
based application DMFit available at http://www.combase.cc/toolbox.html. 
Statistical analysis. Two replicate experiments were performed, except for the growth 
analysis in the Bioscreen, which was carried out in triplicate. In case of colony counts, mean 
values of each data point were based on 4 to 12 values dependent on the number of dilutions 
plated. Colony counts were log transformed to calculate standard deviations. Statistical 
significances of differences in lag phases, growth rates and log reductions were calculated 
with one-way analysis of variance (ANOVA) followed by Turkey’s multiple comparison test 









 CFU/g), viable counts of the different Salmonella strains in stationary phase declined 
less than 1 log unit in the meat during 336 days of freezing (Figure A3 in the Appendix). 
When comparing the survival of S. Typhimurium DT12 and U292 during freezing for 49 
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days, the level of viable stationary phase cells also remained unchanged during the whole 
freezing period, whereas significant reductions of exponential cells were observed: 2.04 to 
1.60 log for DT12 after 20 and 49 days .and 1.34 log for U292 at 49 days (P < 0.05) (Figure 
1). The uninoculated controls were all found negative for Salmonella.  
Growth of Salmonella in meat juice after freezing in minced meat. After thawing the 
meat, we established growth curves in meat juice at 25 °C. Neither the lengths of lag phase 
nor the growth rates differed significantly between strains in stationary phase (P > 0.05) 
independent on the start concentrations (Figure 2 and 3). When comparing growth of S. 
Typhimurium DT12 and U292 in meat juice, the average lag phases of both strains in 
exponential phase (3.51 h for DT12 and 1.83 h for U292) tended to be shorter compared to 
the stationary phase cells (5.50 h for DT12 and 5.04 h for U292). This difference in lag phase 
was only found statistically significant for U292 at day 5 and for DT12 at day 20 (P < 0.05). 
The growth curves of day 49 could not be fitted to the model of Baranyi and Roberts (9) and 
lag phases could not be established. Therefore, complete growth curves from the beginning 
(day 2) and the end (day 49) of the experiment are shown in Figure 3. The maximum growth 
rates for DT12 and U292 (exponential and stationary) ranged from 0.26 to 0.64 CFU/ml/h 
and were not significantly different (P > 0.05).   
Survival of Salmonella during dehydration at two temperature/humidity conditions.  
After 7 days of storage in the low humidity chamber (49 % RH [SD 5.252], 25 °C [SD 
0.420]), the inocula of all Salmonella strains were completely dried out. Until day 7, the 
viable cell counts of all strains remained almost the same, thereafter, the concentration of the 
bacteria decreased (Figure 4). Between day 14 and 28, the concentration of all S. Derby 
isolates and S. Typhimurium DT170 strain no. 32 were below the detection limit of 2 log 
CFU/ml. After 56 days only S. Typhimurium U292 strain no. 68, and the S. Infantis strains 
no. 127 and 10 could be detected with 2.0, 2.7, and 2.8  log CFU/ml, respectively.  
The liquid of the inocula in the high humidity chamber (82 % RH [SD 2.158], 10 °C [SD 
0.131]) never evaporated completely. At day 1, the viable counts of nearly all isolates 
increased compared to the initial counts of day 0. A decrease in cell counts was observed 
after 28 days but at the end of the sampling period (112 days), all isolates were still 
detectable. After 112 days, the highest reductions of more than 3 log units were observed for 
S. Typhimurium DT104 (no. 2) and DT12 (no. 16), S. Derby (no. 13) and S. Infantis (no. 
127). However, the high decrease of the latter isolate occurred only after 84 days of exposure 
to high humidity. Before that, this strain decreased about 0.7 log units and belonged to the 
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group of strains with the lowest log reduction. A low log reduction, defined as a 1.0 log units 
or less during 112 days of dehydration was also observed for S. Typhimurium U292 (no. 68) 
and S. Infantis (no. 10). The controls were negative for Salmonella, during the whole 
sampling period (112 days). 
Growth of Salmonella after dehydration at two temperature/humidity conditions.  Lag 
phases and growth rates of the different Salmonella isolates were investigated. Figure 5 
shows the length of lag phase at day 0 and after 1, 21 and 56 days of exposure to the two 
temperature/humidity conditions. To illustrate how the individual lag phases were scattered, 
the average lag phases at day 21 and 56 (dashed lines) are also shown. Lag phases after 1 day 
of dehydration were not much different from the untreated samples of day 0. Thereafter, the 
lengths and variations of lag phase increased constantly for all isolates. This observation was 
particularly characteristic for the low humidity condition. After 56 days at low humidity, no 
growth of S. Typhimurium DT104 (no. 02), DT12 (no. 16 and 23), S. Newport (no. 44), S. 
Virchow (no. 42) and S. Derby (no. 13 and 26) was detected. Under high humidity 
conditions, all strains were capable of growing after 56 days of dehydration. Under both 
conditions, S. Derby (strains no. 13 and 15), S. Typhimurium DT12 (no. 16), DT104 (no. 02), 
DT170 (no. 32) and U288 (no. 07) had a longer lag phase than the average after 21 and 56 
day of dehydration, whereas the lag phases of S. Typhimurium U292 (no. 68), DT135 (no. 
05), DT104 (no. 01 and 17) and S.  Infantis (no. 127) were clearly shorter. The maximum 
growth rates were similar for all isolates at all sampling days under both humidity conditions 
(ranging from 0.11 to 0.22 h
-1
) except for S. Derby (no. 13) which had generally a 




Salmonella serovars and subtypes hereof differ in their food safety importance (22,23,35,36) 
and diversity in robustness to food handling procedures might contribute to this divergence. 
Raw meat is a common source of human salmonellosis (41) and in Denmark, pork products 
are among the main sources in this respect (4). We hypothesised that specific handling 
procedures of the fresh meat chain, such as freezing, thawing, and dehydration, may affect 
Salmonella subtypes differently and may contribute to the epidemic success among particular 
Salmonella clones. Based on epidemiological data, Salmonella sero- and phagetypes with 
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different antimicrobial resistance pattern were characterized as successful or non-successful 
in their overall ability to survive the food chain and to cause human disease (22,23). This 
approach is new and differs from other comparative studies on Salmonella (17,25,26,36). We 
also included outbreak strains in this study, for example from the large outbreaks that 
Denmark experienced in 2008 (19). Since Salmonella has a relatively high dose response (7), 
a particular ability to grow in the food chain may be an advantage in relation to causing 
outbreaks. We compared the survival and growth capability of the Salmonella isolates 
subjected 1.) to freezing and thawing after inoculation of both, stationary and exponential 
phase cells into minced meat and 2.) to two temperature/humidity combinations and we 
examined if the responses correlate with the strain classification into successful and non-
successful.  
With an experimental setup imitating natural conditions, we showed that all Salmonella 
strains in stationary phase, independent of their characterization into successful or non-
successful, survived at least one year in frozen minced pork without a major decline. The 
reduction of exponential phase cells of S. Typhimurium U292 and DT12 of more than 1 log 
units during 49 days indicated that exponential phase cells were more affected by freezing as 
reported earlier (8). The result obtained with stationary phase cells is in accordance with 
other studies on minced meat although these studies were of a shorter duration (10,20,21). Ice 
crystal formation and the increase in solute concentration are the principal factors causing 
freezing injury (28) and they are influenced by the freezing rate and the type of food. Meat 
may have a protective effect on the cells by reducing the freezing injury. It has been 
suggested that this could be due to an insulating effect of fat already at 10 % (16) or to the 
meat matrix that binds free water and thereby reduces the ice formation (15). In our study we 
used minced meat of approx. 10 and 15 % of fat and our survival rates could thus be 
influenced by this. The protective effect does not seem to be unique to minced meat because 
high survival of Salmonella has also been reported in other meat types (15,16).  
The length of the lag phase of a cell after stress exposure is an indicator of the time needed to 
return to conditions that allow replication (15,16,42) and is therefore a useful parameter to 
assess the level of sublethal injury experienced during food processing. In the long-term 
freezing study, we demonstrated that after approx. 6 months of freezing at -18 °C, stationary 
phase cells of Salmonella were capable of growing in meat juice at 25 °C with an average lag 
phase of 1.93 h for the low (10
3
 CFU/g) and 1.49 h for the high (10
6
 CFU/g) inoculum. In the 
short-term freezing study, the lag phases of stationary phase cells were longer (Figure 3). The 
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explanation for this is not clear but it could be due to the different thawing temperatures of 5 
°C used in the short-term study and 25 °C used in the long-term study. Slow thawing allows 
small intracellular ice crystals to grow and coalesce before melting, which is more 
detrimental than a fast thawing rate where the ice simply melts (34). For S. Typhinurium 
U292 and DT12, inoculated in exponential phase, we observed that they generally tended to 
have shorter lag phases after thawing than compared to stationary phase cells (Figure 3). This 
may be because their metabolic state was arrested in growth mode by freezing. Such a 
temporary arrest may be special to freezing, as other stressors may affect exponential cells 
differently. In a study of Mellfont et al. from 2004, (31) exponential cells of S. Typhimurium 
were subjected to osmotic stress and showed longer lag phases than stationary cells. They 
assumed that cells in exponential phase become more injured and that it takes a longer time 
for them to resolve the damage. Overall, the effect of freezing and thawing did not vary 
significantly between the selected Salmonella strains and does therefore not seem to 
contribute to the clonal success of Salmonella with respect to survival and growth capacity 
(length of lag phase and growth rate).  
 In the meat chain Salmonella may be attached to surfaces of process equipment for 
prolonged periods e.g. if cleaning and disinfection are inadequate. Thus, the bacteria will 
potentially experience environments of varying temperatures and humidities which could lead 
to dehydration of the cells. We investigated survival and growth of our selected Salmonella 
strains after prolonged exposure to high humidity (82 % RH) and low temperature (10 °C) 
and compared it to low humidity (49 % RH) and high temperature (25 °C). We generally 
observed that Salmonella survived high humidity and low temperature longer than lower 
humidity and higher temperature. The cell number of most isolates was observed to increase 
by approx. 1.5 log units during the first two days of exposure to high humidity/low 
temperature (Fig 4 A, B). As growth of Salmonella below 10 °C has been reported (14,30), 
this increase may be due to growth of the bacteria with leftovers of the BHI culture medium. 
In contrast to freezing and thawing, prolonged dehydration did impose variations in survival 
and length of lag phase among the 25 Salmonella isolates, most notably during exposure to 
low humidity. Even within the serovar Typhimurium variations were observed.  
Furthermore, survival and length of lag phase after rehydration were observed to correlate. 
Isolates of S. Infantis as well as the S. Typhimurium U292 isolate no. 68 survived longer 
during the dehydration period and they had also shorter lag phases after exposure to both, low 
and high humidity conditions reaffirming the tolerance to dehydration. The S. Derby isolates 
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and S. Typhimurium DT170 isolate no. 32 where more susceptible as they did not survive 
low humidity conditions as long as other strains and as they had a tendency for longer lag 
phases. Like in the freezing and thawing study, the maximum growth rates after rehydration 
were, except for S. Derby no. 13, very similar among the isolates and did not change during 
the experimental period of 3 months indicating that maximum growth rates are independent 
of injury and metabolic state of the bacteria (28). 
Except for S. Typhimurium DT104 no. 02, the isolates that were most affected by 
dehydration with lag phases longer than the average (S. Derby, S. Typhimurium DT12, U288, 
DT170 no. 32), were previously characterized as unsuccessful. S. Derby and S. Typhimurium 
DT12 are very common subtypes in Danish pork production but they are much less prevalent 
in humans (2). One possible reason could be the reduced tolerance to dehydration when 
attached to surfaces in slaughterhouses or kitchens. The isolates with a general shorter lag 
phase than the average are represented by both, successful and unsuccessful strains. In case of 
Salmonella Derby and Infantis, the response to dehydration might be serovar specific but for 
the other isolates, differences occurred within serovars or phagetypes. S. Typhimurium U292 
and DT135 were very uncommon phagetypes before the outbreak that occurred 2008 in 
Denmark (19). Both, especially U292 no. 68, tended to show a higher tolerance to desiccation 
but this connection, if any, remains to be elucidated. The clinical U292 isolate no. 06 from 
the Danish outbreak in 2008 was however only moderately tolerant. 
In conclusion, tolerance to freezing did not appear to be correlated with clonal success, as 
Salmonella, independent of its q-factor, survived remarkably long in frozen meat and was 
capable of growing again without major impairment. Thus, keeping meat free of Salmonella 
by preventing contaminations before the freezing process seems important. The ability of 
Salmonella to survive dehydration, most notably under low humidity conditions, was in 
contrast strain dependent and was shown to be reduced in a group of unsuccessful strains. 
Overall, the success of specific clones may rather be the result of still unknown factors with 
dehydration potentially playing a minor role. Interventions to reduce epidemically successful 
clones should presumably target other processes than freezing and dehydration. To prove this, 
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Tables and Figures 
 















Typhimurium DT104 june 98 human
nal, amp, chl, str, 
smx, tet, cip, spe, 
aug2 q≥1 + +
02
2
Typhimurium DT104 17-08-05 human




17 Typhimurium DT104 01-02-08 pork spe, str q<1 +
16 Typhimurium DT12 15-01-08 pork s
a
q<1 +
23 Typhimurium DT12 16-04-08 pork s q<1 +
04
3
Typhimurium  DT12 06-06-05 human s q<1 + + +
03
4
Typhimurium DT120 10-07-08 human s q<1 + +
31 Typhimurium DT120 22-10-08 human
amp, smx, spe, str, 
tet, tmp q≥1 +
05
4
Typhimurium DT135 16-09-08 human s q<1 + +
32 Typhimurium DT170 05-06-08 human s q<1 +
45 Typhimurium DT170 02-06-09 human smx, str, tet q<1 +
07
5
Typhimurium U288 14-10-08 human (str) q<1 + +
06
4
Typhimurium U292 28-07-08 human s q<1 + + +
68 Typhimurium U292 30-06-05 pig s q<1 +
13 Derby 30-04-08 human s q<1 +
15 Derby 14-04-05 pork tet q<1 +
26 Derby 13-04-05 pork s q<1 +
09 Derby 15-10-08 human s q<1 +
127 Infantis 20-06-07 pig s q<1 +
10
6
Infantis poultry s q<1 + +
39 Newport 06-11-08 human s q≥1 +
44 Newport 15-06-07 human cip, nal q≥1 +
27 Saintpaul 26-04-09 human s q≥1 +
41 Saintpaul 20-11-07 human
apr, chl, gen, smx, 
spe,  tet, (ffn), (str) q<1 +
38 Virchow 11-06-09 human
tmp, tet, smx, neo, 
nal, gen, cip, amp q≥1 +




antibiotics in brackets:  intermediate resistance; 
c
q: factor expressing the overall ability to survive 
the food chain and cause disease, from publications of Hald et al. (22,23) and from the research group 
Epidemiology and Risk Modelling, Danish National Food Institute (unpublished data); q < 1 successful and 
q ≥ 1unsuccessful subtypes; + indicates that the isolate has been used in one of the experiments (1: Survival and 
growth after long-term freezing; 2: Survival and growth of stationary and exponential phase cells after short-
term freezing; 3: Survival and growth after dehydration); Antibiotics: cip, ciprofloxacin; str, streptomycin; tet, 
tetracyclin; nal, nalidixic acid; ffn, florfenicol; sul, sulfonamides; neo, neomycin; smx, sulfamethoxacole; amp, 
ampicillin; chl, chloramphenicol; spe, spectinomycin; tmp, trimethoprim; gen, gentamicin; aug2, amoxicillin + 















Table 2: Sampling times during dehydration when colony counts and growth were measured 
Conditions 0 1 2 7 14 21 28 56 84 112
25 ˚C, 49 % RH
a
+ + + + + + + + + +
10 ˚C, 82 % RH + + + + + + + + + +
25 ˚C, 49 % RH + + - + + + - + - -
10 ˚C, 82 % RH + + - + + + + + + -






RH: relative humidity; + indicates that samples have been taken; - indicates that no samples have been taken 
 
 
Figure 1 Effect of freezing (at -20 ºC) on colony counts of Salmonella Thyphimurium DT12 (circles) and U292 
(squares) in minced meat in different growth phases; exponential cells (solid curves) and stationary cells (dashed 








Figure 2: Lag phase duration [h] in meat juice at 25 °C after frozen storage in minced meat for approx. 180 
days (black bars:  start inoculum of 10
3
 CFU/g; white bars: start inoculum of 10
6
 CFU/g); Error bars represent 




Figure 3: Growth (log CFU/ml) in meet juice at 25 ˚C after frozen storage in minced meat for 2 (closed circles) 
and 49 days (open circles); Typhimurium DT12 (A) and U292 (B) inoculated as exponential (dashed lines) and 















Figure 4: Effect of dehydration on colony counts of Salmonella; dashed lines with closed circles display 
successful Salmonella types; continuous lines with closed squares display unsuccessful Salmonella types ; 
continuous  lines with open squares display outbreak strains of 2008; A, B: 10 ˚C, 82 % relative humidity; C, D: 
25˚C, 49 % relative humidity; Standard deviations based on 2 replicates ranged from 0,06  – 0,38 log CFU/ml 





Figure 5: Lag phase duration [h] in BHI at 25 °C before (white bars) and after 1 (light grey bars), 21 (dark grey 
bars) and 56 (black bars) days of dehydration; the average lag phase duration of all the strains capable of 
growing after 21 (grey) and 56 (black) days is shown by a dashed line; *successful Salmonella types ; + strains 
from the 2008 outbreak; A: 10 °C, 82 % relative humidity; B: 25 °C, 49 % relative humidity; Error bars 
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Multidrug (MR) and quinolone (Q) resistance in non-typhoidal Salmonella is associated with 
an increased burden of illness in humans implicating a virulence or fitness advantage in these 
bacteria apart from the antibiotic resistance. By means of comparative hybridizations using a 
pan-genomic microarray and PCR screenings of antibiotic resistant and susceptible 
Salmonella field isolates, we identified genes and genetic elements associated with MR and Q 
resistance. Three of these genes, recT (SG1183), sugR (STM3753) and trhH 
(AF261825_S012), were deleted for functional analyses. 74 genes dominated in MR and Q 
isolates compared to sensitive ones, of which 43 genes were related to mobile genetic 
elements. The largest fraction accounted for prophage genes, including five single genes and 
23 genes attributed to three phage clusters (P22-like phages, Gifsy-1 and an unknown phage).  
The virulence genes sopE (STY4609) and gipA (STM2599) dominated weakly in Q and MR 
isolates. In contrast, genes involved in metabolism dominated in sensitive isolates. In none of 
the functional assays, the mutants were significantly different from the wildtype, but recT 
seemed to have a weak effect against the early defense of macrophages and to play a minor 
role in decreasing spontaneous mutation rates. The success of MR and Q resistant Salmonella 
could in part be explained by the acquisition of mobile elements, especially bacteriophages 
which are known to confer a fitness advantage and to be involved in virulence. Future 
research should examine if prophage genes can serve as epidemiological markers for 














Salmonella enterica is a leading cause of zoonotic infections in the EU (77) and causes 
foodborne diarrheal disease worldwide (88). but Salmonella differ in their human health 
impact (38,45,47,88). As observed by the Danish Salmonella Surveillance program, antibiotic 
resistant Salmonella are more frequently isolated from human outbreaks than sensitive ones 
(11). It has also been reported that multidrug and quinolone resistant Salmonella clones are 
associated with an increased burden of illness in humans as patients infected with these 
bacteria have a higher risk of hospitalization, mortality and bacteremia as well as a longer 
duration of hospitalization than patients infected with fully susceptible Salmonella 
(40,52,54,81,83). Hence, multidrug and quinolone resistant Salmonella seem to be more 
successful in infecting humans and in causing a disease outcome with increased severity even 
in the absence of antibiotics. Moreover, antibiotic resistance might lead to treatment failures 
in antimicrobial therapy which is required in patient with severe cases of Salmonellosis (51).  
A well described example for a multidrug resistant successful Salmonella clone was S. 
Typhimurium DT104 with an ACSSuT (ampicillin, chloramphenicol, streptomycin, 
sulfonamide and tetracycline) resistance phenotype encoded by the SGI-1 (Salmonella 
genomic island 1). This genetic island was probably taken up in the early 80s and in the 90s, 
the multidrug resistant S. Typhimurium DT104 clone was of global importance because of its 
wide dissemination in many countries. This clone was also reported to be more virulent as an 
unusual high percentage of patients were hospitalized in the UK and in the US, this strain was 
more often isolated from blood than non-ACSSuT stains (79). In general, S. Typhimurium 
belongs to the most important Salmonella serovars in many countries. In Denmark it is the 
dominant serovar in humans since 2008 (8,9,12). Another example of a success clone is a 
multidrug resistant clone of S. Newport that has emerged in the USA and that has been 
associated with tenfold more diseases than the sensitive S. Newport clones in the UK (71). 
However, in vivo or in vitro studies could not prove an association between virulence and 
resistance (4,25) or virulence and major worldwide clones (66). 
There is evidence that resistance and virulence genes can be located close to each other, as 
they have been found on the same plasmids in Salmonella (26,36,41,70,78). Plasmid transfer 
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can thus be accompanied by a simultaneous gain of virulence and resistance traits. There 
might also be other factors than virulence, such as the ability to survive the food chain that 
may contribute to the emergence of salmonellosis cases caused by antimicrobial resistant 
clones (47). In a study by Hald et al. (38), they used a mathematical model based on data from 
the Danish Salmonella Surveillance program to estimate the relative ability of Salmonella 
serovars with different antimicrobial resistance pattern to survive the food production chain 
and to cause human disease. Except for S. Saintpaul, this ability seemed to increase in 
antimicrobial resistant strains (38).  
The resistance to quinolones is most often conferred by point mutations that result in an 
aminoacid change of the DNA gyrase subunit GyrA. Transmission of quinolone resistance can 
be through clonal spread but it can also emerge in susceptible strains within a patient during 
treatment (6,49,55,68).  
By means of array-based comparative genomic hybridization (aCGH) and PCR of antibiotic 
resistant and susceptible Salmonella isolates, we aimed to identify genetic elements or 
patterns that may be related to human infection and/or survival outside the host and that are 
characteristic for multidrug and quinolone resistant Salmonella clones. Overall, the objective 
was to gain knowledge about the genetic background of these clones and to identify novel 
fitness or virulence genes that potentially contribute to the success of multidrug and quinolone 
resistant Salmonella clones. 
 
Material and Methods 
 
Bacterial strains and growth conditions. This study included 81 field isolates (Table 1 and 
Figure 1) of Salmonella enterica spp. enterica, representing different sero- and phagetypes 
originating from sporadic or outbreak cases from humans. Isolates from pigs and pork were 
also included as pork is a common source of human salmonellosis in Denmark (see Figure 2 
for a description of the whole experimental work flow) (8,88). The food and animal isolates 
were obtained from the Danish National Food Institute and the human isolates from the 
Statens Serum Institute. We used a field isolate of Salmonella Typhimurium DT104 
(0703H64730, 109) resistant to streptomycin, sulfametoxazole and spectinomycin to generate 
isogenic mutants with the following gene deletions: ΔtrhH::kmR, ΔrecT::kmR and ΔsugR::kmR. 
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To investigate adhesion and invasion of epithelial cells, we used S. Typhimurium 4/74 and the 
isogenic mutant ΔinvH201::TnphoA (86) as control strains. As donor strains for conjugation, 
we used Alcaligenes faecalis R214 (2) and Salmonella Agona 32 (1).  
Overnight cultures were obtained by growing a colony from sheep or calf blood agar in 10 ml 
LB or BHI broth containing antibiotics where required for 16-20 h at 37 °C. For bacterial 
enumeration, colony counts were determined by plating 10 µl droplets on LB or BHI agar. 
Plasmids and cell cultures. The plasmids pKD4 and pKD46 (28), used as tools for the 
inactivation of chromosomal genes, where provided by the Department of Veterinary Disease 
Biology (University of Copenhagen). The Int407 human epithelial cell line (ATCC CCL-6
TM
) 
was obtained from the Danish National Veterinary Institute (Lindholm) and the RAW264.7 
murine macrophage-like cell line (ATCC TIB-71
TM
) were provided by the Danish National 
Food Institute. The cells were cultured at 37 °C in an atmosphere of 95% O2 and 5% CO2. 
Int407 cells were maintained in modified Eagle’s minimal essential medium (MEM; ATCC) 
supplemented with 10% fetal bovine serum (FBS; ATCC) and 0.1 % penicillin/streptomycin 
(Gibco). RAW264.7 were cultured in Dulbecco’s modified eagles medium (DMEM; 
Invitrogen) supplemented with 10 % FBS (Hyclone; Thermo Scientific) and 0.1 % HEPES 
buffer (1 M; Gibco), 0.1 % sodium pyruvate (100 mM; Gibco) and 0.1 % 
penicillin/streptomycin. One day prior to bacterial infection the cells were grown without 
antibiotics. During bacterial infection, the RAW264.7 cells were grown without FBS. 
MIC determination. The minimum inhibitory concentrations (MIC) for fifteen antimicrobial 
agents were determined using commercially dehydrated antimicrobial agents in microtitre 
wells (SensititreTM; TREK Diagnostic Systems Ltd., UK) as part of the Danish Integrated 
Antimicrobial Resistance Monitoring and Research Programme (10,87). Additionally, the 
resistance to rifampicin, tetracycline and trimethoprim was determined by use of the disc 
diffusion method (following CLSI guidelines).  
Salmonella microarray. The genomic DNA was extracted with the Easy-DNA kit (Invitrogen) 
according to the instructions and examined for purity and quantity by measuring the 
absorbance at 280, 260 and 230 nm with a nanodrop spectrophotometer. 29 Salmonella 
isolates (Figure 1) were selected to perform a comparative genomic hybridization (CGH) 
analysis using a pan-genomic Salmonella microarray comprising the genomes of S. bonogori 
12419 (ATCC 43975), S. Typhi CT18, S. Typhimurium SL1344 (NCTC 13347), S. 
Typhimurium DT104 (NCTC 13348), S. Typhimurium LT2 (ATCC 700220), S. Gallinarum 
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287/91 (NCTC 13346) and S. Enteritidis PT4 (NCTC 13349). The design and the validation 
of the array as well as the experimental procedure have been described earlier by Pan et al. 
(65) and Wu et al (37). 
Analysis of microarray data. The array slides were scanned using the Genepix 4000B 
scanner (Axon Instruments, Inc.) and the images quantified with the Genepix Pro Software 
(Axon Instruments, Inc.). Normalization of the hybridization raw data was performed using 
the quantile normalization as implemented in the preprocessCore library for the R 
environment (16,17). The ratio of the cy5/cy3 signals was calculated and the geometric mean 
signal for each gene was used for further analysis. To distinguish between present and 
absent/divergent genes, a cut-off value of 6.6 was determined by plotting the log data of the 
signal intensity against the signal frequency. The data were validated by first verifying that the 
signals of empty and negative control probes were displayed as absent; second, by analyzing 
the presence of 15 housekeeping genes (aroC, dnaN, hisD, purE, sucA, thrA, panB, icdA, mdh, 
aceK, glnA, tonB, recA, phoP, gabA) in all Salmonella strains; and third, by examining the 
signal distribution of the lowest probes for each gene where the corresponding highest probe 
of the probe replicates was above the cut-off value. Based on all the genes present on the array, 
a dendrogram was established to ensure that the strains were grouped correctly after their 
phylogenetic correlation (Figure 1). The data were analyzed by comparing the present and 
absent/divergent genes within groups of isolates classified by their antibiotic resistance 
pattern and fully susceptible isolates. 
PCR Screening. The DNA from boiling lysates of 52 additional Salmonella strains (Table 1) 
and from strains used in the microarray study was used in a PCR screening intended to verify 
the microarray results. PCR was also used to amplify the km
R
 (kanamycin resistance gene) 
cassette on pKD4 required for gene disruption (see below). Primers with 40 bp homologies to 
the ends of the target genes and 20 bp to the flanking region of the km
R
 cassette on pKD4 
were used for this PCR. The gene disruption was confirmed by PCR amplification using 
primers from the ends or from the flanking sides of the target genes. Oligonucleotide primers 
(Table 2) were designed using Vector NTI Advance 10 software (Invitrogen). The primer 
specificity to the respective gene was confirmed using BLASTN 
(http://blast.ncbi.nlm.nih.gov/). The amplification was carried out in a T3000 thermocycler 
(Biometra). The PCR fragments were purified using the GFX purification kit (GE Healthcare) 
and one amplicon was sent for sequencing to Macrogen (Seoul, Korea) as a control.   
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Sequence analysis. Sequence analyses were performed using the software Vector NTI 
(Invitrogen),  the CLC DNA workbench (CLC bio) and the web tools BLASTN and BLASTP 
as well as the MicrobesOnline operon predictions application. To verify the results of the 
CGH microarray, we performed an in silico screening of gene sequences in publically 
available sequenced and annotated Salmonella genomes. 
Inactivation of chromosomal genes. 50 µl of electrocompetent cells of the S. Typhimurium 
strain no. 109, prepared as in reference 112, were transformed with 1 µl of the helper plasmid 
pKD46. Transformants were selected after incubation for 2 h at 30 °C on LB agar containing 
100 µg/ml ampicillin. The deletion of the genes recT (SG1183), sugR (STM3753) and trhH 
(AF261825_S012) in strain no. 109 harboring pKD46 (109pKD46) was achieved by a method 
described by Datsenko and Wanner (28). Briefly, 5 µl of the purified km
R
 cassette were 
transformed into 100 µl of electrocompetent cells of strain no. 109pKD46. Transformants 
were selected after incubation for 2 h at 37 °C on LB agar containing 50 µg/ml kanamycin. 
Growth curves. An overnight culture was diluted 1000 times in LB broth or DMEM 
supplemented with 0.1 % HEPES buffer and 0.1 % sodium pyruvate and grown without 
shaking at 37 °C in a Bioscreen C reader (Thermo Labsystems) for 24 h (measurement 
intervals: 10 min; OD: 600 nm). Growth was measured in triplicates. 
Adhesion and invasion of epithelial cells. Bacterial adhesion and invasion of Int407 
epithelial cells was determined by a gentamicin protection assay essentially as described by 
Watson et al. (86) and Galan et al. (35). The cells were seeded into 12 well culture plates at a 
concentration of 5 x 10
5
 cells per well and incubated overnight. 1 h prior to inoculation, the 
monolayers were washed twice with MEM and incubated in 1 ml MEM. To obtain 
exponential cultures, overnight cultures were diluted to 10
7
 CFU/ml and incubated for 3 h 
with shaking. The cultures were then washed and diluted to an OD600 of 0.1 with phosphate 
buffered saline (PBS). 100 µl were used to infect the Int407 cells using a moi of 20. After 
incubation for 1 h, the monolayers were washed twice with PBS and incubated with 1 ml 
MEM containing 100 µg/ml gentamicin. Before and 2 h after the addition of gentamicin, the 
cells were washed twice with PBS and lysed using 1 ml PBS per well containing 0,1% Triton 
X-100 (Sigma). For direct counts, appropriate dilutions of the lysates were plated on LB agar 
to determine the number of adherent (before gentamicin treatment) and intracellular (after 
gentamicin treatment) bacteria. Triplicate experiments were performed. 
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Macrophage survival. Analysis of survival and growth of Salmonella in macrophages was 
carried out essential as described by Humphreys et al. (44). RAW264.7 cells were seeded into 
12 well tissue culture plates (Costar) at a concentration of 5 x 10
5
 cells per well. After 
overnight incubation, the cells were washed once with PBS and incubated for 1 h in DMEM 
before bacterial inoculation. Bacteria of an overnight culture were washed and diluted to an 
OD600 of 0.1 with PBS containing 10% heat inactivated mouse serum and opsonized for 30 
min. 100 µl of this cell suspension were used to infect the RAW264.7 cells using a moi of 20. 
The cells were centrifuged (1000 g, 5 min) to synchronize the infection and incubation for 1 h. 
Then, the monolayers were washed once with PBS and overlaid with 1 ml DMEM containing 
100 µg/ml gentamicin. After an additional hour, the washing step was repeated and the cells 
were incubated with 1 ml DMEM containing 10 µg/ml gentamicin. 2, 4 and 24 hours post 
infection, the cells were washed as described above and lysed using 1 ml PBS per well 
containing 0,1% Triton X-100. For direct counts, appropriate dilutions of the lysates were 
plated on LB agar to determine the number of intracellular bacteria. Viability of macrophages 
was determined microscopically using 100 µl/ml Trypan blue (Invitrogen) to stain the dead 
cells. Triplicate experiments were performed but the viability of macrophages was only 
determined twice. 
Spontaneous mutation frequency. A proportion of an overnight culture was transferred to 
fresh BHI medium to obtain a 1000 fold dilution. An equal amount of the overnight culture 
was plated on selective BHI agar plates containing 100 µg/ml rifampicin to confirm that no 
pre-existing mutants were present. The prepared culture was incubated at 37 °C with shaking 
until OD600 of 2 was reached. 10 ml were centrifuged (6000 g, 10 min), resuspended in 100 µl 
BHI and the entire volume was plated evenly on BHI agar containing 100 µg/ml rifampicin. 
In the same time, appropriate dilutions were plated on non-selective BHI agar to obtain total 
counts. The mutation frequency was calculated by dividing the number of spontaneous rif
R
 
mutants by the total counts. Triplicate experiments were performed. 
Conjugation frequency. The conjugation frequencies of the genes tet(A) and dfrA25 from 
the donors A. faecalis, and S. Agona conferring resistance to tetracycline (tet) and 
trimethoprim (tmp) were determined. Exponential cultures were prepared with 20 fold 
dilutions of an overnight culture followed by aerobic growth to an OD600 of 0.5. The cultures 
of the donor strains and spontaneous rif
R
 mutants of the recipients (wild type train no. 109 and 
the mutants 109ΔtrhH::kmR, 109ΔrecT::kmR and 109ΔsugR::kmR) were then equally mixed 
(1:1) and transferred to sterile filters (pore size 0.45 µm) on BHI agar plates. After incubation 
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for 1 h or 24 h, the filter was transferred to 10 ml 0.9 % NaCl (v/w). After resuspension of the 
cell material from the filter, appropriate dilutions were plated on donor-, recipient- and 
transconjugant-selective BHI agar plates containing 64 µg/ml tmp, 100 µg/ml rifampicin (rif) 
and/or 16 µg/ml tet. The experiment was at least carried out in duplicates. 
Statistics. Colony counts were log transformed where appropriate and standard deviations 
(SD) or standard errors of the mean (SEM) were calculated. Statistical significances of 
differences were calculated with one-way analysis of variance (ANOVA) followed by 





Validation of the microarray data. A Salmonella pangenomic microarray was used to 
compare the genomes of 29 Salmonella field isolates categorized according to their resistance 
pattern in order to identify genes that could contribute to a virulence or fitness advantage in 
successful multidrug and quinolone resistant clones. For 20 % of the probe replicates, the 
probes with the lowest signal intensity were below the cut-off value while the corresponding 
probe with the highest signal intensity was above the cut-off value. No positive signals were 
displayed from the negative controls. Two out of 15 housekeeping genes (panB [STY0200] 
and gapA [STY1825]) were absent in 86 % and 93 % of the isolates, respectively. The 
dendrogram, based on all genes present on the array, correlated the isolates according to their 
serovar and grouped them into two major clusters: the Typhimurium and non-Typhimurium 
isolates (Figure 1). The 16 Typhimurium and the 13 non-Typhimurium isolates had a core 
genome composed of 55 % and 56 % of the present genes, respectively. Within the non-
Typhimurium cluster, isolates of S. Virchow showed the closest similarities to each other and 
isolates of S. Saintpaul were more distantly related.  
Genomic comparison of Salmonella isolates categorized according to their resistance 
pattern. The comparative genomic hybridization analysis was carried out with the entire 
dataset of the present and absent/divergent genes of the 29 Salmonella isolates and separately 
with the datasets of either the Typhimurium (n = 16) or non-Typhimurium (n = 13) isolates. 
First, the isolates were classified according to their resistance pattern into four categories: 
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quinolone resistant (reduced susceptibility to at least one fluoroquinolone; Q), multidrug 
resistant (resistant to four or more antibiotic agents; MR), resistant (resistant to less than four 
antibiotic agents; R) and sensitive (susceptible to all antibiotics tested; S). When indicated, the 
Q resistant non-Typhimurium isolates were subdivided into isolates resistant to four or more 
antibiotic agents (QMR) and isolates resistant to less than four antibiotic agents (QR). A gene 
was defined as dominaant in isolates attributed to one of the mentioned resistance categories: 
1) If it was present in 100 % of the isolates of that resistance category and absent in at least 
70 % of the sensitive ones; 2) If it was absent in 100% of the sensitive isolates and present in 
minimum 60 % of the isolates of the respective resistance category; 3) If the total number of 
isolates carrying the gene was higher among all the resistant isolates than among the sensitive 
ones. No analysis was performed for MR non-Typhimurium as this category was only 
represented by one isolate but it was taken into consideration when genes dominating in two 
or more of the resistance categories were identified or when the entire dataset of Typhimurium 
and non-Typhimrium isolates was analyzed.  
None of the S. Typhimurium DT104 isolates that were used for genomic hybridization were 
fully susceptible. Among the Typhimurium isolates, many of the genes that dominated in 
resistant strains turned out to be restricted to S. Typhimurium DT104. These genes were 
excluded from the results because  it is impossible to distinguish between association with the 
phagetype DT104 or with the resistance pattern. We also identified genes that dominate in the 
sensitive Salmonella isolates as they provide information about genes that are typically absent 
or diverged in resistant isolates. These genes were determined in a similar manner and were 
defined as: 1) present in minimum 70 % of the sensitive isolates and absent in the Q and MR 
strains; and 2) present in 100 % of the sensitive strain and in not more than 30 % of the Q and 
MR strains.  
Genes related to mobile genetic elements. In total, 74 genes were observed to dominate in 
MR and Q isolates (Table 3) and a big proportion of these genes also occurred in R isolates. 
Most of these genes (43 genes) were related to mobile genetic elements whereof the largest 
fraction (five single genes and 23 genes belonging to three gene clusters) accounted for 
prophage genes. Eight genes located within the region SDT0325 to SDT0359 were very 
common among resistant Typhimurium and almost always absent in the non-Typhimurium 
isolates. This gene cluster is homologous to P22-like phages such as ST104 and ST64T (104). 
The Gifsy-1 phage cluster (STM2590 - STM2617) belongs to the lambdoid Salmonella 
phages and is present in almost all Typhimurium isolates independent on their resistance 
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pattern but apart from that it dominates markedly in the Q resistant non-Typhimurium isolates. 
A small cluster of three genes (SL1943, SL1944 and SEN1935) that are homologous to genes 
of the P27-like phage ST64B, is present in almost all resistant Typhimurium isolates (DT104 
and DT170) and generally absent in the non-Typhimurium isolates. Four genes within the 
region SDT1841 to SDT1857 seem to belong to a phage cluster as two of them encode phage 
proteins but none could be assigned to a known bacteriophage as no specific sequence 
database hits could be obtained using BLASTN and BLASTP.  
As prophage genes seem to be important elements in MR and Q strains of Salmonella (33,34), 
we selected all 282 available genes on the microarray annotated as phage encoded and 
analyzed their signal distribution among the 29 isolates. Table 3 shows that resistant 
Salmonella among both, Typhimurium and Non-Typhimurim isolates, harbor most of these 
prophage genes. We furthermore investigated the distribution of known phage encoded 
virulence genes among the Salmonella isolates: sopE (137), sodC (138), nanH (139, 140), 
gtgA (139), sseI (141) and sspH1 (142). The gene sopE (STY4609) was absent from 
Typhimurium but present in eight non-Typhimurium isolates: in all Q and MR isolates and 
three out of seven sensitive isolates. One Q isolate of S. Saintpaul (no. 34) hybridized to sodC 
(STY1682) and one susceptible Saintpaul (no. 27) harbored nanH (STY2483). The other three 
phage genes were absent from the microarray and were therefore screened by PCR for 
presence in all 83 Salmonella isolates included in this study. The genes gtgA and sseI were 
present in all the Typhimurium isolates and sspH1 in 89 % of the Typhimurium isolates. These 
three phage genes were variable components among the non-Typhimurium isolates, but 
without any correlation to antibiotic resistance. 
A cluster of 12 genes that dominated in the MR and Q isolates accounted for genes of the 
Salmonella Typhimurium genomic island 1 (SGI-1). Among the Typhimurium isolates, these 
genes were restricted to DT104, except for AF261825_S037 and SDT3847 which were also 
present in DT120 and DT170 respectively. Among the non-Typhimurium isolates, these genes 
were almost exclusively present in the Q (QR and QMR) strains of S. Saintpaul and S. 
Virchow.  
Three single genes were found among the mobile elements dominating in the MR and Q 
isolates: HCM1.167, HCM1.217 and STY4657. The first was an integrase gene that is 
associated with integrons, which frequently lie on transposons or plasmids. The second gene 
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was a pseudogene which is partly (68%) identical to a transposase of IS26 and the last gene 
encodes the insertion element IS1 protein InsB.  
The group of Q isolates was composed of QMR (resistant to at least 4 antibiotic agents) and 
QR (resistant to less than 4 antibiotic agents) isolates. Genes that are exclusively linked to 
quinolone resistance should be dominant in these two groups and absent in the MR and other 
isolates. Among the Typhimurium isolates, it does only apply to one gene: SEN1132, a 
probably phage encoded excisionase. Among the non-Typhimurium isolates, it is the case for 
many genes. Nevertheless, the Gifsy-1 phage cluster (STM2590 – STM2617) and SDT2013, a 
phage tail-like gene, seem to be most characteristic for non-Typhimurium Q strains as they 
were present in nearly all Q isolates. 
To get an indication of genes that are absent or altered in resistant Salmonella strains, we 
identified 37 genes that dominated in susceptible Salmonella isolates (Table A1 in the 
Appendix). Eight (22 %) genes were related to mobile elements of which four genes belonged 
to a cluster originating form pSLT, the Typhimurium virulence plasmid. The remaining mobile 
elements were single genes: three phage encoded proteins and one plasmid encoded 
antirestriction protein.  
Assuming that mobile elements implicate a greater genomic variability, we used the 
microarray results to estimate the genetic diversity of resistant Salmonella versus fully 
sensitive Salmonella isolates by subtracting the number of genes of the core genome from the 
number of genes of the pan genome. The percentage of the variable genes was 34 to 35 % in 
the resistant and sensitive isolates regardless if they belonged to the Typhimurium or the non-
Typhimurium group. 
Genes related to virulence. Among the Typhimurium isolates, 5 genes with an 
experimentally documented or putative function in virulence were found to dominate in the 
MR and Q isolates. One of them, gipA (STM2599), is listed together with the mobile genetic 
elements because it is encoded by the Gifsy-1 gene cluster mentioned above (Table 3). GipA 
was found to be involved in survival within Peyer’s patches (74) and replication of 
Salmonella in macrophages (48). The gene gtrA2 is a variant of gtrA (93% identical) from the 
P22-like phages (ST104, ST64T, SE1 and P22). It is involved in O-antigen conversion and 
has been suggested to contribute to long-term systemic infection in mice (50). No virulence 
associated genes could be identified to dominate among the susceptible Salmonella isolates 
(Table A1 in the Appendix). 
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Genes with other or unknown functions. 17 genes were related to other functions than 
virulence of which the largest part is involved in metabolism. However, two genes could be 
related to stress resistance: STY2115 (cutC), a copper homeostasis protein (144) and 
STY1582 (asr), an acid shock protein (72). Interestingly, orthologs of some of these genes are 
pseudogenes in S. Typhi. Genes of the cbi operon like cbiJ that are involved in cobalamin 
synthesis, are mutated in S. Typhi. Probably as a consequence of the cbi dysfunction, the 
adjacent pdu operon including pduH, involved in propandiol degradation, is not functional as 
well (56). The gene ygbK has also been reported to be a pseudogene in S. Typhi 
(supplementary note of McClelland et al. (56)). Among the 11 genes with unknown function, 
STY4728a is annotated as a pseudogene because it has a deletion of 913 bp within a putative 
pspA gene. Genes that are depleted of their function in certain Salmonella strains were also 
present among the above mentioned mobile elements and virulence genes: sugR (a 
pseudogene in S. Typhimurium SL1344 and S. Typhi) and HCM1.217.  
Among the genes dominating in sensitive isolates, the fraction of metabolic genes accounted 
for the largest part (approx. 35 %) and is listed in Table 4 under genes with other function. 
One gene (stiB) involved in stress resistance could also be found to dominate in these isolates. 
Verification of the microarray results by PCR, sequencing and in silico screening of 
genes. To evaluate the microarray results, the nucleotide sequences of the genes that were 
identified to dominate in MR and Q strains were screened in silico for their distribution in 41 
sequenced and publically available Salmonella genomes. 72% of these genes were confirmed 
to be variable elements in Salmonella (Figure 3), including all the genes located on mobile 
genetic elements, except for AF261825_S037, three out of the five virulence genes (sugR, 
gtrA2 and gipA) and 27 % of the genes with other or unknown function. Several genes 
belonging to mobile genetic elements (HCM1.217, SDT2013, STM2617 and some genes 
within the P22 cluster form SDT0325 to SDT0359), STY2208 and STY4728a turned out to 
have very heterogeneous sequences throughout the Salmonella genomes indicated in Figure 3 
by shadings representing the different degrees of homology.  
For a second evaluation, 22 genes from different gene categories (mobile, virulence, 
metabolic or unknown genes) dominating in Q and MR strains were chosen for a PCR 
screening using additional 52 Salmonella field isolates that were categorized after their 
resistance pattern in the same manner as the isolates used for the microarray analysis (Table 1). 
For 64 % of the genes, the microarray results could be reproduced by PCR. The distribution 
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of these confirmed genes in the 52 isolates of the PCR study and the 29 isolates of the 
microarray study are shown in Table 5. The microarray results could be confirmed for nearly 
all the genes located on mobile genetic elements and for three virulence gene (sugR, gipA and 
sopE), even though the dominance of the virulence genes in the MR and Q strains was not 
very apparent. All the tested genes with other or unknown function were ubiquitous among 
the 52 field isolates except for STY0439 (malZ), STY2249 (pduH) and STY4783 that were 
present in 98%, 92% and 96 % of the strains respectively. One control amplicon per gene was 
sequenced to confirm the primer specificity. The assembled sequences corresponded to the 
investigated genes except for SDT2013 with only 91 % identity. This reflects the results of the 
in silico screening that indicated that the sequence of SDT2013 is heterogeneous in 
Salmonella.  
Phenotypical analysis of mutants. The genes trhH (AF261825_S012), recT (SG1183) and 
sugR (STM3753) were deleted in a S. Typhimurium DT104 field isolate (no. 109) and 
analyzed for their function by a series of phenotypical assays because we assumed that they 
play a role in virulence. The gene trhH (AF261825_S012) is located on SGI-1, belongs to the 
TrhH family of proteins and is annotated as a putative pilus assembly protein (19). We 
hypothesized that it has a function in mediating cell contact to host or bacteria cells. Using 
Microbes Online Operon Predictor (www.microbesonline.org), it seems to be the first gene of 
an operon including a second putative pilus assembly protein (AF261825_S011, trhG) and a 
hypothetical protein (AF261825_S010) (Figure A2 in the Appendix). RecT (SG1183) is a 
phage encoded recombination and repair protein involved in both, homologous and 
illegitimate recombination (73). It might contribute to the tolerance of conditions that induce 
DNA damage such as within macrophages. It is encoded within an operon including the gene 
for the exoribonuclease VIII (Figure A2 in the Appendix). The gene sugR (STM3753) is a 
variable pattern of the Salmonella pathogenicity island 3 (SPI3) (5,14) and 99% identical to 
the ATP binding subunit ClpX of a Clp protease of S. Weltevreden str. 2007-60-3289-1. This 
gene might function as a chaperone and allow tolerance to certain stress conditions such as 
low pH in macrophages (76). It is transcribed as the first genes of an operon including 
STM3754 encoding a hypothetical protein (Figure A2 in the Appendix). Based on lacZ-
fusions, Blanc-Potard et al (14) also suggest that it is transcribed together with STM3755 
(rhuM) even though the distance between the two genes is 580 bp. Mutants of the latter gene 
show decreased epithelial cell invasion (75).  
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No effect of the deleted genes on growth in LB and DMEM could be observed as the growth 
curves were equal for the wildtype and the mutant strains. To assess the impact of the genes 
on virulence, the epithelial cell adhesion and invasion capability and survival/growth in 
macrophages were analyzed using cell culture models. A decrease of 0.66 log CFU/well (SEM 
0.12) for adhesion and 0.88 log CFU/well (SEM 0.04) for invasion of epithelial cells could be 
observed for the control mutant ΔinvH201::TnphoA (86) compared to its wildtype strain S. 
Typhimurium 4/74. The three mutants generated in this study were not restricted in their 
ability to invade and adhere.  
The direct counts of the inocula used to infect macrophages were slightly more variable 
probably due to the 30 min opsonization period directly before inoculation. Thus, to 
standardize the inocula, a correction factor was calculated by subtracting the actual counts 
from the inocula by 10
7
 CFU/well (the ideal inoculum). The number of phagocytosed bacteria 
was determined by subtracting this correction factor from the direct counts of intracellular 
bacteria determined at 2 h post infection. At that time, the mutants ΔrecT::kmR and 
ΔsugR::kmR exhibited slightly diminished but not significantly different (P > 0.05) 
intracellular counts of approx. 0.4 log CFU/well (Figure 4). The number of intracellular 
bacteria increased after 4 and 24 h post infection but no significant differences (P > 0.05) 
could be observed between mutants and wildtype although growth after 24 h post infection of 
ΔsugR::kmR and ΔtrhH::kmR was approximately 0.51 and 0.37 log reduced (Figure 4). The 
cytotoxic effect of the Salmonella strains on the infected macrophages was determined by 
microscopical counts of viable and dead macrophages. The average number of viable 
macrophages ranged from 59% (SD: 6%) at 2 h post infection, 54 % (SD: 7%) at 4 h post 
infection to 31 % (± 4%) after 24 h post infection compared to the non-infected control were 
75 % (SD: 3%) of the macrophages were viable during the whole time period. No significant 
differences (P > 0.05) in respect to cytotoxicity between the mutants and the wildtype were 
detected.  
In order to estimate the importance of the disrupted genes for the ability of the bacterium to 
mutate, spontaneous mutation and conjugation frequencies were established. The spontaneous 
mutation frequency towards rifampicin was 2 times higher but not significantly different for 
ΔrecT::kmR compared to the wildtype strain (Figure 5). The conjugation frequencies were 














Genetic characterization of successful antibiotic resistant Salmonella clones will add 
knowledge to the mechanisms involved in the concomitant acquisition of resistance and 
fitness or virulence determinants. In order to find genetic factors characteristic for these 
clones, we used a pan-genomic Salmonella microarray to compare the genomes of fully 
susceptible Salmonella strains to those with different resistance patterns. The array data were 
validated by PCR and the functions of three genes that dominated in MR and Q isolates of 
Salmonella were analyzed. 
The importance of prophages and recT for Q and MR Salmonella. Using comparative 
genomic hybridization, we have shown that most of the genes that were predominant in Q and 
MR isolates were related to mobile genetic elements when compared to susceptible ones. 
Along with single genes from mobile elements, we could identify several gene clusters related 
to bacteriophages and Salmonella genomic island 1 (SGI-1). In contrast, metabolic genes 
were dominant in sensitive Salmonella isolates.  
Phage DNA seems to be a key element in the genomes of Q and MR strains as prophage 
genes accounted for the largest group of genes dominating in these isolates. This might be 
surprising as resistance genes are more often reported to be mobilized via plasmids and 
transposons or integrons located on plasmids (62,64). Only three genes linked to transposons 
or integrons (int, insB and the putative transposase gene HCM1.217) where found to dominate 
in resistant isolates. Surprisingly, genes related to plasmids (pSLT) were more common 
among sensitive S. Typhimurium isolates. Bacteriophages can carry additional genes that are 
not required for phage proliferation (20) but provide and advantage for the bacterial host and 
thereby indirectly for the phage itself, especially those phages that integrate into the host 
genome and are dependent on the persistence and multiplication of the host. Many Salmonella 
prophages are reported to be involved in Salmonella virulence (reviewed in Brussow et al., 
(21). Among the phage gene clusters that dominated in Q and MR strains were Gifsy-1 and 
ST64B that play a role in Salmonella virulence (21,58). The phage encoded gene for the 
invasion-associated secreted protein SopE was present in 50% of the Q and MR strains 
towards 0% in R and 38% in sensitive strains. The putative phage encoded virulence protein 
GipA was present in 29 % of the Q strains towards 0 % in MR, 0% in R and 25 % in sensitive 
strains. The gene gtrA (STY2627a) was present in two MR Typhimurium isolates and exhibits 
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homology to the SPI-16 gene gtrA (STY0607) but it is not identical. Both genes seem to 
originate from gtrA located on phages such as P22 but seem to have undergone different 
sequence variations. The gene products mediate the transfer of glucose residues to O-antigen 
subunits. This modification of the O-antigen presumably results in an evasion of adaptive 
immunity (15). The blast results from the in silico screening of gene sequences also indicate 
the presence of several orthologous genes of gtrA as the sequences of this genes are 
heterogeneous among Salmonella. Other functional Salmonella phage encoded genes 
providing virulence or fitness advantages might exist but might not have been present on the 
microarray used. The findings of single phage genes and parts of prophages suggest the 
presence of phage remnants that are depleted for their function in phage particle formation 
and lysis. In E. coli, these cryptic phages have been reported to exhibit a positive effect on the 
host bacterium in adverse environmental conditions, like the presence of inhibitory 
concentrations of quinolones (85). Thus, bacteria that are more protected from being 
eliminated by an antibiotic might be more likely to become resistant to that antibiotic, which 
could explain the presence of phage remnants in antibiotic resistant bacteria. Moreover, viable 
prophages could also contribute to the virulence of their host cell. When phages are released, 
they might destroy competing bacteria whereas bacterial cells of the same population will be 
immune to a reinfection (67).  
The repair of DNA damage is necessary for Salmonella virulence in macrophages as mutants 
in the genes recA, recB and recC are attenuated (23). The contribution of recT (STM2633) 
encoded by the phage Gifsy-1 to proliferation of Salmonella Typhimurium LT2 in 
macrophages has also been shown by Klumpp and Fuchs (48). This attenuation was 
documented at 7 h post infection and was relatively small. The recT gene (SG1183) that was 
found to dominate in Q and MR strains has no sequence homologies (neither nucleotide nor 
protein) to recT encoded by Gifsy-1 and Gifsy-2. Among others, it is present in S. Gallinarum, 
S. Dublin, S. Partyphi and S. Typhimurium 14028s and has 95 % sequence homology to the 
phage encoded recT gene in E. coli. In this study, it has been deleted in a S. Typhimurium 
DT104 field isolate for a functional analysis of the gene. No effect on adhesion and invasion 
of intestinal epithelial cells could be observed. In macrophages, the intracellular counts of the 
mutant 109 ΔrecT::kmR at 2 h post infection were slightly reduced indicating a weak effect 
against the early defense mechanism of the macrophages, the oxidative burst (84). As 
expected, it also seems to play a minor role in reducing spontaneous mutations. It may seem 
contradictory that many Q and MR strains harbor an additional recombination and repair 
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protein that reduces mutations because resistances towards certain antibiotics, such as 
quinolones, are more frequently conferred by gene mutations than by horizontal gene transfer. 
But under circumstances where lethal mutations are induced, for example double strand 
brakes within macrophages, RecT might be involved in protecting Salmonella from being 
seriously damaged so that Salmonella can actually replicate and benefit from non-lethal 
mutations generated within macrophages. Quinolones belong to the group of antibiotics that 
are accumulated within phagocytes (39) suggesting that a host infected with susceptible 
Salmonella (maybe carrying recT) and treated with quinolones could serve as a source of 
quinolone resistant strains that are able to survive and proliferate in macrophages.  
The roles of SGI-1 and trhH in Salmonella. Along with prophage elements, genes of the 
SGI-1 represented a big proportion of the genes dominating in Q and MR Typhimurium and 
non-Typhimurium isolates which is consistent with other studies suggesting the wide 
dissemination of variants of SGI-1 (3,18,30,53,57). In S. Typhimurium, SGI-1 includes a 
multidrug resistance regions encoding the genes aadA2, floR, blapse-1, sul1 and tet(G) (102, 96) 
resulting in a pentaresistant phenotype, but according to the microarray hybridization results, 
genes from the island were also present in R isolates (resistant to less than four antibiotic 
agents). This is in agreement with the findings of variants of SGI-1 harboring less resistance 
gene (18,24). SGI-1 is listed here under mobile genetic elements as it can be mobilized via 
conjugative transfer with a helper plasmid (29). It has been suggested to be responsible for the 
successful spread of the S. Typhimurium DT104 clone with the ACSSuT resistance pattern 
and more recent also of S. Paratyphi in Canada (61). In addition to the resistance genes, this 
island and variants of it harbor genes for recombination, conjugation and regulation as well as 
genes with unknown function (60). The latter genes could play a role in virulence or fitness as 
Salmonella clones harboring the island are reported to be more widespread and virulent 
(61,79). But also gene products mediating conjugation, for example pili, might have a second 
function in virulence by improving the adhesion capability to host cells. We investigated if the 
SGI-1 gene trhH (AF261825_S012), presumably encoding a pilus assembly protein, is 
involved, in virulence, mutability and conjugation but no effect could be observed. 
 The roles of SPI-3 and sugR in Salmonella. The Salmonella pathogenicity islands (SPI) are 
also assumed to derive from mobile genetic elements (64). They are conserved among 
Salmonella (7,63,82) but SPI-3 is known to contain variable site (14). The gene sugR, that 
was found to dominate in Q and MR strains, is part of the left end of SPI-3 which is less 
conserved among Salmonella. Due to its homology to the subunit ClpX of a Clp protease, a 
131 
 
member of the stress protein family, and its location on a pathogenicity island, we assumed 
that the deletion of the gene could have an impact for virulence. No effect in adhesion and 
invasion of intestinal epithelial cells could be observed suggesting that no polar mutation 
affecting the expression of the downstream located gene rhuM was generated, as this gene 
was reported to be involved in epithelial cell invasion (75). After 24 h post infection, 
replication in macrophages seemed to be slightly diminished in sugR mutants. The cytotoxic 
effect on the macrophages was, however, not altered. These results are not in accordance with 
studies that have investigated the function of ClpXP. It has been reported that ClpXP is 
involved in down regulating macrophage apoptosis and in down regulating replication within 
epithelial cells (measured after 6 h post infection) (46). Reducing replication and apoptosis 
could be an important feature in establishing a systemic infection as macrophages are used by 
Salmonella as a vehicle for dissemination in the host organism (46). In addition to its 
regulatory function, ClpXP degrades missfolded proteins and might contribute to survival 
during the acidic conditions in the macrophages (377) which would explain why the mutant is 
slightly impaired in intraphogocytic multiplication. As expected, sugR had no influence on the 
conjugation or spontaneous mutation frequency of the host bacterium. 
Genetic diversity in Q and MR Salmonella. As more mobile elements were found within Q 
and MR compared to susceptible isolates, we assume a greater genetic diversity among 
antibiotic resistant strains. By calculating the proportion of conserved genes (core genome) in 
resistant isolates compared to the proportion of non-conserved genes, we could not show that 
the overall genetic diversity for these isolates was higher than for sensitive ones. Saunders et 
al. (71) obtained different results by using an unweighted pair group method with arithmetic 
mean clustering, they could show that MR isolates of S. Newport showed a greater genomic 
variability than sensitive isolates of the same serovar.  
Advantages and limitations of DNA microarrays for genomic comparison. Salmonella 
DNA microarrays have been successfully used to study diversity among Salmonella 
(42,43,65,69). They are powerful tools when the genomes of many strains are compared. 
However, some limitations have to be considered when microarrays are used. False positive 
or negative results can be obtained with divergent genes and the amount of genes that can be 
detected is restricted to the probes present on the array. Furthermore, it is important to 
consider that the detected genes are not necessarily expressed in a cell, which is the case for 
pseudogenes. We observed that several genes that dominate in Q and MR strains hybridized to 
probes originating from the genome of S. Typhi CT18 and belonging to genes that are no 
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longer expressed in S. Typhi. These genes are not necessary also pseudogenes in the test 
strains. We did not perform any further analysis on these genes and can therefore not draw 
any conclusions on their functionality in the test strains. Pseudogene formation is an 
important feature of host restricted Salmonella serovars, such as S. Typhi. It would be 
interesting to see if this also occurs in other serovars within more virulent clones. It proved to 
be important to validate the microarray data either by an in silico (using BLAST) or in vitro 
(using PCR) screening of genes. In our study, we used the hybridization results as a basis for 
the selection of genes for a functional analysis. The huge number of possible functional assays 
makes this approach laborious and time-consuming especially when no indications of the 
gene function are available but the genes that have been studied here exhibit sequence 
homologies to known genes providing information of their putative function. In order to find 
genetic factors characteristic for distinct clones within genetically similar Salmonella, it might 
be more effective to use methods that have the potential to identify completely new genes and 
small sequence alteration, such as whole genome sequencing. Nevertheless, to identify 
genetic patterns shared by distinct clones, comparative hybridization using a pan genomic 
microarray composed of genomes from different serovars covering the whole genus 
Salmonella is a useful method. 
In conclusion, the success of multidrug and quinolone resistant Salmonella could in part be 
explained by the acquisition of mobile elements, especially bacteriophage DNA. 
Bacteriophages are known to confer a fitness advantage to their host bacterium and to be 
involved in virulence. To domesticate these phages by converting them into cryptic prophages 
might be a part in the evolution of successful resistant clones. The mechanisms behind the 
increased uptake and/or domestication of prophages are unclear. On one hand, multidrug and 
quinolone resistant Salmonella might be naturally more predisposed in taking up foreign DNA 
than sensitive ones. On the other hand, in presence of antibiotics, it might be facilitated for 
resistant Salmonella to reach and persist within host cells, like macrophages, were phage 
transfer and mutation frequency are enhanced. Studies have already successfully used 
prophage genes in order to discriminate between field isolates (27). Hence, a combination of 
resistance and prophage genes might serve as epidemiological markers and prospective tools 
for the early detection of emerging successful multidrug and quinolone resistant Salmonella 
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Tables and Figures 
 
 
Figure 1: Salmonella field isolates used for comparative genomic hybridization, their phylogenetic relation 
based on all genes present on the microarrays and their resistance patterns; Antibiotics: cip, ciprofloxacin; str, 
streptomycin; tet, tetracyclin; nal, nalidixic acid; ffn, florfenicol; sul, sulfonamides; neo, neomycin; smx, sulfa-
methoxacole; amp, ampicillin; chl, chloramphenicol; spe, spectinomycin; tmp, trimethoprim; gen, gentamicin; 
aug2, amoxicillin + clavulanat (2:1); Resistance group: Q, reduced susceptibility to at least one fluoroquinolone; 
MR, resistant to four or more antibiotics; R, resistant to less than four antibiotics; S, senstitive to the antibiotics 



















 No. Serovar Phagetype Source Resistance pattern
Resistance 
group Ref.
37 Derby human S
15 Derby pork tet R 1
26 Derby pork S 1
13 Derby human S 1
39 Newport human S 1
44 Newport human cip, nal Q 1
42 Virchow human S 1
43 Virchow human cip, spe, str Q
38 Virchow human tmp, tet, smx, neo, nal, gen, cip, amp Q (MR) 1
41 Saintpaul human apr, chl, gen, smx, spe,  tet, (ffn), (str) MR 1
27 Saintpaul human S 1
40 Newport human S
34 Saintpaul human cip, nal Q
33 Typhimurium DT12 human S
03 DT120 human S 2, 1
32 DT170 human S 1
16 DT12 pork S 1
05 DT135 human S 2, 1
23 DT12 pork S 1
04 DT12 human S 3, 1
29 DT12 human S
17 DT104 pork spe, str, sul R 1
31 DT120 human amp, smx, spe, str, tet, tmp MR 1
01 DT104 human nal, amp, chl, str, sul, tet Q (MR) 4, 1
06 U292 human S 2, 1
45 DT170 human smx, str, tet R 1
07 U288 human (str) S 5, 1
02 DT104 human amp, chl, smx, str, tet, spe (ffn) MR 6, 1
28 DT104 human amp, chl, cip, ffn, nal, smx, spe, str, tet, (aug2) Q (MR)
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Table 1: The number of Salmonella field isolates by serovar and phagetype used for PCR 
screening and their categorization based on their resistance pattern. 
 
Q, resistant to less than four antibiotics and reduced susceptibility to at least one fluoroquinolone; Q(MR), resis-
tant to more than four antibiotics and reduced susceptibility to at least one fluoroquinolone; MR, resistant to four 











Serovar Phagetype Q Q (MR) MR R S
Derby 2 2
Infantis 1 1 2 1 3
Newport 1 1 1 1
Saintpaul 1 1 1
Typhimurium DT104 3 1 1 2
DT12 2




U288 1 1 1
U292 3
Virchow 1 1 1





Table 2: The oligonucleotide primers used in this study 
 
1
Reference: Bertelsen et al. (13); 
2
5 PCR cycles with an annealing temperature of 55 ºC followed by 25 PCR 
cycles with an annealing temperature of 50 ºC 
 
 




temp. (ºC) Sequence forward primer (5'-3') Sequence reverse primer (5'-3')
STM3753 (sugR ) 748 57 TTCGTTGCTTCAGACAGCT GCTGGAGCTGTATTCCAGAT
AF261825_S012 (trhH ) 927 57 GCTGCTTCTTTGTGACATCA TCTTGTCAGTTAGCTCAGGG
HCM1.167 (int ) 655 59 TTGCTGTTCTTCTACGGCAA AATGGCCGAGCAGATCC
STY4657 (insB ) 438 57 TTGGCCTCAACACGATTT ACTTTGTCATGCAGCTCCA
STM2599 688 56 ATGCGTACTACGAGCGAA TTCAGGGATTCGACGCAT
SDT0325 916 58 TCGATAGACTCCCAGCCA ACAAACTGAAGGCAGAAGCA
SDT1852 333 59 TCCACATGCAGTCTGAATACCT TAACGGCAAGGTATTTCACCTT
SEN1952 625 57 TTGCAGATAGCTCTCGAATTT AGCACTTGGTGTACTGGAAGA
SDT2013 700 58 TAACTGAACATCTGCGACGA TATCGGCCAGTATGCGTACT
SDT3832 362 56 AAGAGCTGCTGATAAGAATTGA ATAAATTGGCGTCAACTCCT
SG1183 (recT ) 423 57 TAACTGGTGCATCTTCGTTCT TCAGCTTTATCAACCAGCCT
AF261825_S006 278 59 TGCTCGCAATGCTCTATCAT TCCAGGACATTCCGTGGT
SEN1132 241 56 ATGAGCTTTGTGAGACTTGAAA ACTTCTCCAGCAATGCACT
STY4609 (sopE  ) 490 58 AAGAACACTGAGTCTTCTGCA TCGGCATAGCACACTCA
16S rDNA
1
634 50 GACTACCNGGGTATCTAATCC TGACGGGCGGTGTGTACA A
STY2231 (cbiJ ) 616 57 TCCAGACAGGGCTGAACT TTATGCCGACAACTGGGT
STY2249 (pduH ) 162 57 AGCCTCTGGCACGAAGT ATGTACGACCAGCGAGTGT
STY2208 456 58 TCGGTATTGAGTGGCTTGAT AACGTGGAGCAAACAGTTCT
STY0594 (fimH ) 606 59 CACCAGCGGCAATAATCA ACGTTGGTACATTTGATAGCGA
STY2277 (yeeF ) 431 56 GCCAGTACGGTGATAGTAGAGA AACACTGTGATTGTGGTGCTA
STM2603 519 57 AGTGTTTGGGATAACGGGT GAACGGGAAATACACCAT
STY4783 496 59 TTGTTGGCCTGCTCTCCT ACCAGAGAGCCCAGACCA
STY0439 (malZ ) 546 57 TCAGGACCGAGTGTATTACCA AGCCAGTGACGAACGATACT
gtgA 659 58 TGGATTATCCCATCCTCATG GTGGTGATGTGTGACCCAT
sspH1 698 56 AGGTCTTACCACCTTACCAGAC CGTTATCTTCCAGTCCGAA





























1612 (mt) 56 AACAGGTGAGGCTGGTGTA CTGTTCCTTAACCGGAGGT
ΔrecT ::kmR 
816 (wt), 
1541 (mt) 59 GTTCTCTTCCACGCCAGC CCTAAACAGCCACCTATTGCA
ΔtrhH ::kmR 
1483 (wt), 





















Selection of Salmonella field isolates based on
• isolation source, 
• sero- or phagetype, 
• antibiotic resistance pattern
Comparative genomic hybridization of 29 
Salmonella isolates using a pan-genomic 
microarray 
Validation of microarray data
• Verification of signals of probe replicates, housekeeping genes and negative controls
• Dendrogram
• PCR screening of selected genes
• In silico screening of all genes dominating in Q and MR isolates
Data processing of microarray study 
(normalization and determination of cut-off 
value)
Disruption of three chromosomal genes:
recT (SG1183), sugR (STM3753) and trhH
(AF261825_S012)
Functional analysis of mutants and wildtype
• Growth curves
• Adhesion and invasion of intestinal epithelial cells (Int407)
• Survival and growth in macrophages (RAW264.7) 


















Table 3 (next page): Genes dominating in quinolone and multidrug resistant Salmonella iso-
lates determined by comparative genomic hybridization and PCR  
Table 3 indicates the numbers of isolates where the respective genes were present determined by array-based 
genomic hybridization are shown; 
1
The genes seem to belong to one phage cluster but none could be assigned to 
a known bacteriophage as no specific sequence database hits could be obtained using BLASTN and BLASTP; 
2
The percentage indicates the relative proportion of the single genes within the given gene group compared to the 
total number of genes dominating in multidrug and quinolone resistant isolates; 
3
a selection of genes was 
screened by PCR for presence in further 52 Salmonella isolates, a plus indicates if the results of this screening is 
in accordance with the microarray results; 
4
Percentage of resistant isolates that contain the gene; 
5
Percentage of 
sensitive strains that carry the gene; grey highlighted numbers indicate if a gene dominates in multidrug and 
































AF261825_S004 putative regulator protein 2 1 1 67 0 2 33 0
AF261825_S006 putative regulator protein 2 1 1 67 0 2 33 0 +
AF261825_S012 
(trhH ) putative pilus assembly protein 2 1 1 67 0 2 33 0 +
AF261825_S017 2 1 1 2 67 20 2 33 0
AF261825_S026 putative ATPase 2 1 1 1 67 10 1 17 0
AF261825_S037 
(groEL/intI1 ) GroEL/integrase fusion protein 2 2 1 1 83 10 2 1 50 0
SDT3829 homologous to AF261825_S004 2 1 1 2 67 20 1 1 17 14
SDT3832 homologous to AF261825_S008 2 1 1 67 0 2 33 0 +
SDT3844 homologous to AF261825_S023 2 1 1 1 67 10 0 0
SDT3847 homologous to AF261825_S026 2 1 2 83 0 0 0
SDT3848 (tnpR ) resolvase (homologous to AF261825_S027) 2 1 1 2 67 20 0 0
SDT3850
aadA2 and partially int (homologous to 
AF261825_S028 and AF261825_S029) 2 1 1 67 0 1 1 33 0
HCM1.167 (int ) probable integrase 2 2 1 83 0 2 1 50 0 +
HCM1.217 pseudogene, 68% identity to IS26 transposase 2 33 0 0 0
SDT0325 probable integrase 2 2 2 3 100 30 1 17 0 +
SDT0330 Abc2 protein 2 1 2 2 83 20 1 2 17 29
SDT0332C bacteriophage protein 17 2 1 1 1 67 10 0 0
SDT0341 2 1 2 1 83 10 1 0 14
SDT0343 antiterminator protein 2 2 1 2 83 20 0 0
SDT0356 probable DNA transfer protein 2 2 1 2 83 20 1 0 14
SDT0358 2 1 2 2 83 20 1 17 0
SDT0359 DNA transfer protein 2 1 1 2 67 20 1 17 0
SDT1852
1
putative DT104 specific prophage gene 2 1 50 0 2 33 0 +
SDT1857
1
hypothetical phage protein gp12 2 1 1 1 67 10 1 0 14
SDT2013 phage tail-like protein 2 1 2 9 83 90 4 1 67 14 +
SDT2672 putative phage-encoded DNA methylase 2 1 2 1 83 10 1 0 14
SEN1132 excisionase (probably phage encoded) 2 33 0 1 17 0 +
SEN1952 phage protein 5 0 50 1 1 1 50 0 +
SG1183 (recT ) recombination and repair protein 2 1 1 67 0 2 33 0 +
SEN1935 2 1 2 3 83 30 1 0 14
SL1943 2 1 2 3 83 30 1 0 14
SL1944 2 1 2 3 83 30 1 0 14
STM2590 tail assembly protein I-like 2 2 2 9 100 90 4 2 67 29
STM2592 phage tail component L-like protein 2 2 2 9 100 90 4 1 67 14
STM2599 (gipA ) putative virulence protein 1 1 9 33 90 3 50 0 +
STM2601 minor capsid protein FII 2 2 2 9 100 90 4 1 67 14
STM2603 phage head-like protein 2 2 2 9 100 90 4 1 67 14 variable
STM2604 phage head-like protein 2 2 2 9 100 90 4 1 67 14
STM2605 head-tail preconnector-like protein 2 2 2 9 100 90 4 1 67 14
STM2606 head-tail preconnector-like protein 2 2 2 9 100 90 4 1 67 14
STM2608 terminase-like large protein 2 2 2 9 100 90 4 1 67 14
STM2617 antiterminator-like protein 1 1 10 33 100 3 50 0
STY4657 (insB ) insertion element IS1 protein InsB 1 2 50 0 0 0 +
STM3753 (sugR )
ATP binding protein, variable region of SPI-3 
(98, 99) 1 2 1 67 0 1 0 14 +
STY0166 (ppdD )
major pilin subunit, inducer of IL-8 and TNF-
alpha release in EHEC O157:H7 (97) 2 1 1 3 67 30 3 4 50 57
STY0594 (fimH )
FimH protein precursor, contributes to adhesion 
and invasion (100) 1 2 50 0 2 0 29 ubiquitious
STY2627a 
(gtrA2 )
bactoprenol-linked glucose transferase (O-




acetylglucosaminetransferase 2 1 1 1 67 10 1 3 17 43
STM0855 electron transfer protein beta subunit 1 2 1 1 67 10 1 0 14
STY0043 possible sulfatase regulatory protein 2 1 33 10 1 3 17 43
STY0184 (ygbK )
homologous to 2-keto-3-deoxygluconate 
permease 1 2 1 3 67 30 1 4 17 57
STY1582 (asr ) acid shock protein 1 3 17 30 4 1 2 83 29
STY0439 (malZ ) maltodextrin glucosidase 1 1 2 33 20 3 1 1 83 0 almost ubiquitious
STY0561 (ybbB ) tRNA 2-selenouridine synthase 1 2 2 3 83 30 1 1 6 33 86
STY2115 (cutC ) putative copper homeostasis protein 2 1 1 2 67 20 2 1 5 50 71
STY2231 (cbiJ ) precorrin-6x reductase (pseudogene) 1 1 1 33 10 4 1 1 2 100 29 ubiquitious
STY2249 (pduH ) involved in 1,2-propanediol degradation 0 0 3 50 0 almost ubiquitious
STY2277 (yeeF ) putative amino acid transporter protein 2 33 0 2 0 29 ubiquitious
STY2555 (nuoE ) NADH dehydrogenase I chain E 1 0 10 4 2 67 29
STY2846 (yfiM ) homologous to alpha-ketoglutarate permease 2 2 2 3 100 30 3 1 7 67 100
STY3210 (gcvH ) glycine cleavage system H protein 2 3 33 30 1 17 0
STY3556 (yhdH ) possible oxidoreductase 2 1 3 50 30 2 1 1 3 67 43
STY3732 (rpoB ) DNA-directed RNA polymerase, beta-subunit 2 2 2 3 100 30 3 1 7 67 100
STY4364 (rpsC ) 30S ribosomal subunit protein S3 1 2 1 3 67 30 1 5 17 71
SDT1841
1
2 1 2 83 0 0 0
SEN1389 2 1 1 1 67 10 2 33 0
STY0352 1 2 1 1 67 10 1 4 17 57
STY0357 (yafK ) 2 2 33 20 4 1 2 83 29
STY0579 1 2 2 50 20 1 5 17 71
STY1759 2 1 3 50 30 4 1 4 83 57
STY2208 1 1 3 33 30 3 50 0 ubiquitious
STY4411 2 1 1 50 10 5 0 71
STY4728a pseudogene 1 2 1 3 67 30 2 1 1 6 67 86
STY4783 2 1 1 3 67 30 3 1 67 0 almost ubiquitious

































Genes with other function
147 
 
Table 4: The relative distribution of phage genes (in percent) in the Salmonella isolates com-










2 DT104 MR 55
7 U288 S 54
28 DT104 Q(MR) 52
45 DT170 R 49
23 DT12 S 49
17 DT104 R 48
1 DT104 Q(MR) 48
4 DT12 S 47
29 DT12 S 45
32 DT170 S 45
33 DT12 S 44
5 DT135 S 43
16 DT12 S 42
6 U292 S 42
31 DT120 MR 33
3 DT120 S 29
44 Newport Q 48
43 Virchow Q 46
26 Derby S 37
38 Virchow Q(MR) 37
34 Saintpaul Q 35
40 Newport S 34
42 Virchow S 30
13 Derby S 26
39 Newport S 24
15 Derby R 21
27 Saintpaul S 21
41 Saintpaul MR 20










Figure 3: Sequence similarities of the genes that were dominant in quinolone and multidrug resistant field iso-
lates (vertical axis) in sequenced Salmonella genomes (horizontal axis). Genes that were ubiquitous in all se-
quenced genomes are not shown. Sequence similarity is indicated by shading from dark (100% sequence identity) 
























































Table 5: Percentages of selected genes in Salmonella field isolates (n=81) categorized after 
their resistance pattern determined by PCR and DNA microarray 
 
 
*Significant difference compared to sensitive isolates (P < 0.05) 
 
 
Figure 4: Phagocytosed (intracellular) bacteria at 2 h post infection (A) and subsequent increase of the intracel-
lular counts (CFU/well) (B) at 4 h (white columns) and 24 h (black columns) post infection of the wildtype 
strains 109 (S. Typhimurium DT104) and three isogenic mutants in the macrophage cell line RAW264.7; Error 
bars represent standard errors of the mean (SEM) of three independent experiments  
Gene (synonym) Q (n=12) MR (n=4) R (n=5) S (n=14) Q (n=4) MR (n=7) R (n=8) S (n=27)
AF261825_S012 (trhH ) 42* 25* 0 0 100* 43 25 4
SEN1132 8 25* 0 0 100* 29 13 7
STY4657 (insB ) 8 25 0 7 25* 57* 25 4
HCM1.167 (int ) 58* 50* 0 0 100* 71* 25 4
AF261825_S006 17* 0 0 0 100* 43* 25* 0
SG1183 (recT ) 17 25 20 7 100* 43 25 7
SDT3832 17* 0 0 0 100* 43 13 4
SEN1952 8 50* 40* 0 0 29 25 26
SDT1852 8 0 20 7 100* 14 13 7
STM3753 (sugR ) 25 50 20 14 75 100 88 63
STM2599 (gipA ) 50* 0 0 7 0 57 75 89
SDT0325 8 0 0 0 100* 86 88 44
SDT2013 33 25 20 14 100 71 100 81
STY4609 (sopE ) 75* 50 0 36 0 0 0 4






Figure 5: Spontaneous mutation frequencies of the wildtype strains 109 (S. Typhimurium DT104) and three 
isogenic mutants determined on 100 µg/ml  rifampicin; Error bars represent standard errors of the mean (SEM) 
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Quinolone resistant Salmonella are reported to cause more severe humans illness compared to 
sensitive ones but the underlying bacterial and host factors are largely unknown. Mechanisms 
that lead to the evolution of more virulent and quinolone resistant Salmonella are also not 
clear. Quinolone resistance is mostly caused by point mutations and can develop in 
Salmonella during infection. We assessed the capability of ciprofloxacin (CIP) resistant 
Salmonella to adhere and invade intestinal epithelial cells and to survive in macrophages in 
absence and presence of CIP using cell culture models (the epithelial cell line Int407 and the 
macrophage cell line RAW264.7). We determined spontaneous mutations frequencies of 
ciprofloxacin (CIP) resistant and susceptible Salmonella under non-selective conditions. 
Moreover, we analyzed the frequency at which CIP sensitive Salmonella isolates can acquire 
a reduced CIP susceptibility after macrophage infection in presence and absence of CIP. We 
found strain dependent differences in the mutation rate, the ability to invade intestinal 
epithelial cells and to replicate within macrophages but there was no correlation between 
virulence, mutation rate and resistance pattern. The presence of clinically relevant CIP 
concentrations decreased but did not eliminate the number of CIP resistant intraphagocytic 
Salmonella. We observed an increased frequency of cells that could acquire a reduced CIP 
susceptibility (2 – 8 x MIC) after macrophage infection (for 4 h). When CIP was added to the 
extracellular medium, this frequency increased markedly. Thus, more virulent Salmonella 
strains, that are likely to persist in macrophages for prolonged times might become resistant to 














Salmonellosis is a foodborne diarrheal disease that occurs worldwide and that is one of the 
most reported zoonotic infections in the EU (53,62). It is caused by a variety of Salmonella 
enterica ssp. enterica serovars but the incidence rate and the disease outcomes differ among 
Salmonella (34). It has been reported that the severity of disease for humans is increased by 
infection with quinolone resistant Salmonella (13,28,29,32,55). Salmonellosis usually leads to 
a self-limiting gastroenteritis but patients infected with quinolone resistant Salmonella have a 
higher risk for hospitalization, for mortality and for bacteremia and a longer duration of 
diarrhea compared to patients infected with susceptible Salmonella. Moreover, 
fluoroquinolones, frequently used to treat severe cases of salmonellosis, lose their efficacy in 
patients infected with Salmonella that exhibit low level resistance (MIC 0.12 - 1 µg/ml; 
according to Eucast breakpoints) to flouroquinolones which may worsen the disease outcome 
(52).  
Fluoroquinolones are relatively new broad-spectrum antibiotics that began to receive attention 
in the 1980s and are now widely used to treat clinical and veterinary infections (16). Due to 
the increased occurrence of multiple resistant Salmonella, the usage of fluoroquinolones 
provided an effective alternative when antimicrobial therapy was required. In 2010, they 
belonged to the four most used therapeutic groups for humans in Denmark of which 
ciprofloxacin (CIP) was used most commonly (6). Flouroquinolones target the type II 
topoisomerase enzymes, DNA gyrase and topoisomerase IV, leading to a DNA replication 
arrest and double stranded DNA breaks (31,35). Quinolone resistance in Salmonella is most 
often conferred by point mutations that result in an aminoacid change of the DNA gyrase 
subunit GyrA. A single point mutation within this gene can mediate resistance to nalidixic 
acid and low level resistance to fluorquinolones (46). Mutations in the subunit GyrB of the 
DNA gyrase occur less frequently and mutations in parE and parC of the topoisomerase IV 
are rare and only found in addition to point mutations in gyrA. They might play a minor role 
in the acquisition of high level resistance (31). Furthermore, resistance often involves a 
decreased expression of outer membrane porins and/or an increased production of efflux 
proteins, mainly of the AcrAB-TolC efflux pump. Resistance can be acquired through point 
mutations in regulatory genes of this efflux system resulting in its overexpression (36,48,63). 
Plasmid mediated quinolone resistance also occurs and is increasingly reported (59). A 
combination of these resistance mechanisms may enhance the tolerance towards 
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fluorquinolones. It has been suggested that quinolone resistance can be transferred from food 
animals to humans (2) but it can also emerge from mutations in susceptible strains within a 
patient during the course of treatment (37,40,45). It has been shown that weak mutators 
(bacteria with higher constitutively expressed mutation rates) can drive the evolution of 
fluoroquinolone resistance (44) and indeed, quinolone resistant Escherichia coli and 
Salmonella are observed to exhibit slightly elevated spontaneous mutation rates under non-
selective static laboratory conditions (38,39). Quinolones have been shown to accumulate in 
phagocytes by passive and active transport mechanisms. The intracellular upconcentration of 
CIP corresponds to approx. 4 - 10 times the extracellular concentration (9,10,25,57). The 
frequency at which susceptible Salmonella can become resistant or can reduce their MIC to 
fluoroquinolones in particular host environments, e.g. within phagocytic cells, where the 
bacteria are under strong selective pressure has not been investigated so far.  
The aim of this study was to indirectly estimate the virulence potential of quinolone resistant 
Salmonella compared to susceptible ones using cell culture models of epithelial cells and 
macrophages. We studied macrophages infection of low-level CIP resistant Salmonella in 
presence of CIP to investigate if the antibiotic has an effect on survival and growth of the 
intracellular bacteria. Furthermore, we were interested in the impact of mutation rates and on 
the evolution of quinolone resistance. Thus, we investigated the spontaneous mutation 
frequency to rifampincin of quinolone resistant Salmonella under static non-selective 
condition and the CIP mutation frequency of CIP susceptible Salmonella after different 
pretreatments.  
 
Materials and Methods 
 
Bacterial strains and growth conditions. This study included 48 field isolates of Salmonella 
enterica spp. enterica, representing different sero- and phagetypes originating from sporadic 
or outbreak cases from humans, from  production animals as well as from meat (Table 1). 21 
isolates were quinolone resistant of which at least 17 isolates exhibited low-level 
ciprofloxacin (CIP) resistance (MIC 0.12 - 1 µg/ml; according to Eucast breakpoints). The 
remaining non-quinolone resistant isolates were characterized as multidrug resistant (MR, 
resistant to four or more antibiotic agents), resistant (R, resistant to less than four antibiotic 
agents) and fully susceptible to the tested antibiotics (S). As S. Typhimurium has been the 
dominant serovar in humans in Denmark since 2008 (3-5), we included 14 S. Typhimurium 
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isolates belonging to different phagetypes. The animal and food isolates were obtained from 
the Danish National Food Institute and the human isolates from the Statens Serum Institute. 
Table 1 gives an overview of the isolates and the experiments where they were used. In he 
study where we investigated quinolone adaptation within macrophages, we included the 
mutant ΔrecT::kmR, a field isolate of Salmonella Typhimurium DT104 (no. 109) with a gene 
deletion in recT (SG1183) (unpublished manuscript) For the adhesion/invasion study, we used 
the control strains S. Typhimurium 4/74 and the isogenic mutant invH201::TnphoA (61). To 
investigate spontaneous mutation frequencies, we included Escherichia coli (E. coli) ATCC 
25922 and E. coli CSH 115, a hypermutator strain with a mutation in mutS (42), as control 
strains. Overnight cultures were obtained by growing a colony from sheep or calf blood agar 
in 10 ml LB or BHI broth for 16-20 h at 37 °C. For bacterial enumeration, colony counts were 
determined by plating 3 times 10 µl droplets on LB or BHI agar.  
Cell cultures. The Int407 human epithelial cell line (ATCC CCL-6
TM
) was obtained from the 
Danish National Veterinary Institute (Lindholm) and the RAW264.7 murine macrophage-like 
cell line (ATCC TIB-71
TM
) were provided by the Danish National Food Institute. The cells 
were cultured at 37 °C in an atmosphere of 95% O2 and 5% CO2. Int407 cells were 
maintained in modified Eagle’s minimal essential medium (MEM; ATCC) supplemented with 
10% fetal bovine serum (FBS; ATCC) and 0.1 % penicillin/streptomycin (Gibco). RAW264.7 
were cultured in Dulbecco’s modified eagles medium (DMEM; Invitrogen) supplemented 
with 10 % FBS (Hyclone; Thermo Scientific) and 0.1 % HEPES buffer (1 M; Gibco), 0.1 % 
sodium pyruvate (100 mM; Gibco) and 0.1 % penicillin/streptomycin. One day prior to 
bacterial infection the cells were grown without antibiotics. During bacterial infection, the 
RAW264.7 cells were grown without FBS. 
Antimicrobial susceptibility testing. The minimum inhibitory concentrations (MIC) for 
fifteen antimicrobial agents were determined using commercially dehydrated antimicrobial 
agents in microtitre wells (SensititreTM; TREK Diagnostic Systems Ltd., UK) as part of the 
Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (8). 
Additionally, the resistance to rifampicin (RIF) and CIP was determined using the agar gel 
dilution technique following CLSI guidelines (7). 
Growth curves. For the macrophage survival study, we incubated the infected cell culture for 
24 hours, a time sufficient for the bacteria to replicate. Growth curves in culture medium were 
established prior to the macrophage experiment to analyze for changes in thegrowth 
capability. An overnight culture was diluted 1000 times in LB broth or DMEM supplemented 
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with 0.1 % HEPES buffer, 0.1 % sodium pyruvate. The cultures were grown without shaking 
at 37 °C in a Bioscreen C reader (Thermo Labsystems) for 8 h (measurement intervals: 10 
min; OD: 600 nm). Growth was measured in triplicates. 
Adhesion and invasion of epithelial cells. Bacterial adhesion and invasion to Int407 cells 
was determined by a gentamicin protection assay essentially as described previously (107, 
108). The cells were seeded into 12 well culture plates (Costar) at a concentration of 5 x 10
5
 
cells per well and incubated overnight. 1 h prior to inoculation, the monolayers were washed 
twice with MEM and incubated in 1 ml MEM. To obtain exponential cultures of the bacteria, 
overnight cultures were diluted to 10
7
 CFU/ml and incubated for 3 h with aeration (in a 
shaking incubator with loose lids on the culture tubes). Then, the cultures were washed and 
diluted to an OD600 of 0.1 with phosphate buffered saline (PBS). 100 µl were used to infect 
the Int407 using a moi of 20. After incubation for 1 h, the monolayers were washed twice 
with PBS and incubated with 1 ml MEM containing 100 µg/ml gentamicin. Before and 2 h 
after the addition of gentamicin, the cells were washed once with PBS and lysed using 1 ml 
PBS per well containing 0,1% Triton X-100 (Sigma). For direct counts, appropriate dilutions 
of the lysates were plated on LB agar to determine the number of adherent (before gentamicin 
treatment) and intracellular (after gentamicin treatment) bacteria. Triplicate experiments were 
performed. 
Survival within macrophages in presence and absence of ciprofloxacin. Survival and 
growth of Salmonella in macrophages was carried out essential as described by Humphreys et 
al. (33). RAW264.7 cells were seeded into 12 well tissue culture plates (Costar) at a 
concentration of 5 x 10
5
 cells per well. After overnight incubation, the cells were washed once 
with PBS and incubated for 1 h in DMEM before bacterial inoculation. Bacteria of an 
overnight culture were washed and diluted to an OD600 of 0.1 with PBS containing 10% heat 
inactivated mouse serum and opsonized for 30 min at 37 °C. 100 µl of this cell suspension 
were used to infect the RAW264.7 cells using a moi of 20.  The cells were centrifuged (1000 
g, 5 min) to synchronize the infection and incubated for 1 h. Then, the monolayers were 
washed once with PBS and overlaid with 1 ml DMEM containing 100 µg/ml gentamicin. 
After an additional hour, the washing step was repeated and the cells were incubated with 1 
ml DMEM containing 10 µg/ml gentamicin. 2, 4 and 24 hours post infection, the cells were 
washed as described above and lysed using 1 ml PBS per well containing 0,1% Triton X-100 
(Sigma). To determine the number of intracellular bacteria, direct colony counts of the lysates 
were made as described above. When indicated, CIP was added to the cell culture medium at 
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1 h prior or 1 h post infection. Once CIP was added, the concentration (0.25 or 5 µg/ml) was 
continuously kept at the same level until the end of the experimental period. Viability of 
macrophages was determined microscopically using 100 µl/ml Trypan blue (Invitrogen) to 
stain the dead cells. Triplicate experiments were performed but viability of macrophages and 
survival in presence of CIP was determined twice. 
Spontaneous mutation frequency. For this experiment, 38 Salmonella isolates were chosen. 
The 20 fluoroquinolone resistant isolates corresponded largely to the fluoroquinolone 
susceptible isolates with respect to the serovar, phagetype and the resistance pattern to other 
antimicrobials. A proportion of an overnight culture was transferred to fresh BHI medium to 
obtain a 1000 fold dilution. An equal amount of the overnight culture was plated on selective 
BHI agar containing 100 µg/ml rifampicin in order to confirm that no pre-existing mutants 
were present. The prepared culture was incubated at 37 °C with shaking until OD600 of 2 was 
reached. 10 ml were centrifuged (6000 g, 10 min), resuspended in 100 µl BHI and the entire 
volume was plated evenly on BHI agar containing 100 µg/ml rifampicin. In the same time, 
appropriate dilutions were plated on non-selective BHI agar to obtain total counts. The 
mutation frequency was calculated by dividing the number of spontaneous rif
R
 mutants by the 
total counts. Triplicate experiments were performed.  
Mutation frequency after macrophage infection and treatment with ciprofloxacin. 
Infection and incubation of macrophages with quinolone sensitive Salmonella was carried out 
as described above. In parallel, macrophage-free culture medium (DMEM containing 0.1 % 
HEPES buffer and 0.1 % sodium pyruvate) was inoculated with 10
6
 CFU/ml of the bacterial 
inocula which corresponds to the number of intracellular bacteria after phagocytosis (Figure 
1). At 1 h post infection, CIP in a concentration corresponding to 2 or 20 times the MIC of the 
respective strain was added to the macrophage containing culture medium. At the same time, 
CIP in a concentration of 0.5 times the MIC was added to the macrophage-free culture 
medium. A control without antibiotics was included in both assays. At 4 h post infection, the 
cells were washed once with PBS and lysed using 1 ml PBS containing 0.1% Triton X-100 
per well. The lysates and the samples containing the macrophage-free culture medium were 
diluted 1:10 with LB and incubated at 37 °C for 16 h to an approximate OD600 of 1. Then, 100 
µl of the culture were plated evenly on LB agar containing CIP corresponding to 2 (0.032 
µg/ml for strain no. 109 and 101), 4 (0.032 µg/ml for strain no. 2 and SH-9.2) or 8 (0.064 
µg/ml for strain no. 2 and SH-9.2 or 0.128 µg/ml for strain no. 101 and 109) times the MIC of 
the respective strain. In the same time, appropriate dilutions were plated on non-selective LB 
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agar to obtain total counts. The mutation frequencies after the different pretreatments were 
calculated by dividing the number of colonies from the selective agar plates by the total 
counts. Triplicate experiments were performed.  
Statistics. Colony counts were log transformed where appropriate and standard deviations 
and standard errors of the mean were calculated. Statistical significances of differences were 
calculated with one-way analysis of variance (ANOVA) followed by Turkey’s multiple 




In vitro adhesion and invasion of intestinal epithelial cells. To indirectly investigate the 
virulence potential of quinolone resistant Salmonella isolates compared to strains that are 
sensitive or have another resistance pattern cell culture models were used. The number of 
bacteria capable of adhering to intestinal epithelial cells until 1 h post infection was very 
similar among all field isolates studied (Figure 2). On average, adhesion was achieved by 5.29 
log CFU/well of quinolone resistant isolates, 5.24 log CFU/well of isolates with another 
resistance pattern and 5.29 CFU/well of sensitive isolates. The ability to invade was more 
diverse and varied even within isolates of the same serovar and phagetype. Sensitive S. Derby 
(no. 13), multidrug resistant S. Tyhimurium DT104 (no.2) and quinolone and multidrug 
resistant S. Saintpaul (no. 34 and 41) showed reduced invasiveness. The intracellular counts 
from the latter three isolates were significantly lower compared to all the other isolates 
whereas the counts of S. Derby no. 13 were only significantly lower than 5 of the other 
isolates, including S. Derby no. 26 (P < 0.05). Only one isolate of sensitive S. Staintpaul (no. 
27) had higher intracellular counts than the reference strain S. Tyhimurium 4/74 but this was 
not significant (P = 0.65). No correlation between the capacity to adhere or invade and the 
resistance pattern could be observed. The validity of  the epithelial cell culture model was 
verified by showing a decrease of 0.66 log CFU/well (SEM 0.12) for adhesion and 0.88 log 
CFU/well (SEM 0.04) for invasion of the control mutant ΔinvH201::TnphoA (61) compared 
to its wildtype strain S. Typhimurium 4/74. 
Survival and growth in macrophages in absence of quinolones. The direct counts of the 
inocula used to infect macrophages were slightly more variable probably due to the 30 min 
opsonization period directly before inoculation. Thus, to standardize the inocula, a correction 
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factor was calculated by subtracting the counts from the inocula by 10
7
 CFU/well (the ideal 
inoculum). The number of phagocytosed bacteria was determined by subtracting this 
correction factor from the direct counts of intracellular bacteria determined at 2 h post 
infection. At that time, an average of 6.2 log CFU/well were taken up by the macrophages 
corresponding to approx. 1.1 bacteria per macrophage which was similar for all isolates. 
Figure 4 shows the percent change of the intracellular counts after 4 and 24 h post infection 
compared to 2 h post infection. The number of intracellular bacteria increased slightly over 
time of the experimental period, except for multidrug resistant S. Infantis (no. 97) that showed 
a decrease of 0.43 log CFU/well after 24 h compared to 2 h post infection. Except for this S. 
Infantis isolate and multidrug resistant S. Typhimurium DT104 (isolate no. 2), growth in 
culture medium (LB and DMEM) was equal for all bacteria. The area under the growth curves 
was 1.3 times smaller for these two isolates than the average. A trend that quinolone resistance 
has an impact on invasion and proliferation within macrophages could not be observed, 
except for a small tendency at 4 h post infection where the intracellular counts of the 
quinolone resistant isolates showed an average increase of 0.23 log CFU/well compared to 
0.11 log CFU/well for the other bacteria. This was however not significant (P < 0.30). The 
cytotoxic effect of the bacteria on the macrophages was determined by microscopic counts of 
viable and dead macrophages (Figure A1 in the Appendix). The average number of viable 
macrophages ranged from 65% (SD: 10%) at 2 h post infection, 60 % (SD: 8%) at 4 h post 
infection to 38 % (SD: 17%) at 24 h post infection compared to the non-infected control were 
75 % (SD: 3%) of the macrophages were viable during the whole time period. The percentage 
of viable macrophages varied among the isolates but did not seem to correlate well with the 
intracellular counts or with the resistance pattern of the bacteria. 
Macrophage survival in presence of ciprofloxacin. To investigate, if the presence of 
quinolones has an effect on macrophage survival of Salmonella with low level resistance to 
fluoroquinolones, we analyzed the survival of S. Typhimurium DT104 (no. 28) within 
macrophages in presence of CIP at a concentration of 1 x (0.25 µg/ml) or 20 x (5 µg/ml) the 
MIC. The latter concentration was chosen as it resembles a therapeutic concentration in 
humans (41). CIP was added 1 h prior or 1 hour after infection. At 2 and 4 h post infection, an 
effect could only be observed were 5 µg/ml CIP were added 1 h prior to infection (Figure 4), 
resulting in a reduction of 0.87 and 1.34 log CFU/well respectively compared to the control 
without CIP. After 24 h post infection a clear influence of the antibiotic could be seen in all 
samples that have been incubated in presence of CIP. At that time, a reduction of the 
intracellular bacteria of approx. 1.32 log CFU/well and 2.48 log CFU/ml was observed for the 
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low CIP concentration (0.25 µg/ml) and the high CIP concentration (5 µg/ml), respectively, 
compared to the control. Overall, CIP reduced but did not eliminate the amount of 
intracellular bacteria in low and high concentration. 
Spontaneous mutation frequency. As rifampicin resistance is conferred by single point 
mutations in rpoB, it is a good indicator for determining spontaneous mutation rates in 
bacteria (213). The initial MICs to rifampicin of all isolates were similar and ranged from 8 to 
16 µg/ml. The mutation frequencies to 100 µg/ml rif of the quinolone resistant and susceptible 
Salmonella isolates are shown in Figure 5. Surprisingly, the three human isolates of S. Infantis 
exhibited an elevated mutation frequency that was approx. 6.2 fold higher than the average 
and significantly different from most of the other isolates for 134 and 132 (P < 0.05). The 
average mutation frequency from all quinolone resistant isolates was 3.7 x 10
-09
 and could not 
be distinguished from susceptible isolates or isolates with another resistance pattern regardless 
if the mutation frequencies of S. Infantis were included or excluded from the average. The 
spontaneous mutation frequency for human isolates (n=28) including S. Infantis was 1.9 times 
higher than for food isolates (n=4). Excluding S. Infantis, the human isolates showed only a 
1.2-fold higher mutation frequency than the food isolates. We verified the method by showing 
that the hypermutator control strain E. coli CSH115 had an approx. 100 fold increased 
mutation frequency compared to E. coli ATCC 25922. 
Mutation frequency after macrophage infection and ciprofloxacin treatment. Whether 
macrophage infection and the subsequent exposure to quinolones has an influence on the CIP 
mutation frequency of quinolone (CIP and nalidixic acid) sensitive bacteria was determined 
by adding CIP in different concentrations to the extracellular medium at 1 h post infection. 
For comparison, the effect of direct exposure to a subinhibitory concentration of CIP on the 
mutation frequency of these bacteria was determined. The phagocytic cell lysates were 
transferred to LB medium and grown for 16 h where the total counts amounted to approx. 10
9
 
CFU/ml. This corresponds to approx. 11 generations considering that the macrophage lysates 
contained approx. 10
6
 CFU/ml of bacteria cells. The cells that experienced a reduction in their 
susceptibility to CIP might have had a longer generation time than the other cells. As we do 
not know the precise length of this generation time, we could not calculate the original 
amount of CIP adapted cells within the macrophages at 4 h post infection However, we used 
the non-pretreated control culture as a baseline (Table 2) and subtracted the baseline 
frequencies from the mutation frequencies that resulted from the indicated treatment (Figure 
6). The CIP MICs prior to infection were 0.008 µg/ml for the strain no. 2 and 0.016 µg/ml for 
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the strain no. 109, 101 and 109 ΔrecT::kmR. The latter strain was a mutant included to analyze 
the influence of recT on the intracellular emergence of mutations. Overall, growth was only 
observed on selective media containing CIP in concentrations of 0.032 (all strains) and 0.064 
µg/ml (only strain 2). If not otherwise indicated, reduced CIP susceptibility stands for growth 
on 0.032 µg/ml CIP. The frequency of cells with reduced CIP susceptibility was highest for 
multidrug resistant isolate no. 2 under all investigated conditions. In the control cultures 
pretreated only with culture medium, the frequency was approx. 6.5-fold higher for strain no. 
2 than for the other strains (no. 109 and 101) (Table 2). The direct exposure to subinhibitory 
concentrations of CIP (0.5 x the MIC) generated the highest mutation frequencies (except for 
strain 101). Within macrophages, the frequency of reduced CIP susceptibility was generally 
low in absence of CIP (except for no. 109) and in presence of low concentrations of CIP (2 x 
MIC) but it was higher than in the control culture without any pre-treatment (except for strain 
no. 2). The infection of macrophages and the subsequent exposure to high concentration of 
CIP (20 x MIC) resulted on average in a 3-fold higher mutation frequency than when only 
low concentrations of CIP were added.  Similar results could be obtained for colonies of strain 
no. 2 selected on 0.064 µg/ml CIP (Figure 6). Interestingly, compared to its wildtype, the 
mutant ΔrecT::kmR showed increased frequencies of CFUs with reduced CIP susceptibility 
only when pre-treated with CIP. The mutant showed a 2.7-fold higher mutation frequency 
after infection of macrophages and subsequent CIP exposure (0.32 µg/ml) and a 2.3-fold 
elevated frequency when directly exposed to sub-inhibitory concentration of CIP. These 




It has been suggested that the acquisition of antibiotic resistance, particularly quinolone 
resistance, is associated with an increase in virulence and/or fitness of the pathogen (29) but 
the underlying bacterial and host factors are largely unknown. Mechanisms that lead to the 
evolution of more virulent and quinolone resistant Salmonella are also not clear. Using cell 
cultures, we assessed the capability of ciprofloxacin (CIP) resistant Salmonella to adhere and 
invade intestinal epithelial cells and to survive in macrophages in absence and presence of 
CIP. Furthermore, we determined spontaneous mutation frequencies (to rifampicin) of CIP 
resistant Salmonella under non-selective conditions. Finally, we assessed the frequency at 
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which CIP sensitive Salmonella isolates can acquire a reduced CIP susceptibility after 
different pretreatment (macrophage infection and CIP exposure). 
Quinolone resistant Salmonella did not show an increased invasion or adhesion capability to 
epithelial cells compared to Salmonella being susceptible or resistant to other antibiotics. 
Interestingly, considerable differences could be detected within isolates of serovar S. Derby 
and S. Saintpaul and among isolates of the S. Typhimurium phagetype DT104. Even though 
these bacteria adhered equally well to the epithelia cells, they seem to be impaired in their 
ability to trigger SPI-1 (Salmonella pathogenicity island 1) mediated invasion of host cells 
(21). This supports other studies that have observed that the disease outcome of non-typhoidal 
Salmonella in humans is divers even within strains of the same serovar and that it does not 
only depend on the host immune system but also on the virulence potential of the bacterial 
strain (20,27,34,65).  
The intracellular counts within macrophages short after phagocytosis (2 h post infection) were 
equal for all the test strains, also for those that appeared to have a low ability to invade 
epithelia cells. Unlike non-phagocytic cells, Salmonella can enter macrophages by SPI-1-
dependend and independent mechanisms (24). At 4 h post infection, intracellular levels of 
Salmonella with low level CIP resistance seemed to have slightly more increased in 
macrophages than CIP sensitive isolates but this was without statistical significance. 
However, At 24 h post infection, a clear difference could be observed for S. Infantis, where 
the CIP resistant isolate (no. 134) showed 1.4 times more intracellular bacteria than the CIP 
susceptible one (no. 97). The latter isolate (no. 97) was also impaired for growth in LB broth 
and might rather lack a general fitness factor than a macrophage survival factor. Growth in 
LB was also reduced for MR S. Typhimurium DT104 (no. 2) but that was not reflected during 
growth in macrophages. A study from Wang et al. (60) showed contradictory results as they 
observed a clear decrease of CIP resistant Salmonella in their ability to invade and grow host 
cells (macrophages and epithelial cells). In this study, they focused on in vitro selected CIP 
resistant strains with high MICs. However, there is evidence that in vitro selected mutants 
have a reduced fitness compared to naturally resistant strains (11,12). In our study, we used 
quinolone resistant field isolates which might explain why we did not observe a fitness loss in 
these isolates.   
The epidemiological evidence of more severe illness in patients infected with quinolone 
resistant Salmonella led us hypothesize that quinolones could also be directly involved in 
pathogenicity, e.g. by inducing virulence factors. Overall, the presence of CIP in low (1 x 
164 
 
MIC; 0.25 µg/ml) and therapeutically relevant concentrations (20 x MIC; 5 µg/ml) (41) 
seemed to have an inhibitory effect on macrophage survival of CIP resistant S. Typhimurium 
DT104 (MIC = 0.25 µg/ml) after 24 h post infection. CIP accumulates mainly in the cytosol 
of the macrophages and reaches only poor concentrations in the organelles such as the 
phagosome (56). During a Salmonella infection the phagosome is modified by the bacteria 
and transformed into the Salmonella containing vacuole (SCV) at approx. 1 h post infection 
(24). The SCV seemed to shield the bacteria from the antibiotic as a reduction could not be 
observed within the first 4 h of infection. Only when 5 µg/ml CIP was added 1 h prior to 
infection a reduced uptake followed by a decrease of the intracellular bacteria already during 
the first 4 h of infection could be demonstrated. The high antibiotic concentration (20 x MIC) 
eliminated a major part of the extracellular bacteria before invasion and presumably caused 
injury to many bacteria that resulted in a reduced ability to survive the macrophage defense. 
The general decrease of S. Typhimurium DT104 observed after 24 h could be the result of 
phagocyte lysis and bacterial release into the extracellular medium leading to the elimination 
by CIP. However, even therapeutic concentrations of CIP failed to eliminate all bacteria as we 
were able to recover 3.84 log CFU/well of intracellular bacteria when CIP was added 1 h 
before infection and 4.38 log CFU/well when CIP was added 1 h after infection. It has been 
shown elsewhere that the addition of a higher CIP concentration (20 µg/ml) to the 
extracellular medium reduces the number of intracellular Salmonella for 2 log after 1 h of 
incubation (26). In another study, ofloxacin has been shown to be more effective in killing 
intraphagocytic Salmonella in a concentration corresponding to 10 x MIC of the respective 
test strains (14). After 8 h post infection the intracellular bacteria were completely eliminated. 
Interestingly, it has been observed for Staphylococcus aureus and E. coli that quinolones 
trigger the expression of phage encoded virulence factors (30,47). From the results of our 
study, we cannot conclude that virulence in Salmonella is altered in presence of quinolones. 
Low and high level resistance to fluoroquinolones is most often caused by point mutations 
(29) implicating that the evolution of quinolone resistance may be driven by an increased 
bacterial mutation rate. In our study, the spontaneous mutation frequencies did not correlate 
with the resistance pattern of the Salmonella isolates. This is in contrast to other studies were 
elevated spontaneous mutation frequencies have been observed for quinolone resistant 
Salmonella and E. coli (1,39). However, in the study of Allen and Poppe (1), the control 
group of susceptible Salmonella isolates was very small. In our experiment, the control group 
and the test group of quinolone resistant isolates were equal in size and comparable, at large. 
Our results suggest that in a static environment and absence of any selective pressure, 
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quinolone resistant Salmonella do not seem to mutate more often than sensitive ones. Even 
though constitutive mutator phenotypes have been reported to have a selective advantage 
during infection in mice and subsequent antimicrobial treatment (23), they also quickly 
acquire mutations that are not beneficial (22). In contrast, we observed that human isolates 
exhibited slightly higher spontaneous mutation frequencies than food isolates pointing out that 
the level of mutation frequency may differ depending on the circumstances. The successful 
pathogen might possess a temporary elevated mutation rate that is restricted to the 
environments where genetic variations are needed in order to survive, such as during infection 
(38). 
Quinolone resistance in Salmonella has shown to evolve in vivo and in several cases were this 
has been reported, the original susceptible bacteria were related to severe illness (mild 
gastroenteritis are rarely treated with antibiotics) (37). This could suggest that more virulent 
Salmonella are more likely to become quinolone resistant as they are more likely to come in 
contact with the antibiotic during infection. Invasive strains are suggested to persist within 
macrophages (15) which are known to induce mutations in intracellular bacteria (50) and to 
accumulate fluoroquinolones (56). Thus, we were interested in the impact of macrophages in 
presence and absence of CIP on the frequency of quinolone susceptible isolates to acquire CIP 
resistance (or a reduced susceptibility to CIP). We could show that this frequency was 
increased for most strains after infection of macrophages for 4 h followed by subculturing in 
non-selective LB medium. All investigated Salmonella strains could grow on a CIP 
concentration of at least 2 x their MIC. Strain no. 2 could also grow on a concentration 
corresponding to 8 x its MIC. The molecular mechanisms leading to this MIC shift have not 
been investigated but it is probably the consequence of point mutations as mechanisms 
associated with gene regulation are unlikely to persist after growth in non-selective LB 
medium. In Salmonella, point mutations in gyrA are thought to cause a minimal MIC of 0.12 
µg/ml but point mutations at an MIC of 0.064 have been reported (49). When CIP was added 
to the extracellular medium, the final vacuolar CIP concentration in the macrophage was 
unknown. However, it seemed to have an effect on the bacteria as the addition of high CIP 
concentrations (corresponding to 20 x MIC) at 1 h post infection increased markedly the 
frequency of intracellular bacteria with reduced CIP susceptibilities. Lysis of the phagocytes 
and the release of the bacteria into the extracellular medium until 4 hours post infection are 
unlikely. Thus the CIP mutations were presumably generated within the macrophages. This is 
presumably the result of the bacterial SOS response which is activated inside macrophages 
and in presence of quinolones and which protects the bacteria from lethal DNA damages on 
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the expenses of a transient elevated mutation rate (17,58,64). It is possible that the observed 
reduction in the CIP susceptibility predisposes the bacteria to become resistant to higher 
concentration when survival in macrophages is prolonged. In contrast to the intracellular 
bacteria, were growth was expected to be comparably weak, the bacteria exposed directly to 
subinhibitory concentrations of CIP for 3 h were able to proliferate indicating that mutation 
frequencies in replicating populations are higher.  
RecT (SG1183) is encoded within a phage operon including the gene for the exoribonuclease 
VIII which are both thought to be involved in recombination and repair of DNA (51). In 
presence of CIP, recT seemed to be involved in reducing the emergence of cells with reduced 
CIP susceptibilities. In contrast, recT did not seem to have an effect when CIP was absent 
indicating that it is induced during the quinolone mediated replication arrest. This is backed 
by the findings that bacteriophage genes are induced in presence of quinolones (30,47). The 
results are conflicting with a previous study where recT seemed to be involved in reducing 
mutation rates under non-selective conditions (Manuscript II). In this study recT was more 
frequently found in Salmonella isolates that were resistant to multiple antibiotics and/or 
quinolones. It seems surprising that quinolone resistant strains apparently harbor a gene that 
reduces mutations. However, during a systemic spread, the bacteria may remain for a long 
time within macrophages and might be exposed to prolonged CIP treatment. In these bacteria 
recT might contribute in reducing the number of too many detrimental mutations. Thus, the 
bacteria carrying this gene can survive and profit from non-lethal mutations generated within 
macrophages.  
To conclude, we were not able to show a difference between quinolone resistant and sensitive 
Salmonella in their ability to adhere and invade epithelial cells and to survive and grow in 
macrophages. Thus, cell cultures might not be applicable to indirectly investigate the 
virulence potential of quinolone resistant Salmonella. Alternatively, the invasion of epithelial 
cells and macrophages survival are not important factors for virulence of quinolone resistant 
Salmonella. These bacteria were also not more predisposed to mutate under static non-
selective conditions. However, we observed an increased frequency in the reduction of the 
ciprofloxacin susceptibility after macrophage infection which was enhanced in presence of 
ciprofloxacin. Salmonella that are more invasive may persist within macrophages and have a 
higher chance to encounter ciprofloxacin, frequently used to treat systemic infections. Our 
results suggest that such conditions enhance the adaptation of Salmonella to ciprofloxacin. To 
prevent that more invasive Salmonella develop quinolone resistance during infection, it 
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should be ensured that the antibiotic efficiently eliminates Salmonella in the SCV of 
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Table 1 (next page): Isolates used in the different experiments of this study and their 
categorization based on the resistance pattern  
Antibiotics: cip, ciprofloxacin; str, streptomycin; tet, tetracyclin; nal, nalidixic acid; ffn, florfenicol; sul, 
sulfonamides; neo, neomycin; smx, sulfamethoxacole; amp, ampicillin; chl, chloramphenicol; spe, 
spectinomycin; tmp, trimethoprim; gen, gentamicin; aug2, amoxicillin + clavulanat (2:1), kan, kanamycin. Other 
abbreviations: Sp., spontaneous; adh/inv, adhesion and invasion; MP, macrophage; 
1
The classification of the 
isolates according to the resistance pattern: Q, resistant to at least one fluoroquinolone; MR, resistant to four or 
more antibiotics; R, resistant to less than four antibiotics; S, senstitive. 
2
If nothing is indicated, the MIC has not 
















19. + A plus indicates 







Source Resistance pattern Without cip With cip Ref.
E. coli  ATCC 25922 +
E. coli CSH 115 + 3
26 S. Derby pork S + 4
13 S. Derby human S + 4
119 S. Hadar human R str, tet +
122 S. Hadar human Q cip, nal, str, tet 0.25 +
121 S. Hadar human Q cip, nal, (ffn), str, tet 1 +
120 S. Hadar human R str, tet +
127 S. Infantis pig S +
97 S. Infantis pig MR tet, sul, str, neo, amp + + + +
134 S. Infantis human Q cip, nal 0.25 + + + +
135 S. Infantis human Q
(chl), cip, nal, neo, smx, 
spe, str, tet, tmp 0.25 +
132 S. Infantis human S +
39 S. Newport human S + + 4
35 S. Newport human Q
amp, cip, gen, nal, smx, 
spe, str, tet 0.5 + +
44 S. Newport human Q cip, nal 0.25 + + 4
21 S. Newport pig Q cip +
40 S. Newport human S + 5
117 S. Newport human Q
amp, chl, ffn, nal, cip, neo, 
smx, tet, tmp 0.12 +
114 S. Newport human R smx, str, tet +
118 S. Newport human Q
amp, (aug2), chl, cip, ffn, 
nal, neo, smx, tet, tmp 0.25 +
84 S. Newport pig Q cip +
113 S. Newport human S +
138 S. O:4,12; H:i: - DT120 human           MR amp, smx, str, tet +
137 S. O:4,5,12; H:i:- DT193 human           MR amp, (aug2), smx, str, tet +
136 S. O:4,5,12; H:i:- NT human           Q amp, cip, nal, smx, str, tet 0.12 + +
34 S. Saintpaul human Q cip, nal 0.12 + + + + 5
41 S. Saintpaul human MR
apr, chl, gen, smx, spe,  
tet, (ffn), (str) + + 4
27 S. Saintpaul human S + + + + 4
22 S. Saintpaul cattle Q
amp, gen, nal, spe, str, 
sul, tet, cip 0.25 +
S. Typhimurium 4/74 +
4/74 invH 201::TnphoA + 6
109 S. Typhimurium DT104 human R smx, spe, str 0.016 + + + + + 5
109 ΔrecT ::km
R 
smx, spe, str, kan 0.016 + + 5
101 S. Typhimurium DT104 human S 0.016 +
94 S. Typhimurium DT104 human Q
amp, (aug2), chl, cip, ffn, 
nal, smx, spe, str, tet 0.25 +
2 S. Typhimurium DT104 human MR
amp, chl, mx, str, tet, 
spe, (ffn) 0.008 + + + + + 7, 4
28 S. Typhimurium DT104 human Q
amp, chl, cip, ffn, nal, 
smx, spe, str, tet, (aug2) 0.25 + + + + + 5
1 S. Typhimurium DT104 human Q
nal, amp, chl, str, tet, cip, 
aug2, smx, spe 0.12 + + + + 8, 4
48 S. Typhimurium DT104 pig MR
mp, chlo, flo, spe, str, 
sul, tet +
53 S. Typhimurium DT104 pork Q
amp, chlo, cip, flo, nal, 
spe, str, sul, tet 0.25 +
77 S. Typhimurium DT104 pork R spe, str, sul +
62 S. Typhimurium DT104 pork MR amp, chl, spe, str, sul, tet +
17 S. Typhimurium DT104 pork R spe, str, sul + 4
16 S. Typhimurium DT12 pork S + 4
4 S. Typhimurium DT12 human S + 9
6 S. Typhimurium U292 human S + 10
68 S. Typhimurium U292 pig S +
42 S. Virchow human S + + 4
25 S. Virchow pig Q nal, cip 0.5 + +
43 S. Virchow human Q cip, spe, str 0.5 + 5
86 S. Virchow human Q amp, cip, nal 2 +


















Table 2: Spontaneous frequency of the occurrence of cells with reduced susceptibility to 
ciprofloxacin  
 
DMEM was inoculated with 10
6
 CFU/ml and subsequently incubated at 37 ºC and 5 % CO2. After 4 h, the 
culture was diluted 1:10 in LB and grown at 37 ºC for 16 h. The culture was plated on ciprofloxacin containing 




Figure 1: Experimental workflow. Macrophages (RAW264.7) were infected with bacteria and subsequently 
treated with different concentrations of ciprofloxacin. For comparison, macrophage-free culture medium 
(DMEM) was inoculated with the same bacteria and subsequently incubated with subinhibitory concentrations of 
ciprofloxacin. Both assays included a control without antibiotics. To amplify the bacteria within the 
macrophages and of the macrophage-free medium, the lysates/cultures were transferred to LB and incubated for 










2 210 (161) 17 (11)







107 CFU/ml 106 CFU/ml
Infection/inoculation 
followd by growth at 
37 ºC and 5 % CO2
2 or 20 x the 
MIC
0.5 x the MIC
Macrophage lysis and 
1:10 dilution in LB 
1:10 dilution in 
LB
























Figure 2: The number of cell associated Salmonella in a gentamicin protection assay using the human epithelia 
cell line Int407. Bacteria that adhered to the epithelia cells within 1 h post infection are shown by the black 
columns (log CFU/well). The bacteria that invaded within 3 h post infection are shown by grey columns (log 
CFU/well). Error bars represent standard errors of the mean (SEM) of three independent experiments. The 
classification of the isolates according to the resistance pattern: Q, resistant to at least one fluoroquinolone; MR, 






Figure 3: Percent increase or decrease of the intraphagocytic Salmonella at 4 h (A) and 24 h (B) post infection 
compared to 2 h post infection using the macrophage cell line RAW264.7. Error bars represent standard errors of 
the mean (SEM) of three independent experiments. The classification of the isolates according to the resistance 
pattern: Q, resistant to at least one fluoroquinolone; MR, resistant to four or more antibiotics; R, resistant to less 








Figure 4: Intracellular counts (log CFU/well) of S. Typhimurium DT104 (isolate no. 28) within macrophages 
(RAW264.7) in absence (0xMIC) or presence of ciprofloxacin (CIP) in a concentration of 1xMIC (0.25 µg/ml) 
or 20xMIC (5 µg/ml). CIP was added either at 1 h before or after infection. Error bars represent standard 
deviation (SD) of two independent experiments.  
 
 
Figure 5: Mutation frequencies (small dots) of 38 Salmonella isolates classified after their source (human, 
animal, food) and resistance pattern into Q (resistant to at least one fluoroquinolone), MR  (resistant to four or 
more antibiotics), R (resistant to less than four antibiotics) and S (fully susceptible). The average mutation 
frequency by source or resistance pattern is shown by rectangles including (black rectangles) or excluding (white 


















Figure 6: Frequencies of the occurrence of cells selected on 0.032 (strains no. 109, 101 and 2) and 0.064 (only 
strain no. 2) µg/ml ciprofloxacin (CIP) after different pre-treatments of the cultures (X-axis): after infection of 
macrophages and subsequent incubation with CIP in a concentration corresponding to 20 x, 2 x or 0 x the MIC 
and after incubation in macrophage-free medium (DMEM) in presence of subinhibitory concentrations of CIP 
(0.5 x the MIC). The frequencies after the indicated treatments are subtracted by the frequencies obtained from 
the control cultures pre-treated with DMEM in absence of antibiotics (baseline). For strain no. 109 the 
frequencies of the wildtype (black columns) and the isogenic mutant ΔrecT::kmR (grey columns) are shown. For 
strain no. 2, the frequencies selected on 0.032 (black columns) and on 0.064 µg/ml cip (grey columns) are 





































































2 h post infection
4 h post infection
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Figure A1: The percentage of viable macrophages infected with different Salmonella. Trypan blue 
staining was used to color dead macrophages. The control was inoculated with PBS instead of 
Salmonella. Q, resistant to at least one fluoroquinolone; MR, resistant to four or more antibiotics; R, 
resistant to less than four antibiotics; S, fully susceptible. The isolates investigated include S. 
Typhimurium DT104 (2 x Q, MR, R), S. Saintpaul (S, Q) and S. Infantis (Q); Error bars represent SEM 




Table A1 (next page): Genes dominating in fully susceptible Salmonella isolates determined by 
comparative genomic hybridization  
The numbers of isolates where the respective genes were present determined by array-based genomic 
hybridization are shown; Q, resistant to at least one fluoroquinolone; MR, resistant to four or more antibiotics; 
R, resistant to less than four antibiotics; S, fully susceptible.
 1
The percentage indicates the relative proportion of 
the single genes within the given gene group compared to the total number of genes dominating sensitive 





Gene name Function and other gene Q (n=2) MR (n=2) R (n=2) S (n=10) Q (n=4) MR (n=1) R (n=1) S (n=7)
Mobile genetic elements
PSLT062 0 0 1 8 0 0 0 0
PSLT063 0 0 1 6 0 0 0 0
PSLT068 putative ParB-like nuclease domain 0 0 1 8 0 0 0 0
PSLTtraD conjugative transfer: DNA transport 0 0 1 6 0 0 0 0
SBG0903 hypothetical phage-related protein 0 0 2 8 3 0 0 2
SL1950
bacteriophage terminase (large 
subunit) 0 0 0 8 1 0 0 0
SL2590 phage replication protein P 0 0 1 8 2 0 0 1
SLP2_0032
plasmid encoded putative 
antirestriction protein 0 0 0 6 0 0 0 1
STM0176 (stiB )
fimbrial chaperone, starvation-stress 
protein (101) 0 0 1 7 1 0 0 4
STM2617 antiterminator-like protein 0 1 1 10 3 0 0 0
STY0060 (yaaF )
putative nucleoside hydrolase 
(IUNH family) 0 0 1 9 3 1 1 7
STY0076 (carA )
carbamoyl-phosphate synthase 
small chain 0 0 0 7 3 0 0 5
STY0321 Rhs-family protein 0 1 0 10 1 0 0 2
STY0746 (kdpB )
potassium-transporting ATPase B 
chain 1 0 1 10 4 1 1 6
STY0823 (hutU ) urocanate hydratase 0 0 1 8 2 1 0 5
STY1138 (hpcD )
5-carboxymethyl-2-
hydroxymuconate delta- isomerase 0 0 1 8 4 1 1 6
STY1658 (add ) adenosine deaminase 1 1 1 5 0 0 1 5
STY2378 (stcD ) putative outer membrane lipoprotein 0 0 1 8 2 1 0 3
STY2485 (napA ) probable nitrate reductase 0 0 1 10 3 1 0 7
STY2487 (napF ) ferredoxin-type protein NapF 0 0 1 10 2 1 1 7
STY2492 (yojL ) thiamine biosynthesis protein 0 0 0 6 2 0 1 5
STY2665 (cysZ )
putative sulfate transport protein 
CysZ 0 0 1 6 3 0 0 4
STY2698 (eutG ) putative alcohol dehydrogenase 0 0 1 7 3 1 0 6
STY2771 (ndk ) nucleoside diphosphate kinase 0 0 2 9 3 1 1 6
STY2774
putative anaerobic reductase 
component 0 0 1 8 2 0 0 4
STY4440 (pspG ) phage shock protein G 0 1 0 10 2 0 0 6
STY4451 (ssb ) single-strand DNA-binding protein 0 0 1 6 3 1 1 6
STY4188 (yhjK ) phosphodiesterase 0 0 1 9 2 0 1 7
STY4715 (amiB )
N-acetylmuramoyl-L-alanine 
amidase 0 0 1 7 4 1 1 4
Genes with unknown function:
SG0300 pseudogene 2 2 1 6 0 0 1 6
SG2538 0 0 1 6 1 0 1 4
STM0769 0 0 1 7 3 0 0 6
STY0288 2 2 1 5 0 0 0 5
STY2660 0 0 2 7 4 0 1 6
STY3542 0 0 0 6 2 1 0 4
STY4411 0 2 1 5 0 0 0 5
STY4452 0 0 1 8 3 1 1 6
Genetic 
element
Genes with other function
















Figure A2: Predicted operons of the genes recT (SG1183) in S. Gallinarum 287/91 (NCTC 13346) and sugR 
(STM3753) in S. Typhimurium LT2 (ATCC 700220) using Microbes Online Operon Predictor 
(www.microbesonline.org) and trhH (AF261825_S012) in the Salmonella genomic island 1 (accession no. 
AF261825) as described by Boyd et al. (33). The respective genes are displayed in dark blue, other operon genes 








Figure A3. Effect of freezing (-18°C) on colony counts of Salmonella in minced pork; A: inocula of 10
-6
 
CFU/g; B: inocula of 10
-3
 CFU/g; dashed lines indicate successful Salmonella types (  01 DT104, 
02 DT104,  03 DT120); thin lines represent non-successful Salmonella types (  04 DT12, 
 09 Derby, 10 Infantis); bold lines represent outbreak strains of 2008 (  05 DT135,  
06 U969,  07 U288); Standard deviations based on 2 replicates ranged from 0,23  – 0,51 log CFU/g (not 
shown). 
 
